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ABSTRACT 
Karki, Anju Ph.D., Purdue University, May 2016. Investigating the Role of the Basic 
Helix-Loop-Helix Transcription Factor MIST1 in Pancreatic Diseases Major 
Professor: Stephen F. Konieczny  
 
 
Acinar cells of the exocrine pancreas are dedicated to synthesize, package 
and secrete immense quantities of pro-digestive enzymes to maintain proper 
metabolic homeostasis for the organism. Dysregulation of enzyme secretion in 
acinar cells can give rise to exocrine diseases including acute pancreatitis (AP), a 
disease that targets acinar cells, leading to acinar-ductal metaplasia (ADM), 
inflammation and fibrosis - events that can transition into the earliest stages of 
pancreatic ductal adenocarcinoma (PDAC). The focus of this thesis is to 
interrogate transcriptional regulatory networks that are susceptible to AP and the 
role that these networks play in acinar cell and exocrine pancreas responses. The 
overall goal is to determine the importance of the acinar-specific maturation 
transcription factor MIST1 to AP damage and organ recovery and its role in AP 
induced PDAC upon oncogenic transformation. Analysis of wild-type and Mist1 
conditional null mice revealed that Mist1 gene transcription and protein 
accumulation are dramatically reduced as acinar cells undergo ADM alterations 
during AP episodes. 
xvi 
To test if loss of MIST1 function is primarily responsible for the damaged status of 
the organ, mice harboring a Cre-inducible Mist1 transgene (iMist1) were utilized to 
determine if sustained MIST1 activity could alleviate AP damage responses. 
Surprisingly, constitutive iMist1 expression during AP produced a dramatic 
increase in organ damage followed by acinar cell death. This result suggests that 
the transient silencing of Mist1 expression is critical for acinar cells to survive an 
AP episode, providing cells an opportunity to suppress their secretory function and 
regenerate damaged cells. In order to further define the role of MIST1 in pancreatic 
neoplasia lesion formation (a precursor of PDAC), Mist1 conditional null mice were 
generated that contained a mutated oncogenic KrasG12D allele. Direct comparison 
between embryonic Mist1 null mice with conditional Mist1 null mice in the context 
of KRASG12D activity demonstrated that embryonic Mist1 null mice are more 
susceptible to PanIN formation. The importance of MIST1 to these events 
suggests that modulating key pancreas transcription networks could ease clinical 
symptoms in patients diagnosed with pancreatitis and pancreatic cancer. 
 
1 
CHAPTER 1. INTRODUCTION 
 Cell Types in the Pancreas 
 The pancreas is a complex organ located behind the stomach and 
consisting of endocrine and exocrine components that are essential to maintain 
pancreas homeostasis (Figure 1-1). The endocrine portion comprises about 2% 
of the organ mass and encompasses the islets of Langerhans which synthesize 
and secrete hormones into the bloodstream to regulate metabolism. The islets 
consist of five cell types dedicated to secreting a specific hormone: β-cells, α-cells, 
𝛿 -cells, ε-cells and γ-cells secrete insulin, glucagon, somatostatin, ghrelin and 
pancreatic polypeptide, respectively (Slack 1995; Stefan et al. 1982; Murtaugh & 
Melton 2003). In mice, the central region of the islet consists of β-cells (60-80%) 
while the other cell types such as α-cells (15-20%), reside around β-cells 
(Murtaugh & Melton 2003). The primary hormones insulin and glucagon are 
essential for maintaining normal blood glucose levels. Glucagon produced by 
alpha cells converts glycogen into glucose in the liver and increases the glucose 
production in the blood. In contrast, insulin assists cells in absorbing and utilizing 
the glucose as a metabolite, leading to decreased blood sugar levels. Improper 






Figure 1-1.Anatomy of the pancreas. (A) The mature pancreas is located below 
the duodenum and stomach. The exocrine system consists of acinar cells and duct 
cells. The digestive enzymes are produced and secreted by acinar cells and ducts 
transport them to the intestine. The endocrine system consists of the Islet of 
Langerhans: β-cells (insulin), α-cells (glucagon), 𝛿 -cells (somatostatin), ε-cells 
(ghrelin) and γ-cells (pancreatic polypeptide) and is involved in hormone secretion. 
(B) H&E staining of a mouse pancreas illustrating the three cell types. Basal blue 
color signifies the presence of nuclei and the apical lumens are denoted in pink 
color where the digestive enzymes reside. (C) An acinus with apical-basal polarity 
consists of acinar cell nuclei at the base and the zymogens at the apical region. 
Also shown is a schematic of the exocrine pancreas with acinar clusters. Adapted 





The exocrine portion of the organ occupies nearly 95% of the total 
pancreatic mass and is comprised of acinar cells, duct cells and centroacinar cells. 
Individual acinar cells are grouped into a spherical structure known as an acinus 
as illustrated in Figure 1-1 (Pandol 2010). Each acinus consists of 30-60 pyramidal 
epithelial cells that exhibit a defined apical-basal polarity. The basal aspect of the 
cell contains nuclei and an elaborate highly developed endoplasmic reticulum (ER) 
network that is necessary to produce massive amounts of digestive enzymes. 
Indeed, acinar cells are the largest protein producing factory in the body. Also 
located in the basal region of acinar cells are cholecystokinin (CCK) receptors that 
respond to hormones (CCK) and neurotransmitters as a part of the regulatory 
cascade to control proper secretion (exocytosis) of digestive enzymes (Slack 1995; 
Motta et al. 1997; Pandol 2010; Williams 2001; Pandol et al. 2011). In contrast, the 
apical portion of an acinar cell stores a host of pro-hydrolases as inactive enzymes 
in secretory vesicles known as zymogen granules. Acinar cells are professional 
secretory cells and are tasked with producing, modifying, packaging and secreting 
vast quantities of pro-digestive enzymes (zymogens) that breakdown 
carbohydrates (amylase), proteins (trypsin), lipids (lipase) and nucleic acids 
(DNAse and RNAse) (Stanger & Hebrok 2013; Puri & Hebrok 2010; MacDonald et 
al. 2010; Gittes 2009). Importantly, the enzymes produced by acinar cells remain 
as inactive zymogens located at the apex of the cell until secreted into the digestive 
tract to maintain metabolic homeostasis (Rukstalis et al. 2003; McNiven & Marlowe 
1999). 
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 Each acinar cell within an acinus maintains cell-cell communication by the 
presence of tight junctions and gap junctions. Actin tight junctions located at the 
apical region of the cells are utilized to insure that digestive enzymes are only 
secreted into ductal lumens and not to the outside of cells (Fallon et al. 1995; 
Pandol 2010). In contrast, intercellular gap junctions allow the movement of small 
molecules (i.e., Ca2+) between neighboring acinar cells. This helps to insure that 
Ca2+- regulated secretion affects all of the cells within an acinus simultaneously so 
that all cells in a unit secrete their products in a coordinated fashion. (Yule et al. 
1996). 
The duct cells of the exocrine pancreas play a vital role in transporting the 
enzymes secreted by the acinar cells. Duct cells are both pyramidal and cuboidal 
in shape and form a ductal network which consists of the Duct of Wirsung (the 
main pancreatic duct), numerous interlobular and intralobular ducts, and the 
smaller intercalated ducts which are directly associated with each acinus. Upon 
pancreatic enzyme secretion in to the lumen, this intricate ductal network functions 
as a carrier to release the acinar enzymes into the duodenum (Kern 1993; Reichert 
& Rustgi 2011). The duct cells secrete a high concentration of bicarbonate to 
neutralize acidity in the stomach and also maintain a neutral pH for the enzymes 
to work efficiently after consuming a meal (Steward et al. 2005). In addition to 
critical cell biology functions associated with acinar and duct cells, the exocrine 
pancreas is also subject to a number of disease states, including pancreatic ductal 
adenocarcinoma (PDAC) and pancreatitis. Thus, characterizing the molecular 
pathways associated with these cells is important to understand the biology behind 
5 
devastating exocrine diseases (Yadav & Lowenfels 2013; Bockman et al. 2003; 
Rooman & Real 2012; Kopp et al. 2012). 
The region where the apical portion of acinar cells and duct cells converge, 
consists of paired centro-acinar (CAC) cells which are often referred to as terminal 
end duct cells (Means & Leach 2001). These cells mimic duct cells. CACs gene 
expression patterns appear only in the later part of the pancreas development and 
post birth (Pour 1994). Like duct cells, these cells also produce bicarbonate to 
neutralize the acidity in the stomach (Steward et al. 2005).  Accumulating research 
evidence from mouse experiments implicate CACs as the reservoir for multipotent 
progenitor cells (Rovira et al. 2010; Seymour et al. 2007; Hayashi et al. 1999). For 
instance, experiments performed in rats revealed that CACs proliferate post 
pancreatectomy (Hayashi et al. 1999). These results have opened multiple venues 
of research in investigating potential stem cell markers of the pancreas biology. 
 
 Pancreas Development and Transcription Factors 
In mice, pancreas development occurs in two distinct transition phases: 
primary and secondary. During the primary transition stage, the formation of 
pancreatic buds on the dorsal and ventral sides of the foregut endoderm takes 
place at embryonic day (e) 8.5 (Slack 1995) followed by the organogenesis of the 













Figure 1-2. Development of the pancreas from dorsal and ventral buds. 
(A) The formation of the ventral pancreatic bud (VP) and the dorsal pancreatic 
bud (DP) marks the organogenesis of the pancreas. (B-D) As the pancreas 
matures, the two buds fuse to form the head, body and tail of the pancreas. 




(Figure 1-2). The pancreas develops the differentiated islet cells, acinar cells and 
duct cells during the secondary transition stage (Pictet et al. 1972; Gittes 2009). 
Organogenesis and development of the pancreas is tightly dependent on 
multiple transcription factors. Key transcription factors for pancreas organogenesis 
and maturation include pancreatic and duodenal homeobox 1 (PDX1, also known 
as Ipf1), pancreas transcription factor 1 (PTF1a), Nr5a2/ liver receptor homologue 
1 (LRH-1), MIST1 (also known as bHLHa15), SOX9, HNF6 and HNF1β. PDX1 is 
required for early pancreas development as early as e8.0 when the dorsal and 
ventral pancreatic buds start to form (Guz et al. 1995). The endocrine, exocrine 
and duct compartments all originate from PDX-1 expressing precursor cells (Guz 
et al. 1995; Gu et al. 2002). Accordingly, Pdx1-/- mice fail to form a pancreas 
(Ahlgren et al. 1996). In the adult pancreas, PDX1 is primarily dedicated to 
endocrine specification and PDX1 expression persists in insulin producing β-cells 
(MacFarlane et al. 1994) and is expressed at lower levels in acinar cells (Gannon 
et al. 2001; Gannon et al. 2008). Additionally, PDX1 directly regulates expression 
of a number of islet specific genes including insulin, somatostatin, glucose 
transporter (glut2) and glucokinase (Wilson et al. 2003). Thus, PDX1 is a critical 
transcription factor for both early and late stages of pancreas development.  
 Another protein that plays an essential role in pancreas development is the 
bHLH transcription factor, PTF1a (also known as p48) (Krapp et al. 1996). PTF1a 
plays two unique roles during pancreas development. First, PTF1a is essential for 
the formation of the early pancreas epithelium. PTF1a, along with PDX1, is 
expressed during the primary transition phase to determine a pancreatic fate for 
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the developing endoderm gut tube (Afelik et al. 2006). Ptf1a null mice fail to 
develop a ventral pancreatic bud and as a result formation of acinar cells and duct 
cells are perturbed, suggesting that proper temporal and spatial expression of 
PTF1a is essential for proper pancreas formation and development. Second, 
PTF1a is a key regulator of acinar cell differentiation, regulating genes which 
participate in the synthesis and secretion of digestive enzymes (Rose et al. 2001; 
Krapp et al. 1996; Masui et al. 2010). During the early phases of pancreas 
development, PTF1a partners with RBPJ (the vertebrate Suppressor of hairless) 
and E-proteins (DNA binding protein) to form a trimeric complex called PTF1-J. 
This complex is needed to form a pancreas. The PTF1-J complex consequently 
leads to activation of the RBPJ paralogue known as RBPJL which is essential for 
acinar cell differentiation. Additionally, in mature acinar cells, RBPJL swaps with 
RBPJ forming a PTF1-L complex. The PTF1-L complex is critical for acinar cell 
differentiation. This complex leads to transcriptional regulation of acinar genes 
producing digestive enzymes such as Amylase, Carboxypeptidase and Elastase 
(Masui et al. 2007; Masui et al. 2010; Beres et al. 2006). In the adult pancreas, 
PTF1a expression occurs exclusively in acinar cells and is inactivated in duct and 
islet cells (Masui et al. 2007). Thus, PTF1a transcription dictates the proper 
formation and development of the pancreas and more specifically regulates 
exocrine differentiation.  
Another key transcription factor that contribute to establishing and 
maintaining a healthy pancreas state is the orphan nuclear hormone receptor 
LRH1/Nr5a2. In the initial stages of pancreas development, Nr5a2 expression is 
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prevalent in the inner cell mass in mouse embryos and plays a key role in the 
genesis of multipotent progenitor cells (Hale et al. 2014; Holmstrom et al. 2011). 
Hale et al., using Nr5a2 null mice, revealed that islet cells, acinar cells and duct 
cells are affected resulting in impaired organ formation (2014). In the adult 
pancreas, Nr5a2 coordinates with the PTF1-L complex to transcriptionally regulate 
acinar cell secretory genes such as Carboxypeptidase and Elastase. These 
findings were verified using a mouse model where Nr5a2 was conditionally deleted. 
Indeed, expression of the secretory genes in the acinar cells were lowered when 
Nr5a2 is absent  (Holmstrom et al. 2011). Additionally, through mouse studies it 
was also confirmed that the absence of Nr5a2 sensitizes acinar cells to de-
differentiate to cells resembling ducts (von Figura et al. 2014). Taken together, we 
can conclude that Nr5a2 is a key transcription factor in mediating and maintaining 
acinar cell differentiation during pancreas development. 
MIST1 is a basic helix-loop-helix (bHLH) transcription factor expressed in 
pancreatic acinar cells of the adult pancreas. MIST1 is first expressed at e.10.5 in 
mice (Pin et al. 2001; Zhu et al. 2004). Although MIST1 is not essential for 
embryonic acinar development, it plays a key role in the maturation of acinar cells. 
MIST1 transcriptionally  regulates genes essential for apical-basal cell polarity, the 
assembly and clustering of secretory granules, proper Ca2+ signaling, the 
expansion of the endoplasmic reticulum (ER), unfolded protein response (UPR) 
pathway homeostasis, cell cycle progression and regulated exocytosis (Direnzo et 
al. 2012; Garside et al. 2010; Hess et al. 2011; Jia et al. 2008; Luo et al. 2005; Pin 
et al. 2001; Rukstalis et al. 2003; Zhu et al. 2004). Thus, MIST1 plays an essential 
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role in the overall upregulation of the protein synthesis, processing and secretory 
machinery, often acting as a scaling factor to insure highly efficient regulated 
secretion for each cell type (Mills & Taghert 2012; Hess et al. 2011; Huh et al. 
2010).  
While PDX1, PTF1a, Nr5a2 and MIST1 are required for islet and acinar cell 
formation and maturation, SOX9, HNF6 and HNF1β transcription factors are 
dedicated in ductal specification and maturation. SOX9 is a member of the High 
Mobility Group box (HMG-box) family of transcription factors being expressed 
starting at e.9.5 in both the dorsal and ventral buds of the pancreas during 
organogenesis in mice (Lioubinski et al. 2003; Seymour et al. 2007). During the 
primary transition phase, SOX9 is a well-established marker for progenitor cells 
during pancreas development and this progenitor population gives rise to both 
endocrine and exocrine epithelial cells (Lioubinski et al. 2003; Seymour et al. 2007; 
Akiyama et al. 2005). As pancreas development reaches the second transition, 
SOX9 exclusively expressed in centro-acinar cells and duct cells in the pancreas 
(Kopp et al. 2011; Akiyama et al. 2005). Indeed, mouse studies using conditional 
Sox9 knockouts in the pancreas revealed that due to the reduction in progenitor 
cells the pancreas is  underdeveloped (Seymour et al. 2007; Seymour 2014). 
Hepatocyte nuclear factors (HNFs) are a family of transcription factors that 
also regulate pancreas embryogenesis and pancreas maturation. Some of the key 
factors are HNF6 and HNF1β. HNF6 and HNF1β are expressed in the pancreatic 
endoderm and are required for the dorsal and ventral bud development during the 
primary transition of pancreas organogenesis (Rausa et al. 1997; Haumaitre et al. 
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2005; Jacquemin et al. 2003). Hnf1β knockout mice fail to develop ventral buds at 
e9.5 and are prone to undergo pancreas agenesis by e13.5 (Haumaitre et al. 2005). 
HNF6 and HNF1β transcription factors act upstream of PDX1 and PTF1a 
respectively, which have been previously discussed as key transcription factors 
required for endocrine and exocrine development (Poll et al. 2006). In the later part 
of pancreas development HNF6 is localized to ductal cells (Pierreux et al. 2006). 
Mouse studies revealed that HNF1β gives rise to epithelial ductal cells, but 
interestingly this factor is also found in endocrine cells. However, following birth, 
HNF1β expression becomes restricted to duct cells (Solar et al. 2009). Taken 
together, we can conclude that HNF6 and HNF1β play a universal role in 
determining proper pancreas specification and maintaining ductal differentiation. 
A summary of the transcription factors involved in pancreas organogenesis 





Figure 1-3. Summary of described transcription factors involved in pancreas 
organogenesis and maturation: The primary transition is a phase of pancreas 
specification. All pancreas cell types arise from PDX1+, progenitor cells. The 
secondary phase marks the differentiation and maturation of the exocrine and 
endocrine cells. PTF1a is a key regulator of acinar cell fate and PTF1a, MIST1 and 
Nr5a2 help in acinar cell differentiation. SOX9, HNF6 and HNF1β are the markers 







 Pancreas Diseases 
  Diabetes (Endocrine-specific Disease) 
 
The endocrine compartment of the pancreas has a critical role in producing 
hormones (insulin and glucagon) to maintain blood glucose homeostasis. Under 
normal conditions, β-cells synthesize insulin which gets stored in secretory 
vacuoles. Upon increased blood glucose levels, insulin gets released from the β-
cells into the blood circulation network where it regulates glucose uptake in cell 
types such as fat cells, liver cells and muscle cells (Lin & Sun 2010). Improper 
regulation of insulin and glucagon hormones leads to diseases such as diabetes 
mellitus (Type 1 and Type 2). According to the National Diabetes Statistics Report, 
it is estimated that 9.3% of the U.S population are victims of this metabolic disease 
(2014).  
Type 1 diabetes (insulin-dependent or juvenile diabetes) is an autoimmune 
disease which is caused by selective β-cell damage in the islet of Langerhans. 
Since the body’s immune system is involved in destroying the insulin secreting 
cells, insulin hormone level production is inhibited. As a consequence of no insulin 
production to regulate glucose in the blood, patients develop hyperglycemia (van 
Belle et al. 2011; Moore et al. 2001; Van Belle et al. 2009). The human leukocytes 
antigen (HLA) class III gene, also known as IDDM1, is estimated to cause 40 - 50% 
risk of inheriting type 1 diabetes (Hirschhorn 2003). Various human studies and 
mouse models have been used to unravel the mechanisms, signaling pathways 
and genetics behind Type 1 diabetes (Van Belle et al. 2009). The best mode of 
treatment for Type 1 diabetes patient is to take a lifelong supply of insulin. 
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Type 2 diabetes (non-insulin dependent or adult-onset) is associated with 
insulin resistance whereby cells have impaired response to insulin and dysfunction 
in β-cell insulin secretion. Hyperglycemia is a common consequence of 
dysregulated glucose uptake into cells (Lin & Sun 2010). If chronic hyperglycemia 
and insulin resistance occurs then the β-cells will often begin to die via apoptosis 
resulting in decreased β-cell mass (Butler et al. 2003).  
As discussed earlier, the transcription factor PDX1 is essential for pancreas 
formation and for β-cell function. Heterozygous Pdx1 mice are prone to developing 
glucose intolerance followed by late-onset Type 2 diabetes (Dutta et al. 1998).   
Similarly, patients with mutation in the Pdx1 gene exhibit a very high incidence of 
developing late-onset Type 2 diabetes (Hani et al. 1999; Oliver-Krasinski et al. 
2009).  Another protein associated with Type 2 diabetes is High-mobility group A1 
(HMGA1) which has been shown to regulate expression of the insulin receptor 
(INSR) (Foti et al. 2003). Indeed, studies comparing healthy and Type 2 diabetic 
patients suggested that gene variants of HMGA1 can lead to Type 2 diabetes 







 Exocrine Disease: Pancreatitis 
1.3.2.1 Epidemiology 
Acute pancreatitis (AP), a gastrointestinal pancreatic inflammatory disorder, 
is the most common reason for pancreas symptom hospitalization which accounts 
for 275,000 admissions in 2009 in the United States alone (Peery et al. 2012; 
Yadav & Lowenfels 2013). The yearly AP incidence in the United States is 
approximately 50 individuals per 100,000 people (Yadav & Lowenfels 2013) of 
which 30% of cases are thought to be caused by gallstone, 50% is non-gallstone 
related events and 20% caused by recurrent AP (Yadav & Lowenfels 2013). 80% 
of the AP patients present with mild conditions and recover. However, 20% of 
patients die of AP complications (Lund et al. 2006; Wang et al. 2009).   
Although genetic factors, smoking, diet and obesity can cause AP, 
gallstones and alcohol are the two most common etiologic factors of AP (Yadav 
& Lowenfels 2013; Wang et al. 2009). Gallstone-related AP is induced when the 
pancreatic duct and/or bile duct are obstructed. This blockade results in duct 
pressure followed by the activation of cascades of pancreatic enzymes from the 
exocrine compartment of the pancreas leading to autodigestion of the organ 
(Hazem 2009; Diehl et al. 1997). In cases of alcohol-related pancreatitis, in vivo 
studies have revealed that upon alcohol consumption, cholecystokinin stimulation 
takes place leading to activation of zymogens in the acinar cells making the cells 
susceptible to pancreatitis (Gorelick 2003). Most patients with AP recover. 
However, some patients develop systemic inflammatory response syndrome 
which predisposes the patients to multiorgan failure including lung injury 
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(Banerjee et al. 1995; Pandol et al. 2007). Common treatment options for 
gallstone-related AP is to perform a cholecystectomy - removal of the gallbladder 
(Vitale 2007). Universal treatment options for acute pancreatitis typically involve 
fasting and short-term intravenous feeding and pain management by using non-
steroidal anti-inflammatory drugs (Banks et al. 2010). Importantly, acute 
pancreatitis is mostly curable. However, multiple bouts of AP can lead to a severe 
form of pancreatitis commonly known as chronic pancreatitis (Yadav & Lowenfels 
2013) and is also a precursor for PDAC (Pinho et al. 2014; Guerra et al. 2007). A 
wide range of different treatment options are under investigation to prevent the 
causative factor that leads to AP occurrence.  
 
1.3.2.2 AP Pathophysiology 
Pancreatitis initiation occurs when zymogens in the acinar cells are 
prematurely activated upon insults such as gallstones. Zymogen activation triggers 
the release and autoactivation of a cascade of enzymes including the proteases 
trypsin and elastase, causing acinar cell injury. Furthermore, the leakage of 
enzymes leads to autodigestion of the tissue and subsequently injury markers 
elevate, edema, cell necrosis and vascular damage (Bhatia et al. 2005; Stevenson 
& Carter 2013). However, the mechanism behind the autoactivation of zymogens 
has not been fully elucidated. In order to better understand the mechanism behind 
acute pancreatitis and ultimately develop effective treatment options, various 
experimental models have been utilized including hormone-induced pancreatitis 
(Willemer et al. 1992). Caerulein, a cholecystokinin (CCK) analogue, has been 
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extensively used to induce cell injury in pancreatic acinar cell culture (Saluja et al. 
1999) and in acute pancreatitis in rodents (Bragado et al. 1996). Administration of 
supramaximal doses of caerulein leads to disturbances in calcium signaling which 
triggers activation of trypsinogen inducing acinar cell injury (Ward et al. 1996). The 
finding of calcium dependent premature zymogen activation has been critical in 
our understanding of acute pancreatitis. In mice, injection of caerulein into the 
intraperitoneal cavity leads to cathepsin-B mediated hyperstimulation of enzymes 
from acinar cells that leak into the interstitial space. Consequently, enzymes get 
activated in the interstitial space and start digesting the cells (Halangk et al. 2000). 
This results in inflammation, edema, increased serum-amylase levels and necrosis 
marking the onset of acute pancreatitis (Husain et al. 2007; Mayerle et al. 2013). 
This model presents various advantages including that it can lead to AP in mice, 
rats, dogs and hamsters; it does not require a surgical procedure; intraperitoneal 
injections are sufficient to induce AP; it is a simple and inexpensive procedure; 
experiments can be performed under controlled injections of caerulein that are 
easy to monitor and highly reproducible; and most importantly, this model allows 
us to study tissue injury post-AP induction (Su et al. 2006; Mayerle et al. 2013). 
However, the disadvantage of this model is that only mild AP is induced with no 
overt mortality as can be found in the human condition (Mayerle et al. 2013). 
Pancreatitis presents with various hallmark events in patients and these 
events have been key in investigating the disease in experimental models. 
Inflammation and edema are among the first events post-injury. Early activation of 
trypsinogen triggers AP injury. Studies performed in Trypsinogen-7KO mice 
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revealed that indeed, Trypsinogen-7 is activated within the acinar cells post-AP 
insult, acting as a mediator of AP initiation. In post-AP initiation, the immune cells 
(neutrophils and macrophages) are recruited immediately upon acinar cell injury. 
As a result, pro-inflammatory markers (tumor necrosis factor-α (TNF-α), interleukin 
(IL)-1, IL-2, IL-6) and anti-inflammatory markers (IL-10 and IL-1 receptor) are 
markedly increased (Pandol et al. 2007; Bhatia 2005; Davies & Hagen 1997). 
Among these markers, TNF-α specifically plays a role in protease activation along 
with induction of cell death. This further triggers macrophage activation to progress 
the injury pathway (Sendler et al. 2012). Murine AP studies have also revealed 
that neutrophil depletion attenuates the AP response (Frossard et al. 1999). 
Likewise, intracellular nuclear factor-κβ (NF-κβ) signaling is commonly associated 
with early AP responses (Gukovsky et al. 1998) and upon early activation of NF-
κβ in mouse acinar cells AP responses become more severe (Haojie Huang et al. 
2013). These findings reveal that NF-κβ signaling plays a critical role in AP 
initiation and progression (Jr et al. 2008).  
One of the characteristics of AP is cell death (necrosis and apoptosis). 
Apoptosis (programmed cell death) of acinar cells in AP occurs primarily by the 
activation of cysteine proteases called caspases. Inactive forms of caspases are 
activated when proteases act to cleave them (Pandol et al. 2007; Bhatia et al. 
2012). Cell necrosis during AP occurs when calcium levels in the cytoplasm are 
elevated. The increase in calcium concentration in gallstone-related AP affects the 
function of mitochondria which leads to cell necrosis (Criddle et al. 2007; Kim et al. 
2002). Activation of NF-κβ also contributes to acinar cell death upon AP induction 
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(Murtaugh & Keefe 2014). The initiation and progression of AP is illustrated in 
Figure 1-4. Various biomarkers are being utilized to diagnose acute pancreatitis 
in patients. These biomarkers include amylase, lipase and trypsinogen which are 
elevated in the early AP stages (Matull et al. 2006).  
Another key hallmark of AP is alteration of acinar cell identity where acinar 
cells acquire ductal characteristics through a process known as acinar-ductal 
metaplasia (ADM) (Strobel et al. 2007; Molero et al. 2012; Prévot et al. 2012). In 
experimental models of AP the presence of ADM lesions are confirmed by 
detecting ductal markers including SOX9, K-19 and HNF6 within acinar cells 
(Strobel et al. 2007; Kopp et al. 2012; Prévot et al. 2012). Furthermore, NF-κβ 
signaling is closely associated with both initiation and maintenance of ADM 
(Murtaugh & Keefe 2014).  
In summary, calcium-dependent activation of trypsinogen causes AP 
initiation followed by disease progression through the recruitment of pro- and anti-
inflammatory markers, cell-death and activation of signaling pathways. Importantly, 
during AP acinar cells transiently acquire a ductal phenotype upon the loss of 
acinar markers suggesting that there is a significant change in the acinar cell 









Figure 1-4. Schematic summarizing the pathogenesis of acute pancreatitis. 
Upon insults such as gallstones, alcohol or hormone-induced pancreatitis, 
activation of trypsinogen and NF-κβ occur independently in the early onset of AP. 
Activated trypsin leads to activation of proteases such as lipase and amylase which 
lead to autodigestion of the tissue. Likewise, NF-κβ activation recruits pro- and 
anti-inflammatory markers to progress the disease and assist in local injury. In the 
severe form of inflammation, systemic inflammation of organs such as lung injury 








1.3.2.3 Tissue Regeneration post-AP 
 
Acute pancreatitis presents with acinar cell destruction and loss. However, 
in most cases the tissue repairs by regeneration of acinar cells (Murtaugh & Keefe 
2014). The cell of origin in pancreas regeneration post-AP has been controversial. 
Results from different models of regeneration reveal participation of various cell 
types (acinar cells and ductal cells) to heal the organ. Transgenic mouse-model 
studies using diphtheria-toxin to ablate acinar cells and endocrine cells, but not 
ductal cells, revealed that pancreas regeneration occurred via ductal cell 
proliferation (Criscimanna et al. 2011). In contrast, lineage tracing studies in 
murine models, implied that only preexisting acinar cells give rise to acinar cells 
post-pancreatectomy (Desai et al. 2007). This finding was further confirmed by 
another group via Cre-loxP-based lineage tracing in a chronic injury model. 
Indeed, new acinar cells are derived from the acinar cells (Strobel et al. 2007). 
Taken together, there are multiple lines of evidence that support that acinar cells 
are the main contributors of pancreas regeneration post-pancreatitis. 
The regeneration of the pancreas has been extensively studied via mouse 
models dedicated to various transcription factors. Deletion of Nr5a2, a 
transcription factor required for acinar cell differentiation, leads to ADM formation, 
increases in fibrosis and inflammation followed by tissue atrophy upon 
pancreatitis induction, suggesting that Nr5a2 is critical to maintain proper organ 
homeostasis (von Figura et al. 2014). SOX9, a duct specific transcription factor is 
upregulated in ADM post-acute pancreatitis and acinar cell specific 
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overexpression of SOX9, upon injury leads to the formation of metaplastic lesions, 
precursors for pancreatic ductal adenocarcinoma (PDAC) (Kopp et al. 2012). 
Likewise, germline deletion of MIST1, an acinar cell maturation transcription factor, 
delays tissue recovery post-AP (Kowalik et al. 2007). Recent studies with 
conditional knockout of Ptf1a in mice, led to acinar atrophy along with elevated 
inflammation and stroma accumulation upon acute pancreatitis induction (Krah et 
al. 2015). Taken together, these findings suggest that studying transcription 
factors in the context of tissue regeneration can assist in designing effective drug 
therapies to treat patients. 
 
 MIST1 Transcription Factor Review 
MIST1 (Bhlha15) is a basic helix-loop-helix (bHLH) transcription factor, 
consisting of a loop in between two alpha-helices and a basic region required for 
DNA binding. MIST1 was first isolated by a yeast one-hybrid technique (commonly 
used to determine a protein’s affinity to a certain DNA element) by its affinity to 
bind to a conserved DNA motif referred to as an E- box (-CANNTG-) (Lemercier et 
al. 1997). Detail characterization of the rat Mist1 gene revealed the presence of 
two exons with the entire coding region situated in the second exon and a 2.8 kb 
3’ untranslated region (Lemercier et al. 1997; Lemercier et al. 1998; Lemercier et 
al. 2000). The Mist1 gene encodes a 197 amino acid MIST1 protein. Studies 
utilizing various MIST1 truncations showed that the HLH domain is essential for 
MIST1 dimerization while addition of the basic region (bHLH) is essential for active 
DNA binding and gene transcription (Zhu et al. 2004; Tran et al. 2007; Lemercier 
23 
 
et al. 1998). Interestingly, MIST1 lacks a separate transcription activation domain 
(TAD) or a separate transcription repression domain (TRD) (Tran et al. 2007) 
suggesting that it utilizes cofactor proteins in order to regulate transcription. In vitro 
studies performed to identify protein binding partners identified Sin3-associated 
polypeptide 18 (SAP18), a component of the histone deacetylase complex, as a 
possible binding partner of MIST1. This finding suggests that a MIST1:SAP18 
complex could be one mechanism by which MIST1 functions as a repressor (Jia 
2008). However, because this study utilized pancreatic cancer cells to identify the 
binding partners of MIST1, a better model is required. An ideal mammalian system 
needs to be established to find the relevant binding partners to MIST1. 
Molecular studies on MIST1 have demonstrated that MIST1 can both 
homodimerize and heterodimerize with other bHLH factors (Lemercier et al. 1998; 
Zhu et al. 2004). In vitro studies using electrophoretic mobility shift assays (EMSA) 
suggested that MIST1 can form homodimer (MIST1:MIST1) and heterodimer 
(MIST1:E12; MIST1:E47) complexes (Lemercier et al. 1998). However, in vivo 
studies performed by Tran et al., demonstrated that MIST1 preferably forms 
homodimers and binds to TA-E-box DNA conserved sites (Tran et al. 2007).   
Mist1 is an evolutionary conserved gene across various organisms. In 
Drosophila melanogaster, its homolog is known as DIMMED and has 78% 
similarity in the bHLH domain to mammalian Mist1 (Moore et al. 2000). DIMMED 
is dedicated to regulate neuroendocrine cells and to help determine their fate. Loss 
of function studies revealed severe reduction in neurosecretory peptides (Hewes 
et al. 2006; Hewes et al. 2003; Park & Taghert 2009). Likewise, the zebrafish 
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(Danio rerio) Mist1 was first identified in 2007 with 77% similarity in the bHLH 
region to mouse Mist1 (Guo et al. 2007). Mist1 knockdown in zebrafish develop 
morphological embryonic defects. In situ hybridization studies revealed that Mist1 
morpholino injected (to induce gene knockdown) zebrafish were unable to develop 
a normal pancreas and the embryos also lost the hindbrain boundary (Guo et al. 
2007). 
MIST1 is not only evolutionarily conserved, but is also expressed in various 
mammalian tissues. MIST1 is expressed primarily in serous secretory cells 
including the acinar cells of the submandibular and lacrimal of the salivary glands 
(Pin et al. 2000), chief cells of the stomach (Ramsey et al. 2007; Pin et al. 2000), 
and lactating cells of the mammary gland (Zhao et al. 2006; Pin et al. 2000). Recent 
studies have also revealed MIST1 expression in antibody secreting plasma cells 
(Yeung et al. 2011). In the adult pancreas, MIST1 is expressed in the acinar cells 
of the exocrine compartment (Pin et al. 2000). This ubiquitous expression of MIST1 
in secretory cells strongly suggests its role in establishing or maintaining proper 
secretory capabilities.  
 
 MIST1 in the Pancreas and Pancreatic Diseases 
During pancreas development, MIST1 expression is first detected at e.13.5 
in mice (Pin et al. 2000) and in the adult pancreas, MIST1 is exclusively restricted 
to the acinar cells of the exocrine compartment (Pin et al. 2001). Studies conducted 
to investigate the role of MIST1 in the pancreas involved the generation of Mist1KO 
mice by replacing the Mist1 alleles with LacZ gene. These mice revealed that 
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embryonic deletion of Mist1 disrupts the apical-basal polarity in acinar cells which 
was confirmed by mislocalization of nuclei, ER, golgi apparatus and zymogens 
(Luo et al. 2005; Pin et al. 2001). Additionally, Mist1KO mice also show increased 
nuclear dysplasia and vacuole formation (Pin et al. 2001).  
Furthermore, Pin et. al. (2001) confirmed that in the absence of the Mist1 gene, 
the genes dedicated to perform calcium exocytosis, including the CCK A receptor 
and IP3 Receptor Type 3 are all affected, suggesting a key role for MIST1 in 
maintaining proper cellular exocytosis.  
Acinar cells closely depend on cell-cell communication to perform their task 
of synthesizing, packaging and secreting digestive enzymes. Studies performed in 
Mist1KO mice also confirmed that CONNEXIN32 (a gap junction protein) was 
markedly reduced suggesting that indeed Mist1 is essential for maintaining the 
proper communication among acinar cells (Rukstalis et al. 2003). Confirming the 
critical role of Mist1 in exocytosis, Mist1KO mice were defective in proper calcium 
signaling (Luo et al. 2005). Defects in calcium signaling directly affected enzyme 
secretion (Williams 2001). Indeed, Mist1KO mice are deficient in secreting digestive 
enzymes including amylase, trypsin and lipase (Luo et al. 2005; Direnzo et al. 
2012). Taken together, MIST1 plays a role of gatekeeper in maintaining acinar cell 
identity, cell-cell communication and exocytosis.  
As a TF, MIST1 is tasked with controlling gene transcription. Mist1KO mice 
show decreased transcripts level of Connexin32 (Cx32), which encodes a gap 
junction protein involved in exocytosis and cell-cell communication (Rukstalis et al. 
2003). Likewise, studies performed in chief cells of the stomach revealed that 
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MIST1 regulates the transcription of Rab26 and Rab3D, which encode for small 
GTPases and are essential for granule maturation (Tian et al. 2010). Additionally, 
MIST1 directly regulates a gene encoding a secretory calcium ATPase (Atp2c2) 
that is required for proper calcium-mediated exocytosis in pancreatic acinar cells 
(Garside et al, 2010). In contrast, gene transcription of Rnd2, a gene in the small 
Rho GTPase family, is repressed by MIST1 binding (Direnzo et al. 2012). A gene 
array analysis helped to identify the gene targets of MIST1 where. whole genome 
expression revealed 949 genes that were differentially expressed between Mist1WT 
and Mist1KO mice (Direnzo et al. 2012). This study further validated two sets of 
genes (activated/repressed) that MIST1 directly regulated including the MIST1 
target genes that were confirmed previously. For example, Rab3d, Htra2, Uba5, 
Rab27a, Abcb6, Cx32, Atp2c2, Wdyhv1, Copz2 and Foxp2 were directly activated 
by MIST1. In contrast, Slc35d1, Nox4, Gstm4, Nfe2l2, Rnd2, Aldh1a1, Ptgr1, 
Cldn10, Ppap2b and Smarca1 genes were repressed by MIST1 (Direnzo et al. 
2012). Together, this study established that MIST1 regulates a wide array of genes 
and that understanding these genes can be helpful in further elucidating the role 
of MIST1. 
Mouse models have been essential tools in deciphering the roles of various 
transcription factors in human pancreatic diseases including pancreatitis and 
pancreatic cancer and MIST1 is not an exception. Studies have revealed that 
Mist1KO mice alone can form pancreatic lesions (a precursor to pancreatic cancer 
development), as the mice age. Immunohistology of the mice pancreata showed 
increased ductal markers including cytokeratin-20. The lesion formation in these 
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mice was directly associated with the loss of β-catenin (required for cell-cell 
adhesion) (Pin et al. 2001), suggesting that MIST1 is essential in preventing 
pancreatic lesion formation. Likewise, in a caerulein (analog of cholecystokinin) 
acute pancreatitis model, Mist1KO mice were shown to develop pancreatitis with a 
significant delay in organ recovery (Kowalik et al. 2011). Additionally, Mist1KO mice 
developed accelerated pancreatic intraepithelial neoplasia (PanIN) lesions upon 
oncogenic KrasG12D activation (Shi et al. 2009). This phenomenon is associated 
with epidermal growth factor receptor (EGFR) and Notch signaling pathways (Shi 
et al. 2009). Together, these studies show that MIST1 plays a protective role in the 
diseases including acute pancreatitis and PDAC, suggesting its role as a tumor 
suppressor. 
 Interestingly, the defects of Mist1KO mice can becompletely restored by 
using a Cre-mediated inducible Mist1 transgenic mouse model (Mist1KO; LSL-
Mist1Myc) (Direnzo et al. 2012). Upon Mist1 re-expression in adult Mist1KO mice, 
these mice were able to form organized apical-basal polarity. Likewise, 
cytoskeletal restoration occurred with membranous actin and E-cadherin 
expression being induced upon Mist1 expression in pancreatic acinar cells. 
Additionally, the mice also re-established proper cell-cell communication and 
amylase secretion. Importantly, gene array analysis performed in Mist1WT, Mist1KO 
and Mist1KO; LSL-Mist1Myc mice revealed 37% of MIST1 target genes were re-
expressed in Mist1KO; LSL-Mist1Myc mice as early as 36 hours (Direnzo et al. 2012).  
The inducible Mist1 transgenic mouse model also showed that sustained Mist1 
expression was able to inhibit PanIN and ADM formation under Kras conditions 
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(Shi et al. 2013). These findings suggest that MIST1 has a role in preventing 
diseases. 
Most of the above mentioned studies utilized germline Mist1KO mice to 
characterize the role of MIST1 in the context of pancreatic diseases. It is yet to be 
explored if the embryonic defects in Mist1KO mice make these mice more 
susceptible to diseases. One focus of this thesis was to generate a conditional 
Mist1KO mouse in order to fully elucidate the role of MIST1 is diseases, including 
pancreatitis and pancreatic cancer. 
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CHAPTER 2. MATERIALS AND METHODS 
 Mouse Strains  
Mist1CreERT/+ and LSL-Mist1myc (iMist1myc) mice used in this research have 
been described previously (Shi et al. 2009; Direnzo et al. 2012; Habbe et al. 2008). 
Mist1lox/+ mice were produced by generating a Mist1 targeting vector containing 
loxP sites flanking the entire Mist1 coding region within exon 2 (Pin et al. 1999). In 
addition, a small biotin-tag (de Boer et al. 2003) and MYC-tag were added to the 
N-terminus and C-terminus of the MIST1 open reading frame, respectively. ES cell 
electroporation and blastocyst injections were performed by the Purdue University 
Transgenic Mouse Core Facility. Mist1 conditional knock-out (Mist1 cKO) mice 
(Mist1CreERT/lox) were produced by standard crosses. Induction of Cre-ERT2 activity 
was accomplished by administration of tamoxifen (Tam) (200 µl of 20 mg/ml) via 
oral gavage to adult mice (6-8 wk). A typical experiment involved two injections on 
two consecutive days. The zero time point post-Tam was taken at seven days 
following the last administration. All experiments were performed with mice on a 
C57BL/6 background and all animal studies were conducted in compliance with 
NIH and the Purdue University IACUC guidelines.
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 Tamoxifen Preparation 
Tamoxifen (SIGMA: T-5648) was freshly prepared in corn oil (SIGMA: C-
8267) a day before each oral gavage administration. In order to make 20mg/mL 
concentration, 5 mL corn oil was placed in a scintillation vial and heated to 42°C in 
a water bath for 30 mins. The equilibrated (at room temperature) tamoxifen was 
then weighed and added to the oil. The vial was covered in aluminum foil to keep 
it from light and placed on a shaker incubator at 37°C incubator for six hrs or until 
the tamoxifen was completely dissolved. Tamoxifen was then stored at 4°C until 
use.  
 
 Acute Pancreatitis (AP) Induction 
Caerulein (Sigma-Aldrich) preparation for injections was done by dissolving 
in sterile PBS. The stock solution was stored at -20°C and the dilution was 
prepared fresh on the day of injections. AP was induced by caerulein via 
intraperitoneal (i.p) injections. In brief, 6-8 wk adult mice were given eight hourly 
i.p. injections of caerulein for two consecutive days (50-μg/kg) body weight). 
Control mice received PBS, a vehicle control. Mice were sacrificed by CO2 
inhalation and pancreata samples were harvested for paraffin blocks, protein and 
RNA at various time points following the last caerulein injection, which was 
considered time 0.  
The mice were also administered the thymidine analog BrdU (5-bromo-2’-
deoxyuridine) (200µl of 10mg/ml) in PBS at least six hours prior to sacrifice. For all 
analyses, 3-7 mice per time point/genotype/experimental condition were used. 
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 Histology and Immunohistochemistry 
Mouse pancreata were immediately fixed in 10% neutral buffered formalin. 
Fixed tissues were processed using Shandon Citadel 1000 tissue processor and 
then embedded in paraffin. Sections were cut at thickness of 5µm and used for 
histological staining including immunohistochemistry (IHC), immunofluorescence 
(IF) and hematoxylin and eosin (H&E). For all histological techniques, sections 
were deparaffinized in Xylenes (3X) and a series of Ethanol (100% (2X), 95% (2X), 
70% (1X) and 50% (1X)) followed by ddH2O (2X) and retrieved using the 2100-
Retriever (Electron Microscopy Sciences, Hatfield, PA) and antigen unmasking 
solution (Vector Laboratories, Burlingame, CA). For IHC, sections were incubated 
in 3% H2O2 for 5 min to block endogenous peroxidase activity followed by an hour 
long blocking using the M.O.M. blocking reagent (Vector Laboratories, Burlingame, 
CA). Tissue sections were incubated in primary antibodies for 1 hr at room 
temperature. Biotinylated secondary antibodies were used at 1:200 dilution for 20 
min at room temperature. IHC development was performed using vector reagents 
and DAB (diamonibenzidine) peroxidase substrate (Vector Labs, Burlingame, CA). 
Immunoflurescence secondary antibodies typically used an avidin-conjugated 
Alexa Fluor 588 or anti-rabbit Alexa Fluor 555 antibodies (Invitrogen, Camarillo, 
CA). The detailed information of the primary antibodies used in this research is 
listed in Table 1. 
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Table 1. Antibodies used for IHC, IF and IB 





CLUSTERIN goat Santa Cruz sc-6420 1:1000 1:200 
AMYLASE goat Santa Cruz sc-12821 1:1000 n/a 





troma3 1:1000 1:100 
SOX9 rabbit Millipore ab5535 1:3000 1:4000 
HSP90 rabbit Santa Cruz sc-7947 1:1000 n/a 
MIST1 (c175) rabbit Konieczny Lab n/a  1:500 
S6 mouse Santa Cruz sc-74459 1:1000 n/a 
VIMENTIN rabbit Cell Signaling 57415 1:1000 1:100 
MYC mouse Konieczny Lab n/a 1:500 1:500 
E-CADHERIN rabbit Abcam ab53033 n/a 1:50 
SMA (IA4) mouse Santa Cruz sc-32251 1:100 n/a 
CD45 mouse Pharminogen 550286 n/a 1:50 
INSULIN rabbit Proteintech 15848-1-AP n/a 1:100 
CONNEXIN-32 rabbit Abcam ab66613 n/a 1:100 
BRDU rat Abcam ab6326 n/a 1:100 




Pancreata samples were lysed in ice-cold Radioimmunoprecipitation assay 
(RIPA) buffer (125 mM Tris pH 7.6, 750mM NaCl, 5% NP-40, 5% sodium 
deoxycholate, 0.5% SDS) supplemented with 50µM protease and 100uM 
phosphatase inhibitors (Roche) and 200µM sodium orthovanadate (an inhibitor of 
protein tyrosine phosphatases and ATPases). Pancreata were lysed with 5-7 
pulses using Tissue Tearer (Biospec Products, Inc). Protein samples were 
centrifuged at 4°C at 5000 rpm for 10 mins to remove debris. Protein 
concentrations were measured using the BCA protein assay kit (Thermo Scientific, 
Waltham, MA). Thirty micrograms of protein whole cell protein extracts were 
resolved on 12% SDS-PAGE, and transferred onto PVDF membranes (Bio Rad, 
Hercules, CA). Membranes were blocked overnight at 4°C in 5% non-fat dry milk 
prepared in Tris-buffered saline plus 0.1% Tween 20. The membranes were 
incubated in primary antibodies (Table 1) at room temperature for 1 hour followed 
by three 10 minute washes. The membranes were then incubated in horseradish 
peroxidase (HRP) conjugated secondary antibodies at 1:5000 dilution at room 
temperature for 30 minutes followed by three 10 mins washes. Immunoblots were 
visualized on X-ray films using an enhanced chemilluninescence (ECL) kit 
(Thermo Scientific, Waltham, MA) or on a ChemiDoc Touch Imaging System (Bio 




 RNA Expression Analysis 
Total cellular RNA from pancreata was isolated using the E.Z.N.A midi kit 
(Omega Bio-Tek, Inc, Norcross, GA). For quantitative RT-PCR analysis, reverse 
transcription on 1µg of RNA was performed using the iScript cDNA synthesis kit 
(Bio-Rad, Hercules, CA) and gene amplification was performed using FastStart 
Universal SYBR Green (Roche Applied Science, Indianapolis, IN) using a Roche 
LightCycler 96 thermocycler (Roche Diagnostics Corporation, Indianapolis, IN). 
PCR was performed in duplicates and all genes were normalized to RNA encoding 
the ribosomal protein Rplp0 as a control. The basic procedure for performing a 
quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) is as follows. Each 
PCR set-up consists of SYBR Green fluorescent mix (Roche, 10μl), cDNA (2μl), 
forward and reverse primers (10uM each, 1µl) and ddH2O (7μl) for a total working 
volume of 20µl (performed in 96-well plates). The thermal cycling parameters for 
40 cycles were as follows: 95°C for 10 sec, 59°C for 10 sec and 72°C for 10 sec. 
Quantitative RT-PCR primers are listed in Table 2. GraphPad Prism 6 software 














Table 2. RT-qPCR Primer Sets  
Gene Oligos 
Rplp0 5'-agaaactgctgcctcacatcc-3', 5'-caatggtgcctctggagatt-3 
Cpa1 5'-ttaaaaaggcctcagacctca-3', 5'-cttcaagtgctccaactcctc-3' 
Amylase 5'-cagagacatggtgacaaggtg-3', 5'-atcgttaaagtcccaagcaga-3' 
K19 5'-cctcccgagattacaaccact-3', 5'-aggcgtgttctgtctcaaact-3' 
Sox9 5'-cacggaacagactcacatctc-3', 5'-cctctcgcttcagatcaactt-3' 
Mist1 5'-tggtggctaaagctacgtgt-3', 5'-catagctccaggctggtttt-3' 
Atp2c2 5'-ttccagactgaaaacctgagc-3', 5'-ccccttggagtggttagtaca-3' 
Copz2 5'-cttagataatgacgggcgaag-3', 5'-aagcacagacatgagcatcag-3' 
Rab3d 5'-agtgtgacctggaagacgaac-3', 5'-ccagggattcattcatcttgt-3' 
Rnd2 5'-tgtcctcaagaagtggcaag-3', 5'-tgacagggatgagtctctgc-3' 
Mist1 cKO 5'-ggctaaagctacgtgtccttg-3', 5'-tccatcttttgggagtctagg-3' 
Cx32 5'-gtgccagggaggtgtgaat-3', 5'-gataagctgcagggaccatag-3' 
Elastase 5'-gcaccgagcagtatgtgaac-3', 5'-gggagagttgttagccaggat-3' 
Vimentin 5'-tttccaagcctgacctcact-3', 5'-tccggtactcgtttgactcc-3' 
Sma 5'-tgtgctggactctggagatg-3', 5'-gcacagcttctccttgatgtc-3' 










 Microscopy, Image Analysis and Statistics 
All H&E, IHC and IF images were taken using an Olympus BX51 
microscope and a Dual CCD DP80 camera (Olympus Life Science Solutions). 
Image analysis including cell counts and area quantification, were performed using 
ImageJ software (NIH). In order to quantify INSULIN, AMYLASE and immune cell 
areas, 12-15 randomly chosen 10X fields were imaged. The pixels were first 
converted to µm within ImageJ in order to establish the area quantification in µm2. 
MYC+ and MYC- acinar cells were counted in ImageJ software. All calculations 
were performed in GraphPad Prism 6. All the statistical analyses were presented 
using standard error of the mean.  
P values were determined using two-tailed unpaired tests and P values of less 
than 0.05 were considered as statistically significant. 
 
 Image Fluorescence Quantification 
Overall fluorescence intensity was measured using ImageJ, a public 
domain program supported by the National Institutes of Health. For each staining 
and time point, three image fields in the fluorescent channel for each respective 
staining were measured for mean gray value across the field. These values were 
then compiled, averaged, and normalized to control values to determine relative 
fluorescent intensity at various time points. The normalized values and their 




 Generation of Elastasepr-HA-BirA construct 
The coding sequence for HA-tagged-BirA was cloned into an Elastase 
promoter to permit pancreatic acinar cell specific expression. Briefly, the HA-BirA 
plasmid was generated by amplifying the full length HA-BirA by PCR from pcDNA-
HA-BirA. The ends of the insert were digested with MfeI and inserted into the EcoRI 
site of the Elastasepr-Cre-ERT2 plasmid in which Cre-ERT2 was removed by EcoRI 
digest. This elastase promoter drives exocrine pancreas-specific (acinar cells) 
expression. It is designed to work in transgenic animals. To release the Elpr-HA-
BirA region for transgenic pronuclear injections, the DNA was digested with Not1 
and the 2.7Kb fragment was isolated from the 2.9 Kb plasmid band. A NotI/XmnI 
double digest cut the vector fragment into a 1 Kb and 1.9 Kb fragment to permit 
better gel separation of the 2.7 Kb fragment. The targeting construct was then sent 
to the Purdue Transgenic Mouse Core Facility where Judy Hallet performed 
electroporation of the Elpr-HA-BirA (2.7. Kb product) Figure 3-7A construct into the. 
pronuclei of mouse embryos. Embryos were then implanted into the pseudo 
pregnant female mice. From this procedure we obtained four founder lines (F0). 
Genomic DNA was extracted from tail clips according to the Konieczny Lab 
Protocol. We identified the presence of BirA transgene by PCR using the following 
primer set: 5’-ATG CGC CGT GTT GAA GAG- 3’ and 5’GGA TAT TTC ACC GCC 
CAT CC-3’.  
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 Cell Culture  
Transient transfections were performed using HEK293 (kidney cells). 
HEK293 cells were cultured in high glucose Dulbecco Eagle’s medium (Gibco) and 
10% fetal bovine serum (FBS). Transfections were performed using Fugene6 
transfection reagent. Cells were plated in 60mm dish using 5x105 cells/plate. All 
DNA constructs used for the transfections were used at 1 μg/μl concentration. 
Protein harvests were done 48 hrs post transfection in RIPA buffer with protease 
inhibitor cocktails at 1:50 dilution. 
 
 
 Nuclear and Cytoplasmic Protein Extraction from Mouse Pancreata 
for Mass spectrometry Analysis Using NE-PER Kit 
 Tissue Preparation 
In order to prepare pure nuclear extracts from mouse pancreata to perform 
mass spectrometry, we decided to utilize an NE-PER Nuclear and Cytoplasm 
Extraction Kit from ThermoFisher Scientific. First, 100 mg of mouse pancreas was 
diced into small pieces and were transferred into a 1.5 ml centrifuge tube. The 
tissue was washed with 1 mL of sterile PBS followed by centrifugation of the tissue 
at 800 x g for 5 minutes. The supernatant was discarded using a pipette allowing 
the pellet to stay dry. The tissue was resuspended in 1 mL Cytoplasmic Extraction 
Reagent I - CER I (with protease inhibitor cocktail, EDTA free, Roche) which 
helped in cell membrane disruption to release the cytoplasmic content. A Dounce 
homogenizer (8-10 strokes) was used to homogenize the tissue.  
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 Cytoplasmic and Nuclear Protein Extraction 
The sample containing 1mL of CER I buffer was vortexted vigorously for 15 
seconds to fully suspend the cell pellet and was placed on ice for 10 minutes. Ice 
cold Cytoplasmic Extraction Reagent II - CER II buffer was added to the tube 
followed by vortexing for 5 seconds. The sample was placed back on ice for 
another minute. After vortexing for 5 seconds the sample was centrifuged at 
16,000 x g for 5 minutes. This procedure separated cytoplasmic proteins in the 
supernatant whereas the nuclear extract formed a pellet. After separating the 
supernatant in a pre-chilled tube, the pellet was resuspended in ice-cold NER 
buffer containing protease inhibitor cocktail. The tube content was vortexed for 15 
seconds and placed on ice for 40 minutes for the nuclear proteins to be extracted. 
In order to separate the debris and the nuclear proteins the tube was centrifuged 
at 16,000 x g for 10 minutes at 4°C. The final step was to store the supernatant 
containing soluble nuclear proteins at -80°C until further use. A summary of 




 His-tag Pull-Down  
In order to perform His-tag pull-downs using Dyanbeads, I used the 
recommended protocol provided by Invitrogen (Cat.no.101.03D). Briefly, 50µl of 
the His-tag Dynabeads were transferred to a sterile eppendorf tube. The beads 
were resuspended gently before use. Next, the tubes with beads were placed on 
Tissue Weight CER I CER II NER Protease inhibitor cocktail Sodium orthovanadate Phosphatase 2 Phosphatase 3
1 mg 1 mL 88 μL 800 μL 1:50 1:200 1:100 1:100
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a magnetic stand until the beads and buffer separated distinctly. The supernatant 
was disposed via aspiration. Next 1000 µg of nuclear protein (R26HA-BirA and 
Mist1BT/BT; R26HA-BirA mouse extracts) were added to the beads. The total volume 
was then brought to 700 µl using Binding/Wash buffer (50 mM NA-Phosphate, pH 
8.0; 300 mM NaCl; 0.02% Tween-20). Beads and the protein were mixed well in a 
rotator for 20 mins at 4°C.The tubes were then placed on a magnetic stand for the 
beads with bound His-tag MIST1 complex to be separated from the supernatant. 
The supernatant was discarded and the beads with protein complexes were 
washed four times (3 mins each) with Binding/Wash Buffer by placing them back 
on the magnetic stand. In order to elute the His-tagged protein complexes, 100 µl 
of Elution buffer (300 mM Imidazole; 50 mM Na-Phosphate, pH 8.0; 300 mM NaCl 
and 0.01% Tween-20) was used. The suspension was placed in a rotater for 5 
mins at 4°C. The final step was to place the suspension on a magnetic stand to 
separate beads and supernatant.  
The beads were resuspended 100µl of His-Elution Buffer (300mM Imidazole, 
50mM Na-phosphate pH, 8.0, 300mM NaCl and 0.01% Tween-20). 
 
 
 Streptavidin-beads Pull down Assay 
In order to purify biotinylated MIST1 complexes streptavidin magnetic 
beads (Dynabeads M-280, Invitrogen) were used. Protein extracts from Mist1BT/BT; 
R26HA-BirA and R26HA-BirA mice were taken for performing pull-down assays. 100µl 
of Dynabeads -280 were aliquoted in microcentrifuge tube after a thorough 
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resuspension. The supernatant was discarded using magnetic separation. The 
beads were then washed 4X using 700 µl of Blocking buffer (10mM Tris-HCl, 
150mM NaCl, 10mg/mL BSA) and resuspended in 100µl of TBS-N buffer ( 10mM 
Tris HCl, 150mM of NaCl and 0.03% of NP-40 detergent). One milligram of nuclear 
protein extracts were added to the beads. The volume was brought to 600 µl using 
TBS-N buffer. The mixture content was placed on a rocker at 4°C for 2 hrs. After 
every 30 mins, the tubes were rotated. The supernatant was separated from the 
beads using magnetic stand, and the beads with protein complexes were washed 
5Xusing 500 µl of TBS-N per wash. The beads were further washed 5X with a 
reducing agent TMAB buffer (Tetramethylammonium borohydride) and 
resuspended in 150 µl of 50mM TMAB with 0.1% Rapigest detergent. The beads 
were heated at 95°C for 10 mins for denaturing proteins. Upon separating the 
supernatant, the beads were resuspended in 150 µl of 50mM Ammonium 
Bicarbonate and submitted to Keerthi Jayasundera at Dr. Andy Tao’s laboratory at 
Purdue University to perform mass spectrometry.  
For each round of pull-down samples were collected for silver staining and western 




 Silver Staining 
Silver staining was performed to visualize protein bands present in the input 
and pull-down samples in 12.5% SDS-polyacrylamide gels. The gels were fixed in 
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40% EtOH, 10% Acetic acid, 50% ddH2O for 1.5 hrs in a shaker at room 
temperature. After washing the gels in ddH2O, the gels were sensitized in a 
solution containing 0.02% Sodium thiosulfate for 2 min at room temperature. The 
gels were washed 3X in ddH2O. The gels were then incubated in ice cold 0.1% 
silver nitrate solution containing 0.02% formaldehyde. The gels were further 
washed in ddH2O to get rid of extra silver nitrate. Finally, the gels were developed 
in 3% sodium carbonate with 0.05% formaldehyde. Yellow coloration of the gel 
indicated the proper development of the proteins in the gels. In order to quench 
the developing reaction, the gels were incubated in 5% acetic acid for 5 mins. The 
gels were imaged using a scanner 
 
 
 DNA Tail Isolation 
DNA tail extractions were performed using a standard lab protocol. Briefly, 
1 cm tail was clipped for DNA extraction from mouse. Tails are placed in 500 μL of 
Lysis buffer containing 100mM Tri-HCl, pH 8.5; 10mM EDTA; 200 mM NaCl and 
0.2% SDS detergent along with proteinase K (10mg/mL) and incubated at 56°C 
overnight for efficient digestion. The samples were then vortexted briefly and spun 
at 14,000 rpm for 10 minutes at room temperature. The supernatant was separated 
from the debris pellet and transferred to fresh tubes. In order to precipitate DNA 
from the supernatant, 500 µL of isopropyl alcohol was added and incubated at -
20°C for 10 minutes. The samples were quickly mixed and spun at 14,000 rpm for 
10 minutes at room temperature. The supernatant was discarded and the pellet 
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was washed with 500μL of 70% ethanol and spun at 14,000 rpm for 5 minutes. 
The supernatant was discarded and the pellet was completely air-dried at room 
temperature. The DNA was resuspended in 100 µL of TE buffer (10mM Tris-Hcl, 
pH 8.0; 1mM EDTA) and was dissolved at 56°C for 10 minutes. In order to perform 
PCR analysis, 2 μL of DNA was used. Genotyping primers used for all the projects 


























LSL-Mist1Myc 5'-cgggatccttggtacctatgaag-3'; 5'-cgggatcctcagaagccatagag-3' 
Mist1CreERT/lox 
5'- agc tgc act ggc taa gga ag-3' ; 5'-gcc ggt tct tgg tct tca ta-
3';5'-gcc ggt ttt tgg tct tca ta-3' 
LSL-KrasG12D 
5’ - tct gaa tta gct gta tcg tca agg- 3’; 5’- gtc gag gga cct aat 
aac ttc gta-3’ 
R26-BirA 
5’- gtg taa ctg tgg aca gag gag-3’; 5’- gaa ctt gat gtg tag acc 
agg-3’ 
ZsGreen1 
5’- aag gga gct gca gtg gag ta- 3’; 5’- ccg aaa atc tgt ggg aag 
tc -3’; 5’- ccg aaa atc tgt ggg aag tc - 3’; 5’- aac cag aag tgg 






CHAPTER 3. UTILIZATION OF A NOVEL MOUSE MODEL TO STUDY THE 
IMPORTANCE OF MIST1-DEPENDENT TRANSCRIPTIONAL REGULATION IN 
PANCREATIC ACINAR CELLS 
 Introduction 
MIST1 is a 197 amino acid basic helix-loop-helix (bHLH) transcription factor 
expressed in pancreatic acinar cells of the adult pancreas (Lemercier et al. 1997; 
Pin et al. 2001). Mice lacking the Mist1 alleles (Mist1KO) exhibit defects in acinar 
cell organization, including improper zymogen localization, impaired secretion and 
defective cell-cell communication, highlighting the importance of MIST1 in normal 
acinar cell physiology. MIST1 is also expressed in other serous secretory cells 
including the acinar cells of the salivary glands, chief cells of the stomach, and 
lactating cells of the mammary gland (Pin et al. 2001; Johnson et al. 2004; Ramsey 
et al. 2007; Pin et al. 2000). This ubiquitous presence in secretory cells and the 
common phenotype observed in Mist1KO cells in these different organs strongly 
suggests a role for MIST1 in establishing or maintaining proper secretory 
capabilities. 
Molecular studies on MIST1 have demonstrated that MIST1 can both 
homodimerize and heterodimerize with other bHLH factors (Lemercier et al. 1998; 
Zhu et al. 2004). In vitro studies using electrophoretic mobility shift assays (EMSA) 
suggested that MIST1 can form homodimer (MIST1:MIST1) and heterodimer 
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(MIST1:E12; MIST1:E47) complexes (Lemercier et al. 1998) and bind to a 
conserved DNA motif referred to as an E-box (-CANNTG-). A study using 
pancreatic cell lines confirmed MIST1’s preference to forming a homodimer 
complex and its affinity towards TA-E-box DNA sequences (-CATATG-) (Tran et 
al. 2007).  
MIST1 regulates transcription of numerous genes. The transcript levels of 
Connexin32 (Cx32), which encodes a gap junction protein involved in exocytosis 
and cell-cell communication, are decreased in Mist1KO mice (Rukstalis et al. 2003). 
Likewise, Tian et al. (2010) confirmed that Rab26 and Rab3D, which encode for 
small GTPases and are essential for granule maturation are directly regulated by 
MIST1. Additionally, another group confirmed that MIST1 directly regulates a gene 
encoding a secretory calcium ATPase (Atp2c2) that is required for proper calcium-
mediated exocytosis in pancreatic acinar cells (Garside et al, 2010). Work by other 
Konieczny lab members, however, has established that transcription of Rnd2, a 
gene in the small Rho GTPases family, is actually repressed by MIST1 binding 
(Direnzo et al. 2012). Importantly, whole genome expression analyses have 
revealed that 949 genes were significantly different in their expression patterns 
between Mist1WT and Mist1KO mice (Direnzo et al. 2012). The same study validated 
two sets of genes (activated/repressed) that MIST1 directly regulated including the 
MIST1 target genes that were confirmed previously. For example, in a subset of 
target genes we showed that MIST1 activated Rab3d, Htra2, Uba5, Rab27a, 
Abcb6, Cx32, Atp2c2, Wdyhv1, Copz2 and Foxp2 expression whereas repressed 
Slc35d1, Nox4, Gstm4, Nfe2l2, Rnd2, Aldh1a1, Ptgr1, Cldn10, Ppap2b and 
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Smarca1 genes (Direnzo et al. 2012). Additionally, the same study confirmed that 
MIST1 preferentially bound CATATG or CAGCTG E-box sites to regulate its target 
genes (Direnzo et al. 2012).  
The dual activator/repressor role for MIST1 suggests that a variety of 
cofactors may be necessary to form complexes with MIST1 in order to either 
activate or repress the expression of specific target genes.  Studies utilizing 
truncated forms of MIST1 revealed that the HLH domain is essential for MIST1 
dimerization while addition of the basic region (bHLH) is adequate for active DNA 
binding and gene transcription (Zhu et al. 2004; Tran et al. 2007) (Figure 3-1). 
Interestingly, MIST1 lacks a separate transcription activation domain (TAD) or a 
separate transcription repression domain (TRD). Together, findings from MIST1 
protein and gene target studies led us to hypothesize that MIST1 utilizes cofactor 
proteins as a means to activate or repress specific target genes.  
Experimental approaches to identify and characterize the role of cofactors 
involved in MIST1 transcriptional activity have previously been conducted utilizing 
cell culture approaches (Jia 2008). Here, an in vitro biotin-streptavidin system was 
employed to purify MIST1 complexes from the rat exocrine pancreatic tumor cell 
line, AR42J. In order to identify protein partners from these complexes a tandem 
mass spectrometry approach was used. Jia et al. (2008) identified Sin3-associated 













Figure 3-1. The bHLH domain is sufficient for MIST1 transcriptional activity. 
Selected truncations of MIST1 and their respective transcriptional activity on TA-
E-Box luciferase reporter genes are displayed. Despite the severe truncation, the 
bHLH region (50 - 140 aa) is sufficient to drive transcription (Modified from (Tran 




SAP18 is a component of the histone deacetylase complex suggesting that a 
MIST1:SAP18 complex could be one mechanism by which MIST1 functions as 
atranscriptional repressor of gene targets, including Rnd2 and K19 (Jia 2008). 
Unfortunately, although these studies were suggestive of MIST1 having unique co-
factors, cell culture studies have significant limitations. For example, AR42J cells 
are pancreatic cancer cells and may not be representative of normal acinar cell 
function, including exhibiting regulated secretion. Additionally, this study involved 
overexpression of a MIST1 protein that was far above normal levels. These 
represented serious deficiencies, necessitating the need to develop an alternative 
approach that would allow efficient formation of MIST1-cofactor complexes within 
a physiologically normal environment and that could be easily purified and 
analyzed. One of the alternative approaches to achieve this goal was to use an 
efficient mouse model.  
In an attempt to characterize the normal function of MIST1, we 
hypothesized that MIST1’s transcriptional activity is dependent on cofactor 
interactions. This hypothesis was addressed by taking advantage of a novel BT-
MIST1His-Myc mouse model where a modified MIST1 protein was expressed from 
the endogenous Mist1 locus, permitting us to co-immunoprecipitate MIST1 protein 
complexes using Streptavidin-HRP conjugated magnetic beads. In order to identify 
potential MIST1 binding partners, Liquid Chromatography-Mass 
Spectrometry/Mass Spectrometry (MS/MS) was performed. Following MS/MS, 





 Biotin-Streptavidin System to Purify MIST1 Protein Complexes 
Protein immunoprecipitation is a powerful tool to study protein function and 
regulatory pathways. In order to purify protein complexes for studying protein-
protein interactions, there are a number of affinity-based systems that can be used. 
These systems typically utilize antibodies raised against the protein of interest or 
raised against a specific peptide epitope tag that can be associated with the protein 
of interest (Jarvik & Telmer 1998; Rigaut et al. 1999). These techniques involve 
multi-step affinity purification where the protein complex can be easily washed 
away during the process. To overcome this issue, single-step approaches have 
been developed to purify biotinylated proteins via the use of the streptavidin/biotin 
system (de Boer et al. 2003).  
Biotinylated purification consists of using Biotin (Vitamin H), a small 
coenzyme that is produced by plants, fungi and many bacteria (Cronan 1990).  In 
the presence of a biotin ligase, such as BirA, the biotin molecule is covalently 
added to specific lysine residues in an amino acid sequence specific fashion. 
Individual biotin ligases exhibit different specificities. The E. coli biotin ligase BirA 
recognizes a single lysine (K) residue in the amino acid sequence 
MASSLRQILDSQKMEWRSNAGGS. Thus, proteins containing this biotin tag (BT) 
can be specifically modified solely by BirA. (Streaker & Beckett 2006; Choi-Rhee 
et al. 2004; Wilson et al. 1992). 
The affinity of biotin to avidin/streptavidin is remarkably high compared to 
that of any generic affinity purification system. This noncovalent interaction is the 
51 
 
strongest characterized protein-ligand non-covalent interaction known, with a 
dissociation constant (Kd) of 10-15 M (Anon n.d.). Due to this property, avidin-biotin 
interactions have been utilized to purify biotinylated proteins from cell or tissue 
extracts in many different systems (Driegen et al. 2005; Huang & Jacobson 2010; 
Cronan 1990). The biotin/streptavidin technique has multiple advantages over 
other affinity-purification strategies including (i) high affinity allows efficient protein 
purification; (ii) the avidin-biotin interaction can endure stringent washing 
conditions; (iii) the high affinity minimizes non-specific background proteins; and 
(iv) this system avoids the use of antibodies which are likely to bind to non-specific 
proteins (Kim et al. 2009; de Boer et al. 2003). Given these advantages, I set out 
to generate a biotinylated mouse model to study the binding partners of MIST1.  
 
 Efficient Biotinylation of BT-tagged MIST1 via Cell Transfection Studies in 
HEK293 Cells. 
Prior to generating a biotinylated mouse model to study MIST1 co-factors, it was 
essential to validate the streptavidin/biotin system in cell culture. Our laboratory 
had successfully introduced a 23 aa BT tag (a biotin acceptor) on to the N terminus 
of MIST1 along with two other epitope tags: (i) 10 aa MYC tag and (ii) 6X His-tag 
to the C-terminus (BT-MIST1Myc/HIS- hereafter known as MIST1BT/Myc). The 
presence of two tags (BT, MYC) allows efficient purification of biotinylated proteins 
via a tandem purification process. Likewise, another epitope tag, HA was 








Figure 3-2. Schematic for the biotinylation of MIST1BT/Myc by BirA ligase. 
HEK293 cells were transfected with expression plasmids Mist1BT/Myc and HA-BirA. 
Both DNA constructs are driven by the CMV promoter. The 23 aa BT tag fused to 
the N terminus of MIST1 is shown above with the asterisk indicating the central 
lysine residue that is biotinylated by BirA ligase. This biotinylated complex was 







In order to perform cell culture experiments to validate the efficiency of the 
streptavidin/biotin system, MIST1BT/Myc and HA-BirA (biotin ligase) cDNA 
constructs were cloned into pcDNA3.1 vector plasmids that utilize a human 
cytomegalovirus (CMV) promoter to achieve high-level gene expression (Jia 2008). 
These two constructs were used to carry out transient transfections in human 
embryonic kidney (HEK) 293 cells.  
The schematic to achieve biotinylation of BT-tagged MIST1 by BirA ligase is 
illustrated in Figure 3-2. Briefly, HEK293 cells were transfected with expression 
plasmids encoding different forms of Mist1 and BirA and then whole cell protein 
extracts were harvested 48 hours post-transfection to monitor protein expression 
and biotinylation by immunoblots. As illustrated in Figure 3-3, immunoblot analysis 
using anti-MYC antibody revealed two patterns of bands for MIST1. The shifted 
bands in lane 3 and 4 represent the lower mobility biotin-tagged BT-MIST1 protein 
whereas the lower band in lane 2 represents the unmodified-MIST1Myc protein.  
Another immunoblot using anti-HA antibody confirmed the expression of BirA 
ligase from the transfected HA-BirA construct. Efficient biotinylation of MIST1BT/MYC 
was confirmed using a Streptavidin-HRP conjugate. The biotinylation process did 
not occur when the cells were transfected with unmodified-MIST1Myc only (lane 4) 
or co-transfected with unmodified-MIST1Myc and HA-BirA (lane 2). These results 
also confirmed the absence of endogenous biotin ligases in the HEK293 cells to 
biotinylate MIST1BT/Myc. However, biotinylation did occur when MIST1BT/Myc and 
HA-BirA were co-expressed (lane 3). In all the immunoblots cells transfected with 








Figure 3-3. Immunoblots with anti-MYC, anti-HA and Streptavidin-HRP 
conjugate confirmed the expression and specific biotinylation of MIST1BT/Myc 
by HA-BirA ligase in HEK293. HEK293 cells were transfected with the pcDNA3.1 
vector only as a negative control for the experiment (lane 1), co-transfected with 
unmodified-Mist1Myc and HA-BirA constructs (lane 2), co-transfected with 
Mist1BT/Myc and HA-BirA constructs (lane 3) and Mist1BT/Myc alone. Anti-MYC 
antibody detected the expression of both tagged and untagged MIST1 (lanes 2, 3 
and 4). Likewise, an anti-HA antibody confirmed the expression of BirA ligase 
(lanes 2 and 3). Streptavidin-HRP conjugate specifically detected only the 








Figure 3-4. Immunohistochemistry of tranfected HEK293 cells revealed the 
appropriate expression of MIST1BT/Myc, HA-BirA and biotinylation of BT-
tagged MIST1 by BirA ligase. After transfection with empty vector pcDNA3.1, 
HA-BirA only or Mist1BT/Myc only and co-transfection with HA-BirA /Mist1BT/Myc  the 
cells were immunostained with anti-MYC, anti-HA and streptavidin-HRP conjugate 
antibodies. Anti-MYC staining was positive in cells expressing MIST1BT/Myc. Anti-
HA antibody confirmed the expression of HA-tagged BirA ligase. The cells which 
expressed MIST1BT/Myc were biotinylated by BirA ligase (Streptavidin staining). 




The above results were further confirmed by performing cell staining 
immunohistochemistry on transfected HEK293 cells (Figure 3-4).  Briefly, HEK293 
cells were transfected using the same plasmids as before, and then the cells were 
fixed 48h post-transfection and stained using the DAB peroxide substrate method. 
MYC and HA antibodies confirmed the expression of MIST1 and BirA respectively. 
As predicted, Streptavidin-HRP conjugate detected biotinylated MIST1 only in cells 
co-transfected with Mist1BT/MYC/HA-BirA plasmids. Altogether, these results 
confirm the synthesis of active MIST1BT/MYC and BirA ligase and efficient 
biotinylation of MIST1. Hence, we established an efficient and functional biotin-
streptavidin system which allowed us to proceed to our next step.  
The next goal was to test if the biotinylated MIST1BT/Myc complex could be 
purified using Streptavidin magnetic beads. Transient transfection was again 
carried out in HEK293 cells using the Mist1BT/Myc construct in the presence and 
absence of HA-BirA. 48 hrs post-transfection protein extracts were harvested.  The 
quantified samples were then incubated to bind to streptavidin-coupled Dynabeads 
and washed to remove background/non-specific proteins. The eluted products 
from the beads were subjected to immunoblotting using anti-MYC antibody and 
Streptavidin-HRP conjugate (Figure 3-5). MYC immunoblotting with Mist1BT/Myc 
alone and in combination with BirA confirmed the expression of MIST1BT/Myc (lanes 
1 and 2). Analysis of the “pulled-down” material using MYC antibody and 
Streptavidin-HRP showed efficient biotinylation of MIST1BT/Myc by BirA ligase and 
effective capturing of the biotinylated MIST1 complex by the beads (lane 4). As 
expected, MIST1BT/Myc alone was not biotinylated and the beads did not capture 
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any of the proteins (lane 3). Interestingly, the input materials detected non-specific 
protein bands in the Mist1BT/Myc alone and Mist1BT/Myc/HA-BirA transfected cells. 
However, in the “pulled-down” samples the background bands were absent. This 
phenomenon confirms the efficiency of the Streptavidin beads in capturing true 
binding partners of MIST1 protein. Overall, these results confirmed that tagged 
MIST1 is efficiently biotinylated by BirA ligase and can be purified using the 
Streptavidin-coupled Dynabeads with limited non-specific biotinylation.  
 Once we established the efficacy of the streptavidin/biotin system in 
vitro, I sought out to translate this approach into an in vivo mouse model in order 
to purify and analyze MIST1 binding factors. 
 
 Generation of Elastasepr- HA-BirA mice 
In an attempt to generate biotin-tagged MIST1 protein exclusively in the pancreas 
we first decided to generate a transgenic mouse that would express the BirA biotin 
ligase only in pancreatic acinar cells. To accomplish this goal we took advantage 
of the rat 500 elastase gene’s bp promoter region that is known to drive transgene 
expression in pancreatic acinar cells (Zhu et al. 2004). Briefly, the coding sequence 
for HA-tagged-BirA (generated by PCR) was cloned into the pBS-Elastasepr 
plasmid by standard procedures to generate Elastasepr-HA-BirA (Elpr-HA-BirA) 
(Figure 3-6). The Elpr-HA-BirA plasmid was then further processed to generate a 








Figure 3-5. Immunoblot analysis confirms a successful pull-down of 
biotinylated MIST1BT/Myc using Streptavidin-coupled magnetic beads. Anti-
MYC antibody detected the expression of MIST1BT/Myc. A Streptavidin-HRP 
conjugate immunoblot confirmed that the MIST1BT/Myc protein can be “pulled-down” 
efficiently (red arrow). In the input samples Streptavidin-HRP detected background 









Figure 3-6. Map of Elpr-HA-BirA plasmid construct generated to make a 
pancreatic acinar cell specific BirA ligase mouse. The Elpr-HA-BirA inserted 
was released by Not1 digestion and this fragment was sent to the Purdue 




To generate transgenic mice expressing acinar-cell specific BirA, I first had 
to release the Elpr-HA-BirA region for mouse embryo pronuclear injections. The 
DNA was digested with Not1/Xmn1 and the 2.7 Kb fragment containing the 500 bp 
Elastase promoter, rabbit β-globin intron, the HA-BirA coding region and a 3’ β-
globin flanking region was isolated (Figure 3-6). The transgene construct was then 
sent to the Purdue Transgenic Mouse Core Facility for pronuclear injection into 
C57Bl/6 embryos (Figure 3-7A). This procedure resulted in the generation of 
twelve founder lines (F0). Genomic DNA was extracted from tail clips and used for 
genomic PCR strategies to identify which founders contained the Elpr-HA-BirA 
transgene. As shown in Figure 3-7B, 4 out of 12 animals (1BX, 1BY, 2BZ, 4BX) 
showed the expected 315 bp product, confirming incorporation of the Elpr-HA-BirA 
transgene into the mouse genome. 
In order to confirm appropriate transgene expression of Elpr-HA-BirA in 
acinar cells, pancreata were harvested from lines 1BX, 1BY, 2BZ and 4BX and 
processed for protein and paraffin tissue blocks. Immunoblot analysis using anti-
HA antibody revealed the presence of the 36 kDa HA-BirA ligase in the pancreas 
of the newly generated transgenic mouse lines (Elpr-HA-BirA) as illustrated in 
Figure 3-8A. Similarly, immunohistochemistry (IHC) performed using anti-HA 
antibody revealed expression of the HA-BirA ligase exclusively in acinar cells 
(Figure 3-8B). Interestingly, there was a slight mosaic expression pattern detected 
which has been shown to occur in other transgenic settings using the elastase 
promoter (Zhu et al. 2007). Nonetheless, expression was acinar specific. Islet and 
duct cells remained HA-BirA negative (Figure 3-8B).  
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 In summary, we were able to generate a functional transgenic mouse line 
that faithfully expressed BirA ligase exclusively in pancreatic acinar cells. This line 
could therefore be used to biotinylate MIST1BT/Myc in pursuing our quest to identify 
interacting partners of MIST1. 
 
 Generation of Mist1BT/Myc Mice 
Having generated a functional BirA ligase transgenic (Elpr-HA-BirA) mouse 
line, we next proceeded to establish a BT-tagged MIST1 mouse model that would 
be required to test if BirA-mediated biotinylation would be feasible in vivo using 
transgenic mouse approaches. The goal was to generate a Mist1BT/BT; Elpr-HA-BirA 
mouse where pancreatic MIST1 proteins and any associated co-factors could be 
purified by Streptavidin pull-down and analyzed by LC-MS/MS.  
We independently generated a mouse line in which the BT tag was incorporated 
into the N-terminus of the MIST1 protein through homologous recombination 
strategies (Karki et al. 2015). Briefly, Mist1BT/+ mice were produced by generating 
a Mist1 targeting vector containing loxP sites flanking the entire Mist1 coding 
region within exon 2 (Pin et al. 1999).  In addition, a small biotin-tag (de Boer et al. 
2003) and MYC-tag were added to the N-terminus and C-terminus of the MIST1 
open reading frame, respectively (Figure 3-9A). ES cell electroporation and 
blastocyst injections were performed by the Purdue University Transgenic Mouse 








Figure 3-7. Elpr-HA-BirA was used to generate Elpr-HA-BirA transgenic mice. 
(A) Final DNA fragment of Elpr-HA-BirA (2.7 Kb product) generated to inject into 
embryo pronuclei. (B) PCR analysis of genomic DNA confirmed the incorporation 
of the Elpr-HA-BirA transgene in 4 of the 12 founder lines (1BX, 1BY, 2BZ, 4BX). 
The transgene is identified as a 315 bp product (indicated by the red arrow). WT 
genomic DNA was used as a negative control and the original BirA plasmid was 







Figure 3-8. HA-tagged BirA ligase expressed in the pancreas and found in 
the nuclei and cytoplasm of pancreatic acinar cells harvested from Elpr-HA-
BirA transgenic mice. (A) Immunoblot with an anti-HA antibody demonstrated 
the presence and expression of HA-BirA ligase in the pancreas of transgenic mice. 
(B) IHC using anti-HA antibody showed heterogeneous expression of HA-BirA 
ligase in both the cytoplasm and nuclei of pancreatic acinar cells. (red dotted line). 
Absence of BirA ligase in a subset of acinar cells (designated by yellow dotted line) 
confirmed the specificity of the staining. As expected, expression of HA-BirA was 
absent in islets (black dotted line). WT mice were used as negative control.  
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Subsequent screening on individual 129/SV ES cell clones identified a 
correctly targeted line that was used to generate chimeric mice. The chimeric mice 
were then crossed to C57BL/6 animals to generate germline transmission. The 
new Mist1BT/+ animals were then backcrossed 10 generations on to a C57BL/6 
background and used for subsequent studies (Figure 3-9B).  
 
 Characterization of Mist1BT/+ Mice 
Before generating the required mouse lines for further experiments, 
functionality tests had to be performed to determine if tagged MIST1 was 
expressed correctly in mouse tissues. In order to carry out these tests, pancreata 
from Mist1WT and heterozygous Mist1BT/+ mice were harvested for paraffin sections 
followed by IHC with anti-MYC antibody. As expected, Mist1WT pancreata were not 
stained by anti-MYC antibody while Mist1BT/+ pancreata exhibited strong nuclear 
expression of MIST1 exclusively in pancreatic acinar cells, indicating successful 
homologous recombination, expression, and nuclear localization of the MISTBT/Myc 
protein (Figure 3-10). In order to demonstrate that MIST1BT/Myc protein could 
functionally substitute for MIST1WT protein in acinar cell development and function 
I performed studies to verify that Mist1BT/BT and Mist1BT/+ mice were 
morphologically, phenotypically and functionally identical to Mist1WT mice. For 
these studies, pancreata from Mist1WT and Mist1BT/BT littermates were harvested 








Figure 3-9. Generation of Mist1BT/+ mice. (A) Schematic of how the Mist1BT/+ 
mice were generated through homologous recombination. LoxP sites flank the 
entire Mist1 coding region which is contained within exon 2. Mist1BT/+ contains an 
N-terminal BT tag as well as a C-terminal MYC tag, allowing for tandem purification 
techniques. (B) Genotyping of F2 generations. Mist1BT/+ positive offspring are 
identified as containing two bands (330 bp and150 bp) while the Mist1WT shows 
only the expected 150 bp band. Genomic DNA from a WT mouse was used as a 
negative control and the targeting DNA construct was used as a positive control. 




IHC using anti-MIST1 antibody detected MIST1 in Mist1WT samples but no 
signal in Mist1KO mouse pancreata.  Anti-MYC staining on Mist1BT/BT mice showed 
acinar-specific expression of the Mist1BT/Myc gene. Importantly, Mist1BT/BT mouse 
pancreata also exhibited correct acinar polarity when compared to Mist1KO acini 
which exhibit defective apical-basal organization (Figure 3-11A). Immunoblot 
analysis confirmed that Mist1BT/BT mice express 2-fold higher levels of MIST1BT/Myc 
when compared to Mist1BT/+ mice (Figure 3-11B). These results confirmed that 
Mist1BT/BT, Mist1BT/+ and Mist1WT mice were phenotypically similar. 
To further verify that Mist1BT/BT mice are functionally identical to Mist1WT mice, we 
examined the expression patterns of known MIST1 target genes. RT-qPCR 
analysis revealed that normal MIST1 target genes are expressed to appropriate 
levels in both Mist1WT and Mist1BT/BT mice. As demonstrated in Figure 3-12, Cx32, 
Foxp2, Rnd2 and Atp2c2 gene expression was similar in Mist1+/- and Mist1BT/BT 
pancreata. These experiments confirmed that acinar cell morphology and 
transcriptional activity in Mist1+/+ and Mist1BT/BT mice are identical. This allowed us 
to proceed to generate a mouse line consisting of both BT tagged MIST1 and the 







Figure 3-10. Myc-tagged MIST1 is expressed in Mist1BT/+ acinar cells. IHC 
using anti-MYC antibody detected no signal in Mist1WT pancreata (left- red arrows). 
In contrast, anti-MYC staining revealed positive nuclear staining in Mist1BT/+ acinar 
cells (right-yellow arrows), but not in islet cells (red dashed lines) centroacinar and 
duct cells (red arrows). IF staining using anti-MYC and AMYLASE also confirm the 
expression of BT-tagged MIST1 exclusively in the nuclei of acinar cells in Mist1BT/+ 
mice (yellow arrows) but not in Mist1WT mice. As expected islets (white dotted lines) 
and duct cells (red arrow) stained negative for MYC. The cytoplasmic AMYLASE 





Figure 3-11. MIST1BT/BT mouse acinar cell organization is identical to Mist1WT 
mice. (A) IHC using anti-MIST1 antibody detected MIST1 protein in Mist1WT and 
no signal in Mist1KO mouse pancreata.  Anti-MYC staining on Mist1BT/BT mice 
showed the proper incorporation of the Mist1BT/Myc gene and appropriate 
MIST1BT/Myc protein localization in the nuclei of acinar cells but not in islet cells. 
Mist1BT/BT mice pancreata have similar acinar cell polarity as observed in Mist1WT. 
Representative H&E stains revealed that Mist1WT and Mist1BT/BT pancreata exhibit 
similar apical-basal polarity relative to the disrupted Mist1KO phenotype. Dotted 
lines outline a single acinus. (B) Immunoblot analysis of protein samples revealed 
that there was a 2-fold increase in MIST1 protein in Mist1BT/BT mice when 









Figure 3-12. Gene expression of MIST1 target genes. Quantitative Real Time 
PCR revealed the gene expression patterns of MIST1 target genes where Cx32, 
Foxp2 and Atp2c2 were up-regulated in both Mist1+/- and Mist1BT/BT mice in a 
similar manner. As predicted, transcript levels of Rnd2 decreased in both Mist1+/- 




Figure 3-13. MIST1BT/Myc is biotinylated by BirA ligase expressed by Elpr-HA-
BirA transgenic mice. IHC using anti-MYC antibody detected MIST1 in the nuclei 
of acinar cells (red arrows) but not in islets (black dotted lines) and 
ducts/centroacinar cells (yellow arrows). Anti-HA antibody revealed the patchy 
expression of BirA ligase mostly in the cytoplasm of acinar cells (yellow dotted 
lines). The absence of BirA is designated by black arrows and orange dotted lines. 
Streptavidin-HRP staining showed mostly positive nuclear staining (purple arrows) 
and also showed cytoplasmic staining, indicating the presence of biotinylated 
protein in the cytoplasmic compartment as well. 
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 Generation of Mist1BT/BT; Elpr-HA-BirA Mice 
Once we generated two independent Mist1BT/Myc and Elpr-HA-BirA mouse 
lines, we next sought to generate a mouse line containing both alleles. Hence, 
Mist1BT/Myc mice were crossed to Elpr-HA-BirA mice to generate Mist1BT/+; Elpr -HA-
BirA offspring.  Male and female pups (Mist1BT/+; Elpr -HA-BirA) were then crossed 
to generate Mist1BT/BT; Elpr-HA-BirA mice. The assessment of expression and 
biotinylation of MIST1BT/Myc by BirA ligase (expressed specifically in the pancreas) 
in Mist1BT/BT; Elpr-HA-BirA mice was accomplished by performing 
immunohistochemistry and immunoblotting. IHC using anti-MYC antibody 
detected the expected nuclear localization of MIST1BT/Myc in Mist1BT/BT; Elpr-HA-
BirA mice (Figure 3-13). Unfortunately, anti-HA identified BirA ligase expression 
mostly in the cytoplasm of acinar cells and very low expression in the nuclei 
(Figure 3-13). The localization of BirA in the nuclei is essential for nuclear MIST1 
biotinylation. This could be a problem in conducting further experiments to pull-
down MIST1 complexes. Surprisingly, upon using Streptavidin-HRP to detect 
biotinylated MIST1BT/Myc protein, we confirmed that HA-tagged BirA successfully 
biotinylated the acinar-specific BT-tagged MIST1 protein (Figure 3-13). We next 
subjected the protein samples for immunoblotting. Although anti-MYC and anti-HA 




Figure 3-14. Elpr-HA-BirA ligase failed to specifically biotinylate only the 
MIST1BT/Myc protein. Although immunoblots using anti-MYC and anti-HA 
antibodies showed the presence of MIST1BT/Myc and HA-BirA ligase respectively, 
Streptavidin-HRP blots revealed the presence of numerous background proteins 
besides the biotinylated MIST1 protein extracted from Mist1BT/+;Elpr-HA-BirA mice. 
Blot (1) designates a short exposure blot where the red asterisks show the non-
specific proteins and black asterisk show the biotinylated MIST1 by BirA ligase as 
detected by Streptavidin-HRP. Blot (2) designates a long exposure of the 
Streptavidin-blot showing a numerous amount of background proteins in all in all 







Figure 3-15. Successful biotinylation of MIST1BT/BT by R26HA-BirA. (A) 
Streptavidin-HRP IHC staining showed that there was no biotinylation in Mist1+/+ 
mice. However, Mist1BT/BT;R26HA-BirA pancreata showed positive nuclear staining 
in acinar cells (arrows), indicating the presence of biotinylated MIST1 protein. (B) 
Immunoblot analysis of protein samples showed successful biotinylation in 
Mist1BT/BT; R26HA-BirA and Mist1BT/+; R26HA-BirA mice. The MIST1 level in Mist1BT/BT 
samples was comparatively higher than found in Mist1BT/+ samples as detected by 
anti-MYC antibody. The biotinylated MIST1BT/Myc was detected by Streptavidin-
HRP. Anti-HSP90 served as a loading control. The extra band on the third lane in 
the Streptavidin-HRP blot occurred because of lane spillover. 
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Streptavidin-HRP detected a large number of background proteins that were 
present in all tested genotypes (Figure 3-14). Therefore, although the Mist1BT/BT; 
Elpr-HA-BirA mice showed promising results for use in pull-down experiments on 
biotinylated MIST1BT/Myc, the detection of non-specific proteins by Streptavidin-
HRP made us seek an alternative approach. 
 
3.2.7 Generation of Mist1BT/BT; R26HA-BirA Mice 
Because Mist1BT/BT; Elpr-HA-BirA mice contained numerous amount of 
unspecific proteins we did not proceed to perform pull-down experiments with this 
model. Instead, we decided to utilize an alternative BirA mouse, the R26HA-BirA line 
that was provided by Dr. Dies Meijer from Erasmus University Medical Center, 
Netherlands. R26HA-BirA mice contain an HA-tagged birA coding region 
incorporated into the Gt(ROSA)26Sor locus, allowing for constitutive gene 
expression of the HA-BirA transcript (Driegen et al. 2005). Although these mice 
presumably constitutively express HA-BirA in all tissues, it was unknown whether 
BirA was expressed in the pancreas. Thus, R26HA-BirA mice were crossed with 
Mist1BT/Myc mice to generate Mist1BT/BT; R26HA-BirA progeny. In this fashion we could 
take advantage of the acinar-specific expression of the Mist1BT/Myc locus to insure 
acinar-restricted MIST1 biotinylation. 
 Analysis of BirA activity in Mist1BT/BT; R26HA-BirA mice using 
Streptavidin-HRP IHC staining revealed strong, positive nuclear staining 
exclusively in pancreatic acinar cells (Figure 3-15A). In contrast, there was no 
detected biotinylation in Mist1+/+ samples. Analysis of protein extracts from Mist1+/+, 
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Mist1BT/BT, Mist1BT/+; R26HA-BirA and Mist1BT/BT; R26HA-BirA mice using anti-MYC and 
Streptavidin-HRP showed that MIST1BT/Myc protein was successfully biotinylated 
by HA-BirA (Figure 3-15B).  As expected, the protein level MIST1 in Mist1BT/BT 
mice was higher than that in Mist1BT/+ mice (Figure 3-15B). This also verified that 
homozygous BT-tagged-MIST1 could enhance the amount of MIST1 protein 
available for pull-down experiments. Hence, we decided to use Mist1BT/BT; R26HA-
BirA mice instead of Mist1BT/+; R26HA-BirA mice for our MS/MS studies. 
The successful biotinylation of BT-tagged MIST1 by BirA ligase in R26HA-
BirA mice allowed us to proceed to immunoprecipitate MIST1 protein complexes. 
Studies have shown that there are very few naturally biotinylated proteins in mice 
(de Boer et al. 2003) and of these most are located in the cytoplasmic and 
mitochondrial compartments. To eliminate or minimize background binding 
proteins in the biotinylated MIST1 protein complexes, we focused on preparing 
pure nuclear extracts from mouse pancreata to perform mass spectrometry. To 
test the fractionation of the cytoplasmic and nuclear proteins, immunoblot analysis 
was performed using antibodies for the nuclear marker-SP1 and the cytoplasmic 
marker-GAPDH (Figure 3-16). As predicted, SP1 protein was mostly detected in 
nuclear extracts whereas GAPDH was predominantly found in the cytoplasmic 








Figure 3-16. Immunoblots of cytoplasmic and nuclear extracts fractionated 
using the NE-PER kit. Cytoplasmic and nuclear extracts from Mist1BT/BT mice, 
R26 HA-BirA mice and Mist1BT/BT; R26HA-BirA mouse pancreata were immunoblotted 
using SP1 (nuclear protein marker) and GAPDH (cytoplasmic marker) antibodies. 
The immunoblots confirmed that the NE-PER kit successfully enriched for nuclear 
and cytoplasmic proteins. The same kit was used to prepare nuclear samples for 
mass spectrometry analysis.  
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 Co-immunoprecitation of MIST1BT/Myc Complexes from Mist1BT/BT; R26HA-BirA 
mice Using Streptavidin-Dynabeads 
Once we optimized the conditions to isolate pure nuclear extracts from 
mouse pancreata, the next step was to perform a pull-down assay to purify MIST1-
interacting protein complexes. Pancreatic nuclear protein extracts were isolated 
from R26HA-BirA and Mist1BT/BT; R26HA-BirA mice as in Figure 3-16. Biotinylated 
MIST1 from the nuclear extracts was pulled down using Streptavidin-coated 
magnetic beads. Immunoblot analysis showed a successful immunoprecipitation 
of MIST1 protein where anti-MYC antibody detected the presence of MIST1BT/Myc. 
Likewise, a Streptavidin-HRP blot demonstrated that the biotinylated MIST1BT/Myc 
protein could be pulled down efficiently (Figure 3-17A). We also attempted an 
alternative pull-down using His-tag magnetic beads. This method also produced a 
successful pull-down of the MIST1 complexes (Figure 3-17B). As predicted, a 
Streptavidin-HRP blot confirmed the effective pull-down of biotinylated MIST1 by 
the His-tag magnetic beads (Figure 3-17B).  
  Mass Spectometry Analysis 
In order to prepare samples for mass spectrometry analysis, 1000 μg of 
protein samples from R26HA-BirA (control) and Mist1BT/BT; R26HA-BirA mouse 
pancreata were used. For on-bead digestion, the Streptavidin Dynabeads along 
with the MIST1 complexes were washed and re-suspended in 50 mM ammonium 
bicarbonate and 6M urea to denature and reduce proteins. Upon purification of the 
complex, input and pull-down aliquots were subjected to immunoblot analysis. 




Figure 3-17. Immunoblot analysis showing successful pull-down of MIST1 
using Streptavidin coupled magnetic beads and His-tag magnetic beads. (A) 
Immunoblot analysis of pull down of MIST1 using Streptavidin-coupled magnetic 
beads. Anti-MYC antibody revealed the presence of MIST1BT/Myc. The Streptavidin-
HRP blot demonstrates that the biotinylated BT-tagged MIST1 protein can be 
isolated. (B) Immunoblot analysis showing successful pull down of MIST1 using 
His-tag magnetic beads. Anti-MYC showed the presence of MIST1BT/Myc. The 




Immunoblot analysis revealed a successful pull-down of MIST1 complexes using 
Streptavidin-coated magnetic beads. Silver staining of SDS-PAGE was performed 
to determine if additional protein bands could be detected from the pull-down 
material. As illustrated in Figure 3-18, Streptavidin-HRP immunoblot confirmed a 
successful pull-down of the biotinylated MIST1 complex. Lane 2 detected the input 
material whereas lane 4 revealed the biotinylated MIST1 protein. As predicted an 
anti-MYC immunoblot showed the presence of MIST1BT/Myc in both input and 
pulled-down groups (lane 2 and lane 4, respectively) materials only in the 
Mist1BT/BT; R26HA-BirA mice. Silver staining SDS-PAGE showed a similar band 
pattern in the input protein samples from R26HA-BirA and Mist1BT/BT; R26HA-BirA mice 
pancreata (lane 1 and 2). The pulled-down samples from Mist1BT/BT; R26HA-BirA 
mice pancreata showed numerous protein bands associated with biotinylated 
MIST1 protein (lane 4). As expected, pulled-down samples from control mice 
(R26HA-BirA) showed fewer protein bands (lane 3) confirming the enrichment using 
Streptavidin-Dynabeads (Figure 3-18). The remaining protein samples were 
denatured and reduced for 30 mins at 50°C in a buffer, consisting of 50mM 
trimethyl ammonium bicarbonate with 0.1% RapiGest (Waters) and 5mM 
dithiothreitol. Additionally, the proteins were alkylated in 15mM iodoacetamide for 
one hour at room temperature in a dark room. This was followed by digesting the 
samples with proteomics grade trypsin at 1 to 100 dilution at 37°C overnight.  In 
order to lower the pH (below pH3), 100mM HCl was added to the peptide mix. The 
samples were then incubated for 40 mins at 37°C. The samples were centrifuged 
at 16,100xg for efficient removal of RapiGest and the supernatant collected.  
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The sample was mixed in equal volume of 1% trifluoroacetic acid and cleaned 
using a Sep-Pak C18 tips (Waters) to remove buffer and small molecules. The 
peptides were eluted in a buffer containing 0.1% trifluoroacetic acid in 80% 
acetonitrile. The samples were dried completely using a SpeedVac before 
processing through a LC-MS/MS system to identify the proteins in the MIST1 
complexes. The mass spectrometry analysis of the digested samples was 
performed by Keerthi Jayasundera in Dr. Andy Tao’s laboratory at Purdue 
University.  
We performed a total of 6 independent rounds of MS/MS using R26HA-BirA 
mouse (control) and Mist1BT/BT; R26HA-BirA mouse (experimental) samples. The 
data collected from each run was further analyzed by Dr. Ernesto Nakayasu using 
MAXQuant software (Tyanova et al. 2015) dedicated to perform a quantitative 
proteomics of multiple datasets. This allowed us to refine/filter the dataset for 
further analysis. Dr. Hyung Won-Choi then processed these datasets using 
another computational scoring tool named Significance Analysis of INTeractome 
(SAINT) which generated confidence scores of bait-prey interactions in order to 
precisely identify true interacting protein partners (Choi et al. 2011). This tool used 
spectral count-based scoring for quantitative analyses of the mass spectrometry 
data. The principle idea of determining the true interaction between MIST1 and 
another protein using this system is that if a particular protein is a real binding 
partner of MIST1, then its concentration in the experimental pull-down material 





Figure 3-18. Representative immunoblots and silver staining analysis on the 
samples prepared for various rounds of mass spectrometry. Immunoblots 
performed on the input and the pull-down samples using anti-MYC antibody and 
Streptavidin-HRP confirmed the effective pull-down of the MIST1 complex. HSP90 
immunoblot served as a control. Silver staining gel image is the visual 





Hence, the greater the spectral counts in the experimental sample signifies a real 
interaction. The data output is summarized in Table 4. 
After the proteins were sorted out based on each round, I further sorted the 
proteins that were captured in at least 2 replicates (Table 5).There were a total of 
23 unique proteins that were identified from the six MS/MS runs. As predicted, 
MIST1 (Bhlha15) was pulled-down in each round with a Saint score of 1 
(confirming a true interaction). Studies have shown that MIST1 can homodimerize 
(Tran et al. 2007) and therefore the presence of MIST1 in each round validated the 
efficiency of the pull-downs performed for mass spectrometry. Previously, cell 
culture studies had identified SAP18 as a binding partner of MIST1 (Jia 2008). 
However, in this mouse study I was unable to detect SAP18 on the prey protein 
list, suggesting that tissue culture and intact pancreata utilize different transcription 
mechanisms.  
Besides MIST1, another frequently pulled-down (3 times) prey protein was 
Cathepsin B, a lysosomal protease, which is often overexpressed in various 
cancers such as brain and lung (Rempel et al. 1994; Krepela et al. 1990). Likewise, 
Syndecan-1, a cell surface proteoglyacan essential for cell-cell adhesion in 
epithelial cells (Leppä et al. 1996; Teng et al. 2012) and involved in inflammatory 
responses was also identified as a putative MIST1 partner. Filamin, Tropomodulin 




Table 4. Summary of protein-protein interactions analyzed by SAINT analysis. 
The terms in each column are as follows: Bait name and round of mass 
spectrometry (For example MIST1 1.1 refers to round 1 (Column 1); Prey 
UNIPROT ID (Column 2); Prey gene symbol (Column 3); Spec: spectral count of 
the prey in that purification of bait (Column 4); CtrlCounts: spectral counts in the 
control purifications i.e R26HA-BirA samples (Column 5); SaintScore: probability of 
true interaction (between 0 and 1) (Column 6); FoldChange: estimated fold change 
between prey protein abundance in real bait purification over controls (Column 7); 
BFDR: Bayesian false discovery rate (usually the criterion for selection, e.g. 1%, 
5%, depending on the stringency) (Column 8); Prey Protein Description: Based on 
MaxQuant analysis (Column 9).  
 
Bait Prey PreyGene Spec ctrlCounts SaintScore FoldChange BFDR Prey Protein Description
MIST1.1 A0JNZ0 Nedd4 2 0|0|0|0|0|0 0.9 20 0.01 HECT (E6AP-type E3 ubiquitin-protein ligase)
MIST1.1 A1BN54 Actn1 9 0|0|0|1|0|0 1 18 0 Actin binding
MIST1.1 D3YWL1 Rab3d 2 0|0|0|0|0|0 0.9 20 0.01 Ras-related protein rab-3D
MIST1.1 D3Z637 Tpd52 2 0|0|0|0|0|0 0.9 20 0.01 Tumor-protein D52
MIST1.1 E9Q5B2 0610011F06Rik 2 0|0|0|0|0|0 0.9 20 0.01 T-complex protein 1 subunit delta
MIST1.1 G5E839 Cct4 4 0|0|0|0|0|0 1 40 0 T-complex protein 1 subunit delta
MIST1.1 P00688 Amy2 151 42|12|54|58|50|5 1 2.7 0 Pancreatic alpha-amylase
MIST1.1 P05132 Prkaca 9 0|0|0|0|0|0 1 90 0 cAMP-dependent protein kinase catalytic subunit alpha
MIST1.1 P48036 Anxa5 2 0|0|0|0|0|0 0.9 20 0.01 Annexin A5
MIST1.1 P62814 Atp6v1b2 2 0|0|0|0|0|0 0.9 20 0.01 V-type proton ATPase subunit B, brain isoform
MIST1.1 P63028 Tpt1 32 0|0|6|4|0|2 1 6.4 0 Translationally-controlled tumor protein
MIST1.1 P70562 Bhlha15 8 0|0|1|0|0|0 1 16 0 Class A basic helix-loop-helix protein 15
MIST1.1 Q059I1 Rps28 10 0|0|2|2|1|2 0.98 5 0.01 40S ribosomal protein S28
MIST1.1 Q3TBF1 Padi2 3 0|0|0|0|0|0 0.98 30 0 Protein-arginine deiminase type-2
MIST1.1 Q3TFB5 Nans 2 0|0|0|0|0|0 0.9 20 0.01 Putative uncharacterized protein
MIST1.1 Q3UD94 Psmc3 2 0|0|0|0|0|0 0.9 20 0.01 26S protease regulatory subunit 6A
MIST1.1 Q3UL02 Gspt1 2 0|0|0|0|0|0 0.9 20 0.01 Eukaryotic peptide chain release factor GTP-binding subunit ERF3B
MIST1.1 Q3UL78 Cdc42 2 0|0|0|0|0|0 0.9 20 0.01 Cell division control protein 42 homolog
MIST1.1 Q3UMP2 Hmgcl 3 0|0|0|0|0|0 0.98 30 0 Hydroxymethylglutaryl-CoA lyase, mitochondrial
MIST1.1 Q3UPH1 Prrc1 2 0|0|0|0|0|0 0.9 20 0.01 Protein PRRC1
MIST1.1 Q4V9T8 Eif1 3 0|0|0|0|0|0 0.98 30 0 Eukaryotic translation initiation factor 1A, X-chromosomal
MIST1.1 Q544B1 Aldh2 6 0|0|0|0|0|0 1 60 0 Aldehyde dehydrogenase, mitochondrial
MIST1.1 Q545F0 Mif 2 0|0|0|0|0|0 0.9 20 0.01 Macrophage migration inhibitory factor
MIST1.1 Q561N4 Ube2l3 2 0|0|0|0|0|0 0.9 20 0.01 Ubiquitin-conjugating enzyme E2 L3
MIST1.1 Q5NC81 Nme1 2 0|0|0|0|0|0 0.9 20 0.01 Nucleoside diphosphate kinase;Nucleoside diphosphate kinase A
MIST1.1 Q65ZC0 Igkc 5 0|0|0|0|0|0 1 50 0 Ig kappa chain C region;Ig kappa chain V-II region 26-10
MIST1.1 Q6LAF6 Ctsb 2 0|0|0|0|0|0 0.9 20 0.01 Cathepsin B;Cathepsin B light chain;Cathepsin B heavy chain
MIST1.1 Q7JD03 COX2 3 0|0|0|0|0|0 0.98 30 0 Cytochrome c oxidase subunit 2
MIST1.1 Q80X90 Flnb 3 0|0|0|0|0|0 0.98 30 0 Filamin-B;Filamin-C
MIST1.1 Q8BH64 Ehd2 3 0|0|0|0|0|0 0.98 30 0 EH domain-containing protein 2
MIST1.1 Q8BKE0 Psma2 2 0|0|0|0|0|0 0.9 20 0.01 Proteasome subunit alpha type;Proteasome subunit alpha type-2
MIST1.1 Q8BP47 Nars 4 0|0|0|0|0|0 1 40 0 Asparagine--tRNA ligase, cytoplasmic
MIST1.1 Q8BPD3 Prdx6 3 0|0|0|0|0|0 0.98 30 0 Peroxiredoxin-6
MIST1.1 Q8BSZ7 Ap1g1 2 0|0|0|0|0|0 0.9 20 0.01 AP-1 complex subunit gamma-1
MIST1.1 Q8BTU6 Eif4a2 2 0|0|0|0|0|0 0.9 20 0.01 Eukaryotic initiation factor 4A-II
MIST1.1 Q8BWT1 Acaa2 4 0|0|0|0|0|0 1 40 0 3-ketoacyl-CoA thiolase, mitochondrial
MIST1.1 Q8C165 Pm20d1 3 0|0|0|0|0|0 0.98 30 0 Probable carboxypeptidase PM20D1
MIST1.1 Q8CCJ3 Ufl1 3 0|0|0|0|0|0 0.98 30 0 E3 UFM1-protein ligase 1
MIST1.1 Q8R2E9 Ero1lb 21 0|0|4|6|0|3 1 4.2 0 ERO1-like protein beta
MIST1.1 Q8R3V2 Aimp2 3 0|0|0|0|0|0 0.98 30 0 Aminoacyl tRNA synthase complex-interacting multifunctional protein 2
MIST1.1 Q8VCT4 Ces1d 5 0|0|0|1|0|0 0.96 10 0.01 Carboxylesterase 1D
MIST1.1 Q8VE47 Uba5 2 0|0|0|0|0|0 0.9 20 0.01 Ubiquitin-like modifier-activating enzyme 5
MIST1.1 Q99JZ4 Sar1a 2 0|0|0|0|0|0 0.9 20 0.01 GTP-binding protein SAR1a
MIST1.1 Q9CRF4 Oxct1 2 0|0|0|0|0|0 0.9 20 0.01 Succinyl-CoA:3-ketoacid-coenzyme A transferase
MIST1.1 Q9D8V7 Sec11c 5 0|0|0|1|0|0 0.96 10 0.01 Signal peptidase complex catalytic subunit SEC11C
MIST1.1 Q9DB27 Mcts1 2 0|0|0|0|0|0 0.9 20 0.01 Malignant T-cell-amplified sequence 1
MIST1.1 Q9JJD8 Cct2 7 0|0|0|0|0|0 1 70 0 T-complex protein 1 subunit beta
MIST1.1 Q9QXB9 Drg2 3 0|0|0|0|0|0 0.98 30 0 Developmentally-regulated GTP-binding protein 2
MIST1.1 Q9QXT0 Cnpy2 2 0|0|0|0|0|0 0.9 20 0.01 Protein canopy homolog 2
MIST1.1 Q9R071 Eif6 2 0|0|0|0|0|0 0.9 20 0.01 Eukaryotic translation initiation factor 6
MIST1.1 Q9WTP6 Ak2 2 0|0|0|0|0|0 0.9 20 0.01 Adenylate kinase 2, mitochondrial
MIST1.2 E9Q5B6 Hnrnpd 2 0|0|0|0|0|0 0.9 20 0.01 Heterogeneous nuclear ribonucleoprotein D0
MIST1.2 P70562 Bhlha15 5 0|0|1|0|0|0 0.96 10 0.01 Class A basic helix-loop-helix protein 15
MIST1.2 Q3TYX1 Srebf1 2 0|0|0|0|0|0 0.9 20 0.01 Sterol regulatory element-binding protein 1
MIST1.2 Q6ZWX2 Tmsb4x 2 0|0|0|0|0|0 0.9 20 0.01 Thymosin beta-4
MIST1.2 Q7JD03 COX2 2 0|0|0|0|0|0 0.9 20 0.01 Cytochrome c oxidase subunit 2
MIST1.2 Q80WW4 Serpinb9c 2 0|0|0|0|0|0 0.9 20 0.01 Serine (or cysteine) peptidase inhibitor, clade B, member 9c
MIST1.2 Q8BL32 Hnrnpr 2 0|0|0|0|0|0 0.9 20 0.01 Heterogeneous Nuclear Ribonucleoprotein R
MIST1.2 Q9D094 Hars 2 0|0|0|0|0|0 0.9 20 0.01 Histidine--tRNA ligase, cytoplasmic
MIST1.3 A2BGI8 Ppih 2 0|0|0|0|0|0 0.9 20 0.01 Peptidyl-prolyl cis-trans isomerase
MIST1.3 P11983 Tcp1 2 0|0|0|0|0|0 0.9 20 0.01 T-complex protein 1 subunit alpha
MIST1.3 P43275 Hist1h1a 5 0|0|0|1|0|0 0.96 10 0.01 Histone H1.1
MIST1.3 P70562 Bhlha15 12 0|0|1|0|0|0 1 24 0 Class A basic helix-loop-helix protein 15
MIST1.3 Q1WWK3 Hist1h1b 2 0|0|0|0|0|0 0.9 20 0.01 Histone H1.5
MIST1.3 Q3TQS1 Larp1b 2 0|0|0|0|0|0 0.9 20 0.01 La Ribonucleoprotein Domain Family, Member 1B
MIST1.3 Q3UDX4 Dhx15 2 0|0|0|0|0|0 0.9 20 0.01 Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15
MIST1.3 Q3UWI9 Kif5b 2 0|0|0|0|0|0 0.9 20 0.01 Kinesin heavy chain isoform 5C;Kinesin-1 heavy chain;Kinesin heavy chain isoform 5A
MIST1.3 Q5NTY0 Dnaja1 2 0|0|0|0|0|0 0.9 20 0.01 DnaJ homolog subfamily A member 1
MIST1.3 Q6LAF6 Ctsb 2 0|0|0|0|0|0 0.9 20 0.01 Cathepsin B;Cathepsin B light chain;Cathepsin B heavy chain
MIST1.3 Q6ZPS0 Rrbp1 8 0|0|0|0|0|0 1 80 0 Ribosome Binding Protein 1
MIST1.3 Q923D4 Sf3b5 2 0|0|0|0|0|0 0.9 20 0.01 Splicing factor 3B subunit 5
MIST1.3 Q9ME04 mt-Nd4 3 0|0|0|0|0|0 0.98 30 0 NADH-ubiquinone oxidoreductase chain 4
1 2 3 4 5 6 7 8 9
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 Different colors in the table symbolize six different mass spectrometry rounds. 
 
Bait Prey PreyGene Spec ctrlCounts SaintScore FoldChange BFDR Prey Protein Description
MIST1.4 A2A6U3 Sept9 4 0|0|0|0|0|0 1 40 0 Septin-type G (guanine nucleotide-binding)
MIST1.4 A2AFS1 Sars 2 0|0|0|0|0|0 0.9 20 0.01 Serine--tRNA ligase, cytoplasmic
MIST1.4 A4FUV5 Sec24a 2 0|0|0|0|0|0 0.9 20 0.01 Protein transport protein Sec24A
MIST1.4 E9Q5B6 Hnrnpd 2 0|0|0|0|0|0 0.9 20 0.01 Heterogeneous nuclear ribonucleoprotein D0
MIST1.4 E9Q6T6 Tdrd3 2 0|0|0|0|0|0 0.9 20 0.01 Tudor domain-containing protein 3
MIST1.4 G3XA10 Hnrnpu 13 0|0|3|4|0|0 0.96 3.71 0.01 Heterogeneous nuclear ribonucleoprotein U
MIST1.4 K3W4L0 Myo18a 2 0|0|0|0|0|0 0.9 20 0.01 Unconventional myosin-XVIIIa
MIST1.4 P00920 Ca2 2 0|0|0|0|0|0 0.9 20 0.01 Carbonic anhydrase 2
MIST1.4 P70562 Bhlha15 11 0|0|1|0|0|0 1 22 0 Class A basic helix-loop-helix protein 15
MIST1.4 Q1A602 Actn4 2 0|0|0|0|0|0 0.9 20 0.01 Alpha-actinin-4
MIST1.4 Q3U6K9 Psat1 2 0|0|0|0|0|0 0.9 20 0.01 Phosphoserine aminotransferase
MIST1.4 Q3UWI9 Kif5b 2 0|0|0|0|0|0 0.9 20 0.01 Kinesin heavy chain isoform 5C;Kinesin-1 heavy chain
MIST1.4 Q3UZ06 Sec22b 3 0|0|0|0|0|0 0.98 30 0 Vesicle-trafficking protein SEC22b
MIST1.4 Q545K5 Rbm3 2 0|0|0|0|0|0 0.9 20 0.01 Putative RNA-binding protein 3
MIST1.4 Q5RL79 Krtcap2 2 0|0|0|0|0|0 0.9 20 0.01 Keratinocyte-associated protein 2
MIST1.4 Q6LAF6 Ctsb 4 0|0|0|0|0|0 1 40 0 Cathepsin B;Cathepsin B light chain;Cathepsin B heavy chain
MIST1.4 Q6ZWX2 Tmsb4x 2 0|0|0|0|0|0 0.9 20 0.01 Thymosin beta-4
MIST1.4 Q8BN32 Pabpc1 5 0|0|0|1|0|0 0.96 10 0.01 Polyadenylate-binding protein 1
MIST1.4 Q8C2A3 Sept7 2 0|0|0|0|0|0 0.9 20 0.01 Septin-7
MIST1.4 Q8CB58 Ptbp1 2 0|0|0|0|0|0 0.9 20 0.01 Polypyrimidine tract-binding protein 1;Polypyrimidine tract-binding protein 3
MIST1.4 Q8R5C5 Actr1b 2 0|0|0|0|0|0 0.9 20 0.01 Beta-centractin;Alpha-centractin
MIST1.4 Q91VL2 Thrap3 5 0|0|0|0|0|0 1 50 0 Thyroid hormone receptor-associated protein 3
MIST1.4 Q91VM5 Rbmxl1 5 0|0|0|0|0|0 1 50 0 RNA binding motif protein, X-linked-like-1
MIST1.4 Q99PT1 Arhgdia 2 0|0|0|0|0|0 0.9 20 0.01 Rho GDP-dissociation inhibitor 1
MIST1.4 Q9D094 Hars 2 0|0|0|0|0|0 0.9 20 0.01 Histidine--tRNA ligase, cytoplasmic
MIST1.4 Q9D958 Spcs1 2 0|0|0|0|0|0 0.9 20 0.01 Signal peptidase complex subunit 1
MIST1.4 Q9DBR7 Ppp1r12a 4 0|0|0|0|0|0 1 40 0 Protein phosphatase 1 regulatory subunit 12A
MIST1.4 Q9JMG1 Edf1 2 0|0|0|0|0|0 0.9 20 0.01 Endothelial differentiation-related factor 1
MIST1.4 Q9QXT0 Cnpy2 2 0|0|0|0|0|0 0.9 20 0.01 Protein canopy homolog 2
MIST1.4 Q9Z1R9 Prss1 2 0|0|0|0|0|0 0.9 20 0.01 Protease, Serine, 1 (Trypsin 1)
MIST1.5 E9Q3W4 Plec 5 0|0|0|0|1|0 0.96 10 0.01 Plectin
MIST1.5 E9QNH6 Myo1b 5 0|0|0|0|1|0 0.96 10 0.01 Unconventional myosin-Ib
MIST1.5 P70562 Bhlha15 39 0|0|1|0|0|0 1 78 0 Class A basic helix-loop-helix protein 15
MIST1.5 Q1WWK3 Hist1h1b 2 0|0|0|0|0|0 0.9 20 0.01 Histone H1.5
MIST1.5 Q3TJZ6 Fam98a 2 0|0|0|0|0|0 0.9 20 0.01 Protein FAM98A
MIST1.5 Q3UKZ1 Sdc4 2 0|0|0|0|0|0 0.9 20 0.01 Syndecan;Syndecan-4
MIST1.5 Q571K0 Dlg1 2 0|0|0|0|0|0 0.9 20 0.01 Disks large homolog 1
MIST1.5 Q5SYD0 Myo1d 3 0|0|0|0|0|0 0.98 30 0 Unconventional myosin-Id
MIST1.5 Q61879 Myh10 6 0|0|0|0|0|0 1 60 0 Myosin-10
MIST1.5 Q62261 Sptbn1 6 0|0|0|1|0|0 0.99 12 0 Spectrin beta chain, non-erythrocytic 1
MIST1.5 Q9CS50 Prkar1a 2 0|0|0|0|0|0 0.9 20 0.01 cAMP-dependent protein kinase type I-alpha regulatory subunit
MIST1.5 Q9JHJ0 Tmod3 4 0|0|0|0|0|0 1 40 0 Tropomodulin-3
MIST1.5 Q9R071 Eif6 2 0|0|0|0|0|0 0.9 20 0.01 Eukaryotic translation initiation factor 6
MIST1.5 Q9WTI7 Myo1c 4 0|0|0|0|0|0 1 40 0 Unconventional myosin-Ic
MIST1.6 P70562 Bhlha15 9 0|0|1|0|0|0 1 18 0 Class A basic helix-loop-helix protein 15
MIST1.6 Q3UKZ1 Sdc4 2 0|0|0|0|0|0 0.9 20 0.01 Syndecan;Syndecan-4
MIST1.6 Q5SZA3 Hist1h1c 2 0|0|0|0|0|0 0.9 20 0.01 Histone H1.2
MIST1.6 Q60675 Lama2 2 0|0|0|0|0|0 0.9 20 0.01 Laminin subunit alpha-2
MIST1.7 A2AFS1 Sars 2 0|0|0|0|0|0 0.9 20 0.01 Serine--tRNA ligase, cytoplasmic
MIST1.7 G3UYK9 Dtnb 2 0|0|0|0|0|0 0.9 20 0.01 Dystrobrevin beta
MIST1.7 G5E839 Cct4 2 0|0|0|0|0|0 0.9 20 0.01 T-complex protein 1 subunit delta
MIST1.7 P48036 Anxa5 4 0|0|0|0|0|0 1 40 0 Annexin A5
MIST1.7 P70562 Bhlha15 9 0|0|1|0|0|0 1 18 0 Class A basic helix-loop-helix protein 15
MIST1.7 Q3TJZ6 Fam98a 5 0|0|0|0|0|0 1 50 0 Protein FAM98A
MIST1.7 Q3TML0 Pdia6 2 0|0|0|0|0|0 0.9 20 0.01 Protein disulfide-isomerase A6
MIST1.7 Q3UKZ1 Sdc4 2 0|0|0|0|0|0 0.9 20 0.01 Syndecan;Syndecan-4
MIST1.7 Q65ZC0 Igkc 2 0|0|0|0|0|0 0.9 20 0.01 Ig kappa chain C region;Ig kappa chain V-II region 26-10
MIST1.7 Q80X90 Flnb 2 0|0|0|0|0|0 0.9 20 0.01 Filamin-B;Filamin-C
MIST1.7 Q8R5C5 Actr1b 2 0|0|0|0|0|0 0.9 20 0.01 Beta-centractin;Alpha-centractin
MIST1.7 Q91VA7 Idh3b 2 0|0|0|0|0|0 0.9 20 0.01 Isocitrate Dehydrogenase 3 (NAD+) Beta
MIST1.7 Q9D6R2 Idh3a 2 0|0|0|0|0|0 0.9 20 0.01 Isocitrate Dehydrogenase 3 (NAD+) Alpha
MIST1.7 Q9JHJ0 Tmod3 2 0|0|0|0|0|0 0.9 20 0.01 Tropomodulin-3
MIST1.7 Q9WTI7 Myo1c 2 0|0|0|0|0|0 0.9 20 0.01 Unconventional myosin-Ic
MIST1.8 D3Z369 Wdr12 2 0|0|0|0|0|0 0.9 20 0.01 Ribosome biogenesis protein WDR12
MIST1.8 E9QPE7 Myh11 28 0|0|0|0|3|2 1 11.2 0 Myosin-11
MIST1.8 G5E839 Cct4 2 0|0|0|0|0|0 0.9 20 0.01 T-complex protein 1 subunit delta
MIST1.8 P70562 Bhlha15 12 0|0|1|0|0|0 1 24 0 Class A basic helix-loop-helix protein 15
MIST1.8 Q3TJZ6 Fam98a 2 0|0|0|0|0|0 0.9 20 0.01 Protein FAM98A
MIST1.8 Q5SYD0 Myo1d 4 0|0|0|0|0|0 1 40 0 Unconventional myosin-Id
MIST1.8 Q61879 Myh10 6 0|0|0|0|0|0 1 60 0 Myosin-10
MIST1.8 Q6NV50 Ctnna1 2 0|0|0|0|0|0 0.9 20 0.01 Catenin alpha-1
MIST1.8 Q6R891 Ppp1r9b 2 0|0|0|0|0|0 0.9 20 0.01 Neurabin-2
MIST1.8 Q80X73 Pelo 2 0|0|0|0|0|0 0.9 20 0.01 Protein pelota homolog
MIST1.8 Q80X90 Flnb 2 0|0|0|0|0|0 0.9 20 0.01 Filamin-B;Filamin-C
MIST1.8 Q8K419 Lgals4 2 0|0|0|0|0|0 0.9 20 0.01 Galectin-4
MIST1.8 Q8R3V2 Aimp2 2 0|0|0|0|0|0 0.9 20 0.01 Aminoacyl tRNA synthase complex-interacting multifunctional protein 2
MIST1.8 Q9JHJ0 Tmod3 2 0|0|0|0|0|0 0.9 20 0.01 Tropomodulin-3









Table 5. List of highest represented proteins that were identified by mass 
spectrometry analysis. MIST1 protein (highlighted in yellow color) was pulled-down 







Protein ID Gene ID Protein Description Pull-down Frequency
Q8R5C5 Actr1b Beta-centractin;Alpha-centractin 2
Q8R3V2 Aimp2 Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 2
P48036 Anxa5 Annexin A5 2
P70562 Bhlha15 Class A basic helix-loop-helix protein 15 8
G5E839 Cct4 T-complex protein 1 subunit delta 3
Q9QXT0 Cnpy2 Protein canopy homolog 2 2
Q7JD03 COX2 Cytochrome c oxidase subunit 2 2
Q6LAF6 Ctsb Cathepsin B;Cathepsin B light chain;Cathepsin B heavy chain 3
Q9R071 Eif6 Eukaryotic translation initiation factor 6 2
Q3TJZ6 Fam98a Family With Sequence Similarity 98, Member A 3
Q80X90 Flnb Filamin-B;Filamin-C 3
Q9D094 Hars Histidine--tRNA ligase, cytoplasmic 2
Q1WWK3 Hist1h1b Histone H1.5 2
E9Q5B6 Hnrnpd Heterogeneous nuclear ribonucleoprotein D0 2
Q65ZC0 Igkc Ig kappa chain C region;Ig kappa chain V-II region 26-10 2
Q3UWI9 Kif5b Kinesin heavy chain isoform 5C;Kinesin-1 heavy chain 2
Q61879 Myh10 Myosin-10 2
Q9WTI7 Myo1c Unconventional myosin-Ic 2
Q5SYD0 Myo1d Unconventional myosin-Id 2
A2AFS1 Sars Serine--tRNA ligase, cytoplasmic 2
Q3UKZ1 Sdc4 Syndecan;Syndecan-4 3
Q9JHJ0 Tmod3 Tropomodulin-3 3
Q6ZWX2 Tmsb4x Thymosin beta-4 2
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Surprisingly, despite predicting that MIST1 binds to different transcription factors, 
we failed to unequivocally identify any striking transcription factor in the list of the 
most frequently pulled-down prey proteins. In conclusion, we were unsuccessful in 
finding a promising binding partner of MIST1. 
 
 Discussion 
MIST1 is a bHLH transcription factor expressed in pancreatic acinar cells. 
Gene array and ChIP-seq analyses have identified a number of MIST1 target 
genes where MIST1 binding activates or represses gene expression, although the 
molecular mechanisms underlying these responses remain unknown (Direnzo et 
al. 2012). Previous studies have revealed that MIST1 does not have a TAD and 
only the central bHLH domain of MIST1 is required for full transcriptional activity in 
transgenic mice (Zhu et al. 2004).Additionally, MIST1 is thought to function as a 
homodimer bHLH complex, suggesting that other proteins may interact with MIST1 
dimer to act as c-regulators of MIST1 transcriptional activity. Herein, I exploited a 
novel mouse model to identify the protein binding partners of MIST1 by LC-MS/MS 
via a biotinylation pull-down system to immunoprecipitate MIST1-associated 
complexes. 
In an attempt to characterize the function of MIST1, we hypothesized that 
the transcriptional activity of the MIST1 homodimer complex is dependent on a co-
regulator binding partner. We utilized biotin/avidin approach to purify MIST1 as it 
is the strongest non-covalent interaction known in nature (Green 1990). 
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Accordingly, we generated a mouse model consisting of an N-terminal BT tag, C-
terminal 6XHis-Myc tag and two loxP sites that were introduced via homologous 
recombination into the MIST1 locus, generating the Mist1BT/Myc line. Mist1BT/Myc 
mice were crossed with a BirA ligase (R26HA-BirA) mouse that biotinylated the BT-
tagged MIST1 protein allowing us to immunoprecipitate the MIST1 complex using 
streptavidin magnetic beads to perform mass spectrometry analysis. We have 
shown that this model is efficient in purifying the MIST1 complex as R26HA-BirA 
ligase specifically biotinylated the MIST1BT/Myc protein. Using tandem mass 
spectrometry and bioinformatics software (MaxQuant and SAINT), we identified 23 
unique proteins that were significantly enriched in Mist1BT/BT; R26HA-BirA pancreata 
samples. The goal of this project was to identify transcription factors that might 
bind to the bHLH transcription factor MIST1. Unfortunately, no definitive nuclear 
binding partner of MIST1 was identified in this LC-MS/MS analysis.  
Cell culture studies have shown that SAP18 and SP1 serve as potential 
binding partners of MIST1 (Jia 2008). However, my in vivo study using a mouse 
model did not identify either of these proteins. This suggests that under correct 
physiological conditions (e.g.an intact pancreas), the same interactions identified 
using established cell lines may not occur. There are several reasons as to why 
these two studies do not agree. First, the pancreas is a complex organ dedicated 
to conducting the immense task of food digestion and maintaining a proper balance 
of blood glucose levels. The high content of hydrolases produced by pancreatic 
acinar cells makes it the most difficult tissue in the body to isolate intact proteins 
and protein complexes (Börner et al. 2009). Due to this challenge, I speculate that 
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the protein purification that we performed was not sufficient to fractionate pure, 
intact nuclear protein complexes. Second, the mass spectrometry analysis of my 
samples revealed that the identified prey proteins of MIST1 were mostly 
cytoplasmic or membrane associated proteins suggesting that the sample extracts 
that I prepared consisted of numerous non-specific background proteins which 
should have been eliminated during the purification process. Improper nuclear 
fractionation may have occurred due to inappropriate buffer conditions. It has been 
shown that complex organs like the pancreas require a detergent-based sequential 
extraction process in order to properly fractionate extracts from various 
compartments of the tissue (Ramsby & Makowski 2011; Börner et al. 2009). Thus, 
the commercial kit we used to isolate nuclear extracts (NE-PER kit) may not have 
been an ideal approach to prepare nuclear extracts for mass spectrometry. 
Because the Mist1BT/Myc mouse also contain Myc and His tags, future studies could 
utilize a tandem pull-down approach to see if this would improve MIST1-interacting 
specificity.  
An additional experimental modification that could be attempted would be 
to adjust the detergent components in the lysis and isolation protocols. Detergents 
are essential to prepare samples for mass spectrometry analysis. However, ionic 
detergents such as NP-40 tend to inhibit ionization and also reduce the 
chromatographic resolution which can interfere with the analysis process (Chen et 
al. 2007; Katayama et al. 2001; Zhang & Li 2004). NP-40 is one of the detergents 
I used to prepare my samples. Therefore, I speculate that the presence of this 
detergent may have contributed to a low peptide-yield. Alternative nonionic 
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detergents, such as n-dodecyl-β-D-maltoside (DDM) or 5-cyclohexyl-1-pentyl-β-D-
maltoside (CYMAL-5) could be tested to see if they increase overall peptide yield 
(Hess 2013).  
 Finally, it is possible that the MIST1 dimer does not actually utilize another 
transcription factor as a co-factor binding partner. Certain epigenetic modifications 
such as DNA methylation and histone modification may simply dictate which genes 
MIST1 binds to under different developmental or physiological contexts. Studies 
performed in mouse embryonic stem cells have revealed that TFs such as NRF1 
cannot bind to its target motif when DNA is methylated, suggesting that NRF1 
depends on other binding factors in order to create a hypomethylated condition to 
bind to its target site (Karemaker & Vermeulen 2016; Domcke et al. 2015).Future 
studies examining the importance of epigenetic regulation of MIST1 target genes 
will be needed to address this issue. Of course, we also need to consider that 
MIST1 may have other a non- transcription factor function where it binds to a 
cytoplasmic protein partner. Hence, in order to elucidate the role of MIST1 in other 
cellular processes, future studies could follow the cytoplasmic prey proteins 
identified in this current study (i.e.,Cathepsin-B and Syndecan-1) to determine if 




CHAPTER 4. SILENCING MIST1 GENE EXPRESSION IS ESSENTIAL FOR 
RECOVERY FROM ACUTE PANCREATITIS 
 Introduction 
The majority of the exocrine pancreas consists of acinar cells which are 
tasked with synthesizing, modifying, packaging and secreting vast quantities of 
pro-digestive enzymes (zymogens) into the duodenum to maintain metabolic 
homeostasis for the organism (Stanger & Hebrok 2013; Puri & Hebrok 2010; 
MacDonald et al. 2010; Gittes 2009). The ability of acinar cells to produce high 
levels of appropriately packaged proteins requires the coordination of pathways 
responsible for the accumulation and assembly of critical components of the 
secretory apparatus, the establishment of proper apical-basal polarity and cell-cell 
communication and the proper management of mis-folded proteins through the 
Unfolded Protein Response (UPR) (MacDonald et al. 2010; Pin et al. 2015; Chevet 
et al. 2015; Glimcher 2010; Schröder & Randal J Kaufman 2005; Schröder & 
Randal J. Kaufman 2005). Because of the high levels of potentially dangerous 
hydrolases synthesized by the exocrine pancreas, the organ is prone to a number 
of disease states including pancreatitis and pancreatic cancer.  
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Pancreatitis is a disease that targets pancreatic acinar cells, leading to organ 
inflammation, fibrosis and overall tissue disruption (Pasca di Magliano et al. 2013). 
It is commonly associated with gallstones and excessive alcohol consumption 
which leads to cell damage through intracellular activation of zymogens (Grady et 
al. 1998). Importantly, pancreatitis is also a known risk factor for pancreatic ductal 
adenocarcinoma (PDAC) (Lowenfels et al. 1993; Malka et al. 2002; Pinho et al. 
2014) and a number of mouse genetic studies have shown that episodes of acute 
pancreatitis (AP) can serve as a driving force for KRASG12D-induced PDAC 
(Carrière et al. 2009; Carrière et al. 2011; Collins et al. 2014; Guerra et al. 2011; 
Guerra et al. 2007; Molero et al. 2012; Pinho et al. 2011; Siveke et al. 2008; Kopp 
et al. 2012). Indeed, a hallmark of AP is alteration of acinar cell identity where 
acinar cells acquire ductal characteristics through a process known as acinar-
ductal metaplasia (ADM) (Molero et al. 2012; Pinho et al. 2011; Prévot et al. 2012; 
Prévot et al. 2013). ADM is thought to represent a precursor state that can progress 
to PDAC under conditions of oncogenic and tumor suppressor mutations (Carrière 
et al. 2011; Collins et al. 2014; Shi et al. 2009; Zhu et al. 2007; H Huang et al. 2013; 
Collins et al. 2012; Ardito et al. 2012). Despite a wealth of information concerning 
the broad phenotype associated with pancreatitis, little is understood regarding the 
transcriptional regulatory networks that are susceptible to AP episodes and how 
these networks allow acinar cells and the exocrine organ to recover.   
Key transcription factors that establish and maintain a healthy acinar cell 
state include PTF1a, MIST1 (also known as Bhlha15), GATA6, and Nr5a2 
(MacDonald et al. 2010; Mills & Taghert 2012; Hale et al. 2014; Direnzo et al. 2012; 
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Holmstrom et al. 2011; Masui et al. 2010; Xuan et al. 2012; Martinelli et al. 2015; 
Flandez et al. 2013). PTF1a and MIST1 are basic helix-loop-helix (bHLH) factors 
that have been shown to exhibit tumor suppressor properties where acinar cells 
lacking each factor are highly susceptible to KRASG12D-induced transformation 
(Shi et al. 2009; Shi et al. 2013; Krah et al. 2015). Both factors play important roles 
in acinar differentiation events. PTF1a is essential for Mist1 gene expression and 
expression of most zymogen encoding genes including elastase, 
carboxypeptidase and amylase (Hale et al. 2014; Beres et al. 2006; Masui et al. 
2007; Rodolosse et al. 2004). 
Although not essential for embryonic acinar development, MIST1 plays an 
essential role in the maturation of acinar cells by regulating genes critical for apical-
basal cell polarity, the assembly and clustering of secretory granules, proper Ca2+ 
signaling, the expansion of the endoplasmic reticulum (ER), UPR pathway 
homeostasis, cell cycle progression and regulated exocytosis (Direnzo et al. 2012; 
Garside et al. 2010; Hess et al. 2011; Jia et al. 2008; Luo et al. 2005; Pin et al. 
2001; Rukstalis et al. 2003; Zhu et al. 2004). What sets MIST1 apart from PTF1a 
is that it exhibits a broad tissue specificity, being present in most serous secretory 
cells in the body, including salivary acinar, stomach zymogenic, mammary alveolar 
and immunoglobulin secreting B cells (Aure et al. 2015; Huh et al. 2010; Pin et al. 
2000; Bredemeyer et al. 2009; Capoccia et al. 2011; Tian et al. 2010; Zhao et al. 
2006; Habbe et al. 2008). In all cases, MIST1 is responsible for the overall 
upregulation of the protein synthesis, processing and secretory machinery, often 
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acting as a scaling factor to insure highly efficient regulated secretion for each cell 
type (Mills & Taghert 2012; Hess et al. 2011; Huh et al. 2010).  
The importance of MIST1 to maintaining a healthy cellular state for secretory 
cells is also evident in a number of different cancers. Both stomach cancer and 
PDAC tumors have been shown to initiate from Mist1-expressing secretory cells 
(Shi et al. 2009; Zhu et al. 2007; Habbe et al. 2008; Lennerz et al. 2010; Nam et 
al. 2010). However, early in the transformation process, stomach zymogenic cells 
and pancreatic acinar cells that are undergoing metaplasia silence Mist1 gene 
expression, suggesting that inhibiting MIST1 activity is a critical step in allowing 
cells to enter into a proliferative phase (Shi et al. 2009; Shi et al. 2013; Jia et al. 
2008; Lennerz et al. 2010; Nam et al. 2010; Nozaki et al. 2008). Furthermore, 
sustained Mist1 expression in KrasG12D-expressing acinar cells inhibits ADM and 
PDAC development, again highlighting the concept that MIST1 exhibits tumor 
suppressor properties (Shi et al. 2009; Zhu et al. 2007).  
Because pancreatitis is a known risk factor for PDAC, and MIST1 is critical 
to PDAC development, we set out to examine if Mist1 gene expression is silenced 
under AP conditions and to test if sustained MIST1 activity would alleviate AP 
damage responses. Our studies demonstrate that during AP damage in both 
mouse and human, Mist1 gene transcription and protein accumulation are 
dramatically reduced. In mice subjected to caerulein-induced AP, Mist1 silencing 
is a transient event. As cells recover from AP damage, the Mist1 locus is 
transcriptionally re-activated and MIST1 protein levels are restored. Despite this 
re-expression, analysis of conditional Mist1 knock-out (Mist1 cKO) mice revealed 
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that Mist1-deficient pancreata responded similarly to AP treatment as control 
animals, with an initial damage phase that was rapidly followed by recovery. We 
next examined if sustained Mist1 expression (iMist1) in genetically engineered 
mice could alleviate AP-induced damage. Surprisingly, in iMist1 animals, AP 
produced a dramatic phenotype of significant tissue damage followed by cell death 
in cells that expressed iMist1. Despite the extreme damaged response in iMist1 
mouse pancreata, the pancreas partially recovered by regenerating healthy acini 
from the small minority of acinar cells that failed to activate the iMist1 transgene. 
We conclude that silencing Mist1 expression is a critical event for acinar cells to 
survive an AP episode where down regulating MIST1 activity may allow cells to 
suppress their secretory function and permit a window of cell proliferation. 
However, to fully re-establish a functional acinar cell capable of efficient exocytosis, 
the Mist1 gene must be reactivated to scale up the appropriate intracellular 
machinery that generates secretory vesicles, expands the ER and establishes cell 
communication via gap junction signaling. The importance of MIST1 to these 
events suggests that devising strategies to modulate transcriptional networks 
could ease clinical symptoms in patients diagnosed with pancreatitis and 





 Mist1 Gene Expression is Silenced during KrasG12D-induced PanIN and 
PDAC Formation  
The MIST1 transcription factor (also known as BHLHA15) regulates key 
genes that are required for acinus polarity, cell-cell junctions and the processing 
of zymogen granules (Mills & Taghert 2012; Direnzo et al. 2012; Garside et al. 
2010; Tian et al. 2010). Loss of MIST1 function leads to deficiencies in acinar cell 
integrity, cell polarity, ER expansion and regulated exocytosis (Direnzo et al. 2012; 
Pin et al. 2001; Zhu et al. 2004; Luo et al. 2005; Rukstalis et al. 2003). Similar 
defects in polarity and acinar cell properties are also hallmarks of KrasG12D-driven 
transformation events where acinar cells exhibit acinar-ductal metaplasia (ADM) 
that progresses to pancreatic intraepithelial neoplasia (PanIN) and pancreatic 
ductal adenocarcinoma (PDAC) (Shi et al. 2009; Shi et al. 2013; Habbe et al. 
2008). PanINs and PDAC tumors, each derived from acinar cells, lose acinar 
characteristics and no longer express MIST1 protein (Figure 4-1A) (Puri & Hebrok 
2010; Shi et al. 2009; Zhu et al. 2007; Shi et al. 2013; Morris et al. 2010). The 
importance of cell integrity to PDAC disease is also supported by studies showing 
that damage to KrasG12D-expressing acinar cells via an episode of acute 
pancreatitis (AP) accelerates PanIN formation (Carrière et al. 2009; Guerra et al. 




Figure 4-1. Mist1 gene expression is silenced during KrasG12D-induced PanIN 
and PDAC formation. (A) Elastasepr-CreERT, KrasLSL-G12D/+, Trp53LSL-R172H/+ mice 
were treated with Tam to activate the KrasLSL-G12D and Trp53LSL-R172H/+ alleles and 
then stained with anti-MIST1. At early time points, nuclear MIST1 staining is 
detected in normal acinar cells (white arrows) whereas PanINs and late stage 
PDAC tumors are MIST1 negative (yellow arrows). (B) In the absence of AP, 
Mist1CreERT/+, KrasLSL-G12D/+ mice develop sporadic MIST1 negative PanIN lesions 
(yellow arrow) while non-transformed acinar cells remain MIST1 positive (white 
arrows). However, a brief episode of AP quickly transforms the majority of 




Mist1CreERT/+, KrasLSL- G12D/+ mice treated with tamoxifen (to activate KrasG12D 
expression) and caerulein (to induce AP) exhibit extensive PanIN development 
when compared to the no AP control group (Figure 4-1B). In all cases, acinar-
derived PanIN/PDAC epithelial cells remain MIST1 negative.  
 
 Mist1 Gene Expression is Transiently Silenced upon Acute Pancreatitis 
Damage 
4.2.2.1 Characterization of Mist1CreERT/+ Mice Following Acute Pancreatitis 
To evaluate the importance of MIST1 during acinar metaplasia, we 
characterized Mist1 expression during the damage and subsequent recovery 
phases of AP, a known driver of PDAC tumor development (Carrière et al. 2009; 
Guerra et al. 2011; Guerra et al. 2007; Pinho et al. 2011). For these studies, 
Mist1CreERT/+ mice were used as controls as all subsequent mouse lines contained 
the Mist1CreERT knock-in allele (Shi et al. 2009; Habbe et al. 2008). Standard 
caerulein treatment (Figure 4-2A) of 8 week Mist1CreERT/+ mice led to significant 
and rapid damage to the exocrine acinar cells. As early as 6h post-AP, acinar 
lumens were distended and zymogen granules were rapidly lost (Figure 4-2B). 
Morphometric analysis of Mist1CreERT/+ mouse pancreata also confirmed increased 
tissue damage and edema during AP injury (Figure 4-11A). By 1d post-AP, 
significant increases in edema and inflammatory cell infiltrates were observed, 
accompanied by extensive formation of Keratin19 (K19)+/Amylase (AMY)+ ADM 
lesions. Expression of CLUSTERIN, a known marker of acinar cell damage (Greer 
et al. 2013; von Figura et al. 2014), also was greatly elevated at 6h post-AP (Figure 
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4-2B,C and Figure 4-3A). Transcript and protein levels of acinar cell markers, 
including Amylase (Amy), Trypsinogen (Tryp) and Carboxypeptidase (Cpa), were 
significantly reduced over the 6h-2d post-AP period (Figure 4-2C and Figure 
4-3A,B ). In contrast, ductal markers (K19, SOX9) were greatly elevated, 
confirming the formation of extensive ADM (Figure 4-2B,C and Figure 4-3A,B). 
Identical ADM responses were obtained with caerulein-treated wild-type mice 
(data not shown). Despite significant development of ADM lesions upon AP 
induction, AP metaplasia was transient as lesions resolved 4d-10d post-AP. In all 
cases, Clusterin, K19 and Sox9 transcript and protein levels returned to their low 
control states while acinar markers (Amylase, Trypsinogen, Carboxypeptidase) re-
established high expression thresholds as illustrated in Figure 4-2B,C and Figure 
4-3A,B.  
4.2.2.2  The Mist1 Gene is Transcriptionally Silenced during Acute 
Pancreatitis 
 
The major phenotype associated with caerulein-induced AP is loss of acinar 
cell integrity (Siveke et al. 2008; Jensen et al. 2005; Kowalik et al. 2007; Lerch & 
Gorelick 2013). Because the transcription factor MIST1 is critical for maintaining 
acinar cell polarity and function, we examined if MIST1 protein accumulation was 
altered in AP mice. As shown in Figure 4-5B,C, high levels of MIST1 protein were 




Figure 4-2. Characterization of Mist1CreERT/+ mice following acute pancreatitis.  
(A) Time course diagram of caerulein-induced acute pancreatitis. (B) H&E and IF 
analyses of Mist1CreERT/+ pancreas samples in the absence of AP treatment (control) 
or post-AP for the indicated times. At early times acinar cells exhibit elevated levels 
of CLUSTERIN expression and Amylase+/K19+ ADM lesions. However, by 10d 
post-AP the majority of the tissue fully recovers. Arrows in the H&E section point 
out recovered acini whereas arrows in the K19/AMY panels indicate ADM lesions. 
(d, duct) (C) Relative CLUSTERIN, K19 and AMYLASE protein levels in IF sections 
from Mist1CreERT/+ pancreata at the indicated times and normalized to control values. 






Figure 4-3. Acinar and ductal markers in Mist1CreERT/+ mice following acute 
pancreatitis (A) Immunoblot analysis of Mist1CreERT/+ pancreata post-AP. 
CLUSTERIN levels were increased during AP damage. AMYLASE and 
TRYPSINOGEN levels (acinar markers) decreased during AP and returned to their 
high control states upon recovery. In contrast ductal markers K19 and SOX9 
became greatly elevated during AP, confirming the formation of extensive ADM. 
(B) RT-qPCR analysis of gene transcripts confirmed the initial ADM phenotype 





negative (Figure 4-4). However, in AP mice, Mist1 transcripts and protein were 
rapidly lost in damaged acinar cells (Figure 4-5B-D). The absence of MIST1 was 
observed 6h-2d post-AP during the period corresponding to the major time frame 
for ADM lesion induction. Identical loss of MIST1 protein was also observed in 
patients exhibiting pancreatitis- associated ADM (Figure 4-5A). Nonetheless, as 
mouse acinar cells recovered (4d-10d post-AP), Mist1 transcript and protein levels 
greatly increased, achieving levels that were comparable to those observed in 
control acinar cells. The transient change in Mist1 transcripts and protein during 
the AP response was also reflected in the expression profiles of known MIST1 
target genes (Direnzo et al. 2012; Garside et al. 2010; Tian et al. 2010). Transcripts 
from MIST1-induced genes Atp2c2, Copz2 and Rab3d were reduced during the 
6h-2d post-AP period while transcripts from MIST1-repressed genes (e.g., Rnd2) 
were up-regulated (Figure 4-6). Thus, transient silencing of Mist1 influences a 
number of key events associated with acinar cell integrity. These results suggest 
that the process of silencing and then re-expressing Mist1 may be critical in 






Figure 4-4. IF images of Mist1CreERT/+ pancreata revealing nuclear MIST1 
protein exclusively in acinar cells. Nuclei are stained with DAPI and green 
nuclear staining signifying MIST1 localization in the nuclei. Islets and ducts remain 
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Figure 4-5. The Mist1 gene is transcriptionally silenced during acute 
pancreatitis. (A) MIST1 IHC staining (arrows) of healthy and pancreatitis patient 
samples. Human acinar cells undergoing ADM are MIST1 negative. (B) Analysis 
of MIST1 (arrows) in Mist1CreERT/+ pancreata. Damaged acinar cells exhibit greatly 
reduced MIST1 levels that recover by 10d post-AP. (C) MIST1 immunoblot 
analysis of Mist1CreERT/+ pancreata over the indicated post-AP time points. (D) RT-





Figure 4-6. MIST1 gene targets during acute pancreatitis.  RT-qPCR of MIST1 
gene targets, Atp2c2, Copz2, Rab3d and Rnd2 during AP. *p ≤ 0.05; **p ≤ 0.01; 








 Generation and Characterization of Mist1lox/lox Mice 
4.2.3.1 Establishing the Mist1CreERT/lox Model System 
Previous studies reported that Mist1 null animals exhibited a pronounced 
AP phenotype, suggesting that the absence of MIST1 sensitizes acinar cells to an 
AP episode (Kowalik et al. 2007; Johnson et al. 2014; Mehmood et al. 2014).  
However, because these studies could only use germline Mist1 nulls, it was not 
possible to establish if the enhanced AP phenotype was due to embryonic loss of 
MIST1 protein or was the result of inducing AP in already damaged adult 
pancreata. Thus, to directly test if MIST1 protein is required for acute pancreatitis 
recovery, we generated and characterized a conditional Mist1lox/lox mouse line 
(Figure 4-7). Mist1CreERT/+ mice were crossed to Mist1lox/+ animals to generate 
Mist1CreERT/lox offspring where one Mist1 allele expressed CreERT2 while the other 
Mist1 allele, engineered with an N-terminal BT-tag and a C-terminal MYC-tag, was 
flanked by LoxP sites (Figure 4-7). Treatment of 8 wk Mist1CreERT/lox mice with 
tamoxifen (Tam) led to efficient recombination and rapid loss of MIST1 protein in 
99.6% acinar cells as early as 24h post-Tam (Figure 4-8A-C). Deletion of Mist1 
also led to significant changes in the expression patterns of MIST1 target genes. 
As predicted, expression of Atp2c2 and Cx32 decreased while Rnd2 gene 
transcripts (which are normally repressed by MIST1 protein) increased following 
Tam treatment (Figure 4-9A). Similarly, MIST1-regulated CX32 gap junctions 
(Direnzo et al. 2012; Rukstalis et al. 2003) were rapidly lost upon Tam treatment 
of Mist1CreERT/lox mice (Figure 4-9B).  
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4.2.3.2 Mist1CreERT/lox mice exhibit similar AP recovery as Mist1CreERT/+ 
animals 
To determine if AP-induction in Mist1CreERT/lox animals produced a recovery 
delay when compared to Mist1CreERT/+ mice, Mist1CreERT/lox animals were treated 
with Tam (to delete the Mist1 coding region) (Mist1 cKO) and then induced with 
caerulein to generate an AP response (Figure 4-10A). As expected, control and 
AP-treated Mist1 cKO mice failed to express MIST1 protein (Figure 4-13A). 
Caerulein injections in Mist1 cKO animals elicited strong edema, inflammatory cell 
infiltrates and extensive ADM lesions as early as 6h post-AP (Figure 4-10B and 
Figure 4-12). ADM was accompanied by significant increases in Clusterin, K19 
and Sox9 transcript and protein levels with a concomitant decrease in Amylase, 
Elastase and Carboxypeptidase levels (Figure 4-10B-C; Figure 4-12 and Figure 
4-13A-B). As with Mist1CreERT/+ mice, the ADM phenotype was transient and the 
Mist1 cKO pancreas returned to a relatively normal status by 10d post-AP, 
although Mist1 cKO acini remained defective in acinar cell polarity and 
organization due to the absence of MIST1 protein. Surprisingly, with the exception 
of sustained elevated SOX9 protein levels at 10d post-AP, there was little 
difference between the AP responses for Mist1CreERT/+ (Figure 4-2; Figure 4-11 











Figure 4-7. Schematic of how the Mist1lox/+ mice were generated through 
homologous recombination. LoxP sites flank the entire Mist1 coding region 













Figure 4-8. Functional analysis of Mist1CreERT/lox model system. (A) Schematic 
of Tam treatment and time course analysis for Mist1CreERT/lox mice. (B) Immunoblot 
demonstrating the absence of MIST1 protein in pancreata from Tam-treated 
Mist1CreER/lox mice. (C) IF staining with anti-MIST1 confirming that the vast majority 





Figure 4-9. Establishing the Mist1CreERT/lox model system. (A). RT-qPCR 
analysis of MIST1 gene targets revealing loss of MIST1 regulation post-Tam. (B) 
CX32 gap junctions are readily detected in pancreata from -Tam treated 
Mist1CreERT/lox mice but are completely absent in +Tam samples.  *p ≤ 0.05; ***p ≤ 





Figure 4-10. Characterization of Mist1CreERT/lox mice following acute 
pancreatitis.  (A) Time course diagram of caerulein-induced acute pancreatitis in 
Mist1CreERT/lox mice (Mist1 cKO).  (B) H&E and IF analyses of Mist1 cKO pancreas 
samples in the absence of AP treatment (control) or post-AP for the indicated times. 
Arrows indicate AMY+/K19+ ADM lesions. (C) Relative CLUSTERIN, K19 and 
AMYLASE protein levels in IF sections from Mist1 cKO pancreata at the indicated 








Figure 4-11.Quantification of AP damage in Mist1CreERT/+ animals. H&E images 
were used to perform morphometric analysis of Mist1CreERT/+ pancreata over the 
indicated times (C-Control, 6h, 1d, 2d, 4d, 7d and 10d). *p≤0.05;**p≤0.01; 
***p≤0.001; n.s.-not significant 
 
Figure 4-12. Quantification of AP damage in Mist1CreERT/lox (Mist1 cKO) 
animals. (A) Morphometric analysis of Mist1 cKO pancreata over the indicated 






Figure 4-13. Characterization of Mist1CreERT/lox (Mist1 cKO) mice following 
acute pancreatitis. (A) Immunoblot analysis of protein expression from Mist1 cKO 
samples post-AP. Het is a control Mist1CreERT/+ sample. HSP90 was used as a 
loading control. (B) RT-qPCR analysis of acinar and duct gene products during an 




The ability of Mist1 cKO pancreata to recover from an acute pancreatitis 
episode with the same kinetics as Mist1CreERT/+ mice was surprising given previous 
reports showing that Mist1 null pancreata exhibited an enhanced AP response 
(Kowalik et al. 2007; Johnson et al. 2014; Mehmood et al. 2014). The main 
difference between the two models is that with germline Mist1-/- mice, the pancreas 
is significantly disorganized and defective by 8 wk of age (Pin et al. 2001). In 
contrast, Mist1CreERT/lox mice allow us to delete the Mist1 allele in adult animals and 
induce AP prior to the development of overt pancreas damage caused by the 
absence of MIST1. Thus, to establish if short versus long-term loss of MIST1 
activity differentially influences AP responses, Mist1CreERT/lox animals were given 
Tam and then treated with caerulein at 1 week post-Tam or 8 week post-Tam. As 
shown in Figure 4-14A-B, even in the absence of AP, Mist1 cKO pancreata at 8 
week post-Tam exhibited early signs of ADM, with large increases in SOX9 and 
K19 protein levels (compare -AP 1 week versus 8 week). The increase in ductal 
gene expression reflected the ADM damage response that was observed in adult 
Mist1CreERT/CreERT (Mist1 null) animals where the Mist1 locus was absent in the 
germline. Interestingly, AP episodes in 1 week versus 8 week post-Mist1 deletion 
did not reveal a significant difference in how the pancreas responded to this acute 
damage (Figure 4-14A-B). In all cases, 1 week and 8 week post-tam treated mice 
still managed to recover from the bulk of AP-induced damage by 10d post-AP (data 





Figure 4-14. The absence MIST1 protein in adult acinar cells has little impact 
in allowing cells to recover from acute pancreatitis. Comparison of 1 week and 
8 week post-Mist1 deletion in the Mist1 cKO model. Mist1CreERT/lox mice were 
treated with Tam and then analyzed for protein expression (A) IF images and (B) 
immunoblots at the indicated times for -AP and +AP groups. S6 was used as a 




Taken together, we conclude that the absence of MIST1 protein in adult acinar 
cells has little impact in allowing cells to recover from acute pancreatitis. 
 
 Preventing Mist1 gene silencing alters the acinar AP response 
4.2.4.1  Mist1CreERT/+/LSL-Mist1myc mice (iMist1) exhibit acinar-specific 
Mist1myc expression upon CreERT2 activity 
Our studies have shown that Mist1 expression is transiently silenced during 
the peak of AP damage and that Mist1 re-expression is not required for the 
pancreas to recover from an AP episode. Nonetheless, given the importance of 
MIST1 to normal acinar cell polarity and secretory function (Direnzo et al. 2012; 
Jia et al. 2008; Luo et al. 2005; Pin et al. 2001; Rukstalis et al. 2003; Johnson et 
al. 2014; Johnson et al. 2004), we investigated if sustained MIST1 protein 
expression could be used to limit the initial AP damage response. Previous studies 
have shown that formation of ADM and PanIN lesions is significantly attenuated 
when Mist1 expression is maintained in the presence of oncogenic KRASG12D (Shi 
et al. 2009; Shi et al. 2013). Therefore, we hypothesized that a similar lessening 
of AP damage might be achieved by maintaining MIST1 transcriptional activity. For 
these studies, we utilized a Cre-inducible LSL-Mist1myc (iMist1myc) transgenic 
mouse model (Figure 4-15) (Direnzo et al. 2012) and generated 
Mist1CreERT/+/iMist1myc offspring. Administering Tam to Mist1CreERT/+/iMist1myc mice 









Figure 4-15. Schematic of the LSL-Mist1myc transgene in iMist1myc mice. 
Mist1CreERT/+/iMist1myc mice express the iMist1myc transgene exclusively in acinar 










Figure 4-16. Mist1CreERT/+/LSL-Mist1myc mice (iMist1) exhibit acinar-specific 
Mist1myc expression upon CreERT2 activity. (A) Diagram outlining the time 
course of the study. (B) Tam treatment of iMist1 mice leads to rapid accumulation 
of nuclear MIST1myc protein exclusively in pancreatic acinar cells. (C) 
Quantification of MIST1myc+ acinar cells following Tam induction. (D) RT-qPCR 
analysis reveals no deleterious effects on general pancreas properties from 
Mist1myc induction. See (Direnzo et al. 2012) for a full characterization of the iMist1 





Despite elevated levels of MIST1, Mist1CreERT/+/iMist1myc mice exhibited a 
completely normal pancreas phenotype with no significant changes in the 
expression of acinar and ductal genes (Figure 4-16D), data not shown) (Direnzo 
et al. 2012).  
4.2.4.2 Mist1myc pancreata exhibit extensive stromal infiltrates following AP 
induction and Mist1myc acinar cells fail to recover from AP 
We next induced iMist1myc expression by treating Mist1CreERT/+/iMist1myc 
mice with Tam, followed by PBS (control) or caerulein to initiate an AP phenotype 
(Figure 4-17A). Surprisingly, instead of attenuating the AP response, 
Mist1CreERT/+/iMist1myc mice exhibited enhanced damage as early as 6h post-AP 
where extensive disruption of the exocrine pancreas occurred (Figure 4-17B and 
Figure 4-24). By 2d-4d post-AP, the majority of acini structures were grossly 
altered with disorganized and distended lumens, a severe absence of eosinophilic 
zymogens, sustained elevated CLUSTERIN levels, and a large accumulation of 
infiltrating cells that included CD45+ immune cell populations (Figure 4-17B-C; 
Figure 4-24 and Figure 4-18A-B). During this period, the epithelial tissue mass 
was largely replaced by VIMENTIN+ and alpha-SMOOTH MUSCLE ACTIN 
(SMA)+ stromal cells (Figure 4-18A-D). The tissue also exhibited an increased 
islet density as the normal tissue mass that occupied space between available 
islets decreased, leaving the majority of the pancreas consisting of ductal, stromal 
and islet cells. (Figure 4-18A and Figure 4-21A-B). Protein immunoblots and RT-




Figure 4-17. Mist1myc acinar cells exhibit extensive stromal infiltrates 
following AP induction. (A) Time course of iMist1myc induction and AP treatment. 
(B) H&E and IF analysis of iMist1myc pancreata post-AP. Arrows indicate remnants 
of acini structures. IF images of E-CADHERIN and CLUSTERIN revealed the loss 
of acinar cells during AP in iMist1 mice. (C) Relative E-CADHERIN and 
CLUSTERIN protein levels in IF sections from iMist1 pancreata at the indicated 





Figure 4-18. Mist1myc pancreata exhibit extensive stromal infiltrates following 
AP induction. (A) iMist1 pancreata develop large increases in CD45+ immune 
infiltrates as well as VIMENTIN and SMOOTH MUSCLE ACTIN (SMA) expressing 
stromal cells. (B) Relative CD45, SMA and VIMENTIN protein levels in IF sections 
from iMist1 pancreata at the indicated times and normalized to control values. (C) 
Immunoblot and (D) RT-qPCR analysis of Vimentin and Sma levels in iMist1 





Figure 4-19. Mist1myc acinar cells fail to recover from AP. (A) Immunoblots 
revealing sustained expression of duct markers in iMist1 samples. (B) RT-qPCR 
analysis of ADM markers showing that iMist1 pancreata do not recover by 10d. *p 




















Figure 4-20. Mist1myc acinar cells fail to recover from AP. IF analysis showing 
the substantial loss of amylase expressing acinar cells and the persistence of 
K19+/AMY+ ADM lesions (arrows). Note that 4d post-AP acini structures are small 














Figure 4-21. Increase in islet tissue density post-acute pancreatitis in 
Mist1myc mouse pancreata. (A) IF images and quantitative analysis of AMYLASE 
and INSULIN positive areas at 2d-7d post-AP. As a consequence of losing acinar 








expression, decreased expression of acinar gene products and increased 
expression of duct gene products over the 6h-2d post-AP period (Figure 4-19A-B 
and Figure 4-20). However, by 7d-10d post-AP, despite reduced CLUSTERIN 
levels, ADM markers did not recover. Acinar genes (Amy, Cpa) remained 
suppressed while duct genes (K19, Sox9) continued to be expressed (Figure 
4-19A-B and Figure 4-20). Further analysis of these animals revealed a greatly 
decreased AMY+ acinar cell mass. At 2d and 4d post-AP, the vast majority of 
AMY+ acini co-expressed K19 in ADM structures (Figure 4-20). Similarly, MIST1+ 
acinar cells were greatly decreased while stromal cells became more prominent 
within the exocrine tissue (Figure 4-18A-B; Figure 4-21A-B and Figure 4-20). 
4.2.4.3 iMist1myc acinar cells undergo apoptosis but the iMist1myc pancreata 
recover from AP damage through regeneration of a minority iMist1myc-negative 
acinar cell population 
 
The inability of iMist1myc mice to recover from AP damage by 7d prompted 
us to examine animals at extended times. During 7d-10d post-AP, iMist1myc 
pancreata were grossly reduced in size (Figure 4-23A) with no evidence of normal 
acini structures. Instead, the tissue was composed of loose connective tissue 
containing VIMENTIN+ fibroblasts, CD45+ immune cells and areas of edema 
(Figure 4-23A). Within the remaining pancreas tissue, we observed small pockets 
of epithelial ADM structures that exhibited elevated levels of CLUSTERIN and 
retained co-expression of AMY and K19 (Figure 4-22A,B; Figure 4-23A and 




Figure 4-22. iMist1myc pancreata recover from AP damage through 
regeneration of a minority iMist1myc-negative acinar cell population. (A) H&E 
and IF analysis of iMist1myc pancreata over the indicated post-AP time course. 
Arrows in the H&E images indicate acini structures that recover over the 8 week 
post-AP period. Arrows in the K19/AMY stained group show ADM lesions that 
slowly resolve by 3-8 weeks post-AP. The majority of healthy acini present at 3w-
8w post-AP are MIST1myc negative (brackets and asterisks). (B) Relative 
CLUSTERIN, K19 and AMYLASE protein levels in IF sections from iMist1 
pancreata at the indicated times and normalized to control values. *p ≤ 0.05; **p ≤ 





Figure 4-23. H&E images of whole sections from post-AP iMist1myc pancreata. 
(A) Mist1CreERT/+ (left) and iMist1myc (right) pancreata 7d post-AP. iMist1myc 
pancreata contain very few Amylase+ acini structures at this time point. Inset 
shows a higher magnification of the boxed area. (B) Mist1CreERT/+ (left) and 
iMist1myc (right) pancreata 8w post-AP. At this time, iMist1myc pancreata show 
substantial regeneration of healthy acini (arrows). Inset shows a higher 




Figure 4-24. Quantification of AP damage in iMist1 animals 6h-4d post-AP. 
Morphometric analysis of iMist1 pancreata over the indicated times. 
*p≤0.05;**p≤0.01; ***p≤0.001; n.s.-not significant. 
 
Figure 4-25. Quantification of AP damage in iMist1 animals 7d-8w post-AP. 
Morphometric analysis of iMist1 pancreata over the indicated extended times.*p ≤ 




Figure 4-26. iMist1myc pancreata recover from AP damage through 
regeneration of a minority iMist1myc-negative acinar cell population. (A) IF 
analysis of tissue disruption and the dramatic loss of acinar cells in 7d post-AP 
iMist1myc pancreata followed by regeneration of Amylase+ acinar cells from 3w-8w 
post-AP time points. (B) Quantitative analysis of cell types associated with 






Figure 4-27. iMist1myc acinar cells undergo apoptosis followed by 
regeneration of iMIST1myc-negative cells upon AP induction. (A) Acinar cells 
in iMist1myc pancreata undergo extensive apoptosis as detected by cleaved 
CASPASE 3 staining in AMY+ cells. (B) Quantification of Caspase+ cells per field 







this time period with only small groupings of acinar cells remaining at 7d post-AP 
(Figure 4-26A,B). During this time frame there was a significant increase in 
cleaved CASPASE3+/AMY+ epithelial cells, suggesting that cell death was 
primarily responsible for the vivid loss of acini structures (Figure 4-27A,B). Over 
the ensuing 3-8 weeks post-AP iMist1myc pancreata underwent a significant 
recovery as healthy acinar tissue began to appear in the disrupted organs (Figure 
4-23B). Areas of ADM were replaced with relatively normal acini that were AMY+ 
and CLUSTERIN negative (Figure 4-22A and Figure 4-26A,B). Interestingly, 
lineage-tracing revealed that the majority of the recovered acini were MIST1myc 
negative. This was particularly evident in the later (3-8 wk post-AP) times. 
Quantification of these tissues showed that approximately 75% of AMY+ acinar 
cells did not express the iMIST1myc protein (Figure 4-28A,B). The increase in 
AMY+/MYC- acinar cells was exclusively due to an increase in cell proliferation of 
the MYC- population. At 3w post-AP there was an 18.7-fold increase in BrdU-
labelled cells when compared to control pancreas samples. Importantly, of the 
regenerating cell population >90% BrdU+ cells were MYC- (Figure 4-29A,B). At 
8w post-AP pancreata also accumulated small amounts of adipose tissue that 
typically associated with the periphery of the organ (Figure 4-22A). Taken together, 
these results show that sustained MIST1 protein is detrimental to AP recovery and 
that the iMist1myc pancreas recovers from an AP episode by relying on the small 
percentage of acinar cells that failed to initially activate iMist1myc expression, 
allowing this population to re-enter a proliferative state and repopulate the organ.  
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We conclude that sustained Mist1 expression does not alleviate the initial AP 
damage and instead is detrimental to maintaining a healthy acinar cell state under 
AP conditions.  
 Discussion 
 MIST1 is a bHLH transcription factor expressed exclusively in 
exocrine secretory cells, including pancreatic acinar, salivary acinar and stomach 
zymogenic cells (Pin et al. 2001; Aure et al. 2015; Pin et al. 2000; Johnson et al. 
2004; Ramsey et al. 2007). A number of studies have shown that MIST1 is critical 
to establishing intracellular apical-basal polarity, appropriate secretory vesicle 
formation, expansion of the ER and the ability of cells to exhibit proper regulated 
exocytosis of pro-digestive enzymes (Direnzo et al. 2012; Jia et al. 2008; Luo et 
al. 2005; Pin et al. 2001; Tian et al. 2010; Johnson et al. 2004). Additionally, MIST1 
is necessary for maintaining appropriate protein synthesis and processing rates 
when cells are under ER stress (Hess et al. 2011; Huh et al. 2010). In all cases, 
defects in MIST1 activity greatly impact the secretory function of these organs. 
 The importance of the MIST1 transcriptional network also has been 
defined in pancreatic and stomach cancer. In both systems, silencing of Mist1 gene 
expression is an early event associated with metaplasia of stomach zymogenic 
and pancreatic acinar cells (Shi et al. 2009; Zhao et al. 2006; Habbe et al. 2008; 
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Figure 4-28. iMist1myc acinar cells exhibit apoptosis followed by regeneration 
of iMIST1myc-negative cells upon AP induction. (A) Representative IF images 
for anti-MYC staining used to perform lineage tracing. (B) Over time the number 
of MIST1myc+ cells is greatly decreased as the iMist1myc pancreas recovers post-






Figure 4-29. iMist1myc acinar cells exhibit apoptosis followed by regeneration 
of iMIST1myc-negative cells upon AP induction. (A) BrdU pulse labeling 
revealed that regeneration of iMist1myc pancreata following AP is due to 
proliferation of rare acinar cells that did not activate expression of iMist1myc during 
the initial Tam treatment. Arrows indicate AMY+/BrdU+/MYC- cells. (B) 






Indeed, Mist1 silencing is one of the first events associated with Kras-
induced pancreatic ductal adenocarcinoma (PDAC) with MIST1 negative acinar 
cells exhibiting early activation of EGFR signaling and downstream MAPK 
pathways (Zhu et al. 2007; Shi et al. 2009). Similarly, Mist1-deficient acinar cells 
are highly sensitized to Kras transformation, suggesting that MIST1 plays a tumor 
suppressive role in the adult pancreas (Shi et al. 2009; Shi et al. 2013). In support 
of this hypothesis, sustained Mist1 expression in the presence of oncogenic 
KRASG12D dramatically prevents PanIN/PDAC development (Shi et al. 2013). A 
similar phenotype has been shown for the bHLH transcription factor PTF1a where 
deletion of Ptf1a also sensitizes cells to PDAC formation (Krah et al. 2015). Thus, 
bHLH factors are essential for maintaining quiescent, healthy acinar cells. Indeed, 
altering the bHLH transcriptional network can force human PDAC tumor cells to 
redifferentiate into functional acinar cells (Kim et al. 2015)  
Lineage tracing strategies have confirmed that mouse and human PDAC 
can develop from adult acinar cells upon KrasG12D and other oncogenic or tumor 
suppressor gene mutations (Habbe et al. 2008; De La O et al. 2008; Houbracken 
et al. 2011). However, despite the presence of a KRASG12D driver, most acinar 
cells remain refractile to transformation unless secondary stressors are placed 
upon the cells (H Huang et al. 2013; di Magliano & Logsdon 2013). Although loss 
of Mist1 can be a secondary driver to PDAC development, there is little evidence 
that homozygous deletion of Mist1 alleles occurs in PDAC patients. Instead, other 
pathways that result in decreased Mist1 expression could be responsible for 
enhancing PDAC development. For this reason, we investigated how pancreatitis, 
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a known risk factor for PDAC (Lowenfels et al. 1993; Malka et al. 2002; Pinho et 
al. 2014), influences Mist1 gene expression and activity and ultimately the 
development of ADM lesions, the precursors to PanIN/PDAC progression. Our 
studies revealed that the Mist1 locus is transiently silenced during the initial 
damage stage of AP. The Mist1 gene continues to be repressed as acinar cells 
enter an early recovery phase during which a significant increase in cell 
proliferation aids the organ in regenerating. However, as this recovery continues, 
Mist1 transcripts and protein return to normal levels, allowing the restored acinar 
tissue to resume normal secretory activity. This is in contrast to instances where 
AP damage is combined with KRASG12D. In this setting, ADM and PanIN lesions 
never recover Mist1 expression, suggesting that KRAS signaling events 
permanently inhibit the Mist1 gene in a cancer setting.  
Despite re-expression of Mist1 following an AP episode, MIST1 is not 
necessary for acinar cells to recover from AP damage. Mist1 cKO acini recovered 
with similar kinetics as observed for Mist1+/+ and Mist1+/- acinar cells, although 
Mist1 cKO cells continued to exhibit the secretory defects ascribed to Mist1 
deficient cells. The similar response of Mist1+/- and Mist1 cKO pancreata to AP 
was surprising given that previous studies have shown that Mist1-/- (Mist1KO) mice 
display an increased sensitivity to AP with amplified damage responses and a 
delay in regeneration (Kowalik et al. 2007). Related studies have shown that 
Mist1KO pancreata are highly prone to ethanol-induced pancreas damage (Alahari 
et al. 2011), suggesting that the absence of MIST1 sensitizes acinar cells to 
general stress/insult events. The apparent disparity between these reports and our 
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current results is likely due to differences in the Mist1 model systems. In the case 
of Mist1KO mice, the developing and adult pancreas always lacks MIST1 protein, 
leading to a significantly damaged acinar cell state in post-weaned animals 
(Direnzo et al. 2012; Pin et al. 2001). Indeed, the enhanced stress and cell damage 
associated with Mist1KO pancreata highly sensitizes the organ to KRASG12D-
induced transformation events (Shi et al. 2009; Shi et al. 2012). In contrast, Mist1 
cKO animals allow for the conditional deletion of the Mist1 loci in adult animals so 
that episodes of AP occur in Mist1 null, but otherwise healthy cells. This new model 
allows for the direct examination of the role of MIST1 in AP recovery in the absence 
of the long-term stress and injury conditions associated with germ-line Mist1KO 
mice. Thus, we show that deleting Mist1 just prior to induced AP has little effect on 
pancreas recovery, suggesting that the increased sensitivity of Mist1KO pancreata 
to AP was likely due to the prior damaged status of the Mist1KO organ. In support 
of this hypothesis, Mist1 cKO mice expressed increased ADM markers over time 
that approached levels observed in Mist1KO animals. Interestingly, Mehmood et al. 
(2014) recently showed that germ-line Mist1KO pancreata are enriched for 
H3K4Me3 active epigenetic marks on select genes that function within pancreatitis 




Figure 4-30. Model of Mist1 silencing and re-expression following AP 
recovery. For acinar cells to recover from AP damage the Mist1 gene is required 
to be transiently silenced. This allows two main events. First, it allows cells to 
reduce exocytosis function. Second, p21CIP1/WAF1 (controlled by MIST1) is down-
regulated allowing the cells to enter a proliferative regeneration phase (Jia et al. 
2008). Sustained iMist1myc expression during episodes of AP leads to cell death 
via apoptosis. ZG - zymogen granules; rER - rough endoplasmic reticulum.  
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Several of these genes are differentially expressed in Mist1KO animals in response 
to AP damage (Mehmood et al. 2014), demonstrating that the chronic damage and 
stress associated with germ-line MIST1 deficiency results in key epigenetic 
changes that prime cells to increased sensitivity to AP and PDAC tumor formation.  
Thus, we now show that the absence of MIST1 per se is not sufficient to 
produce the increased sensitivity to disease states. Rather, it is the general 
damage and stress conditions associated with germ-line Mist1KO acinar cells that 
lead to increased AP responses and PDAC development. Given that MIST1 is 
critical for maintaining a healthy acinar cell state and Mist1 gene expression is 
transiently silenced during AP episodes, we investigated if sustained MIST1 
activity could attenuate the initial damage response. In contrast to what had been 
shown for PanIN/PDAC development in Mist1KO/KrasG12D pancreata (Shi et al. 
2009; Shi et al. 2013), sustained MIST1 activity was actually detrimental to AP 
recovery. Acinar cells that were prevented from down-regulating Mist1 gene 
expression in the early stages of AP underwent Caspase-3 dependent apoptosis, 
leaving the organ grossly reduced in size with large numbers of infiltrating immune 
and stromal cells occupying vast areas of the pancreas. Over the initial weeks 
post-AP, the number of Amylase expressing acinar cells declined dramatically and 
most of the remaining cells were assembled into small acini that lacked large 
accumulations of zymogen granules. Sustained iMist1 expression also kept the 
majority of cells in a quiescent state, most likely due to MIST1 controlling high 
p21Cip1/Waf1 levels (Jia et al. 2008). MIST1 controls acinar cell growth through 
p21CIP1/WAF1(Jia et al. 2008) therefore the cells need to down-regulate Mist1, which 
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allows p21CIP1/WAF1 to be down-regulated, allowing cells to regenerate. When 
MIST1 levels return to normal then acinar cells become quiescent.  Despite these 
widespread deficiencies, iMist1 organs did slowly recover functional acini over time 
with lineage-tracing confirming that the majority of acinar cells at 8 weeks post-AP 
were descendants of the small percentage of cells that failed to activate expression 
of the LSL-Mist1myc transgene during the initial tamoxifen induction. These normal 
(MYC-) acinar cells that silenced Mist1 expression during AP were able to reactive 
the endogenous Mist1 gene and recover from damage. Indeed, these cells 
regenerated and repopulated much of the damaged pancreas in this model 
system. We propose that silencing Mist1 expression is a critical event that permits 
acinar cells to survive an AP episode (Figure 4-30). Down-regulating MIST1 
activity may allow cells to suppress secretory functions and p21Cip1/Waf1 levels and 
permit a window of cell proliferation. Once established, the Mist1 gene is then 
reactivated so that cells have the appropriate intracellular machinery to assemble 
their secretory vesicles, expand the ER, communicate via CX32-containing gap 
junctions, and resume efficient exocytosis functions. Thus, AP damage and 
recovery phases involve key transcriptional networks that control the terminal 
differentiation and maturation status of these specialized secretory cells.  
  Future studies will be geared towards understanding the regulatory 
mechanisms that control Mist1 expression in both AP and PDAC disease states 
with a long-term goal of devising strategies to modulate transcriptional networks 




CHAPTER 5. CONDITIONAL KNOCKOUT OF THE ACINAR CELL-SPECIFIC 
TRANSCRIPTION FACTOR MIST1 SIGNIFICANTLY ATTENUATES K-RAS 
INDUCED PANCREATIC INTRAEPITHELIAL NEOPLASIA DEVELOPMENT 
 Introduction 
Pancreatic ductal adenocarcinoma (PDAC) is one of the most devastating 
cancers, often being diagnosed at late stages. PDAC is the fourth leading cause 
of death from cancer and estimates suggest it will be the second leading cause of 
death by 2030 (Yadav & Lowenfels 2013; Ryan et al. 2014). Studies have 
speculated that it takes about twenty years for a pancreatic tumor to initiate and 
develop into its metastatic form (Yachida et al. 2010). Because of this long latent 
period, PDAC is minimally diagnosed in patients younger than forty years. Indeed, 
the average diagnosis age for PDAC is 71 years (Jemal et al. 2011).  
Pancreatic intraepithelial neoplasia (PanIN) formation (the precursor 
lesions to PDAC) is one of the critical events that takes place prior to PDAC 
development (Hingorani et al. 2003; Collins et al. 2012). Interestingly, 90% of all 
PanINs contain activating KRAS mutations (Kanda et al. 2012), establishing KRAS 
as a critical driver of pancreatic adenocarcinoma. Nonetheless, in order for PanINs 




For instance, the tumor suppressor genes CDKNA2A, p53 and SMAD4 are 
mutationally inactivated in more than 50%, 60-70% and 50%, respectively, of 
PDAC tumors (Ryan et al. 2014; Bardeesy, Cheng, et al. 2006; Bardeesy, Aguirre, 
et al. 2006). In order to better understand PDAC development and design more 
effective therapeutic approaches, scientists have focused their research efforts in 
understanding the cell of origin of the disease and dissecting the molecular 
pathways that are instrumental in early lesion formation. (Pin et al. 2015; Ryan et 
al. 2014) 
It is well established that the exocrine compartment of the pancreas 
contributes to most PDACs (Furukawa et al. 2006). Hence, one of the much 
debated topics in the field has been in delineating which exocrine cell types (duct 
vs. acinar cells) give rise to PDAC. Because of the ductal phenotype associated 
with PDAC, pancreatic duct cells were thought to be the only cell types contributing 
to PDAC formation. However, studies using genetically engineered mouse models 
have demonstrated that upon Kras activation acinar cells give rise to both PanINs 
and PDAC (Kopp & Sander 2014; Kopp et al. 2012; Ji et al. 2009; Habbe et al. 
2008; Shi et al. 2009; Shi et al. 2013). Surprisingly, although KrasG12D  was 
expressed in all acinar cells in these mouse genetic models, only a small 
population of the cells initially de-differentiate to PanIN lesions, suggesting that the 
majority of acinar cells, despite expressing oncogenic Kras, are refractile to 
transformation (Bailey et al. 2014). Additionally, Kras expression in mice leads to 
very slow progression of PDAC where. it can take up to  two years for mice to 
develop PDAC (Hingorani et al. 2003; Ji et al. 2009). Given this information, Ji et 
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al. (2009) hypothesized that PDAC progression is directly dependent on the levels 
of Ras activity (2009) and verified that transformed lesions contained high Kras 
levels. Using cell culture and mouse models these investigators also showed that 
elevated Ras activity in acinar cells led to spontaneous development of PanIN 
lesions and PDAC tumors when compared to cells that maintained only 
endogenous Ras activity. Another finding from this study showed that high Kras 
activity also led to inflammatory responses that mimicked those that develop upon 
pancreatitis. Thus, it was speculated that an additional insult, such as pancreatitis, 
might be essential for PDAC formation (Ji et al. 2009; Guerra et al. 2007).  
Acinar reprogramming is one of the key events during PDAC initiation and 
development. In this context, fully differentiated acinar cells dedifferentiate to 
acinar-ductal metaplasia upon Kras oncogene activation. Furthermore, when 
insults such as inflammation occur along with accumulation of other mutations, 
Kras activity becomes enhanced, driving  PanINs to progress to PDAC (Murtaugh 
2014). This constant change in cell identity suggests that key transcription factor 
networks known to be essential for acinar cell identity and differentiation may play 
a vital role in PanIN and PDAC formation. Indeed, in Kras activated cell 
reprogramming, the acinar cell-specific transcription factors MIST1 and PTF1a are 
downregulated (Shi et al. 2013; Krah et al. 2015). In contrast, ductal restricted 
transcription factors, including SOX9 and HNF6, are upregulated in the earliest 
stages of reprogramming (Kopp et al. 2012). These results suggest that 
manipulating the transcription factor landscape could have significance 
consequences in Kras-driven PDAC development. 
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MIST1 is a transcription factor which is exclusively expressed in pancreatic 
acinar cells and is essential for acinar cell differentiation (Pin et al. 2000; Pin et al. 
2001). Studies from our laboratory have shown that sustained Mist1 expression, 
in the presence of oncogenic KRAS, dramatically prevents PanIN/PDAC 
development in mice (Shi et al. 2013). In contrast embryonic knockout of Mist1 
mice leads to greatly accelerated PanIN formation (Shi et al. 2009; Shi et al. 2013). 
Together, these studies suggest that MIST1 plays a tumor suppressive role in the 
pancreas. In support that acinar transcription networks are key to preventing Kras 
transformation, Krah et al. (2015) recently showed that conditional knockout of 
Ptf1a similarly accelerates PanIN formation upon KRAS activation, leading to 
aggressive PDAC formation.  
Previous studies done with Mist1 germline knock-out (Mist1KO) mice have 
shown that lack of MIST1 disrupts pancreatic acinar cell organization and polarity 
(Pin et al, 2001). Hence, Mist1KO mice are predisposed to develop pancreatic 
phenotypes and pancreatic diseases. To this day the role of MIST1 in PDAC 
formation has not been fully defined. As discussed earlier, Mist1KO acinar cells are 
highly sensitized to Kras transformation (Shi et al. 2009). However, one of the 
caveats of using germline Mist1KO mice in studying PanIN formation is that it is 
impossible to determine if the cancer phenotype and sensitivity towards Kras 
transformation is due to the loss of MIST1 protein specifically or if it is a result of 
an alternative mechanism such as the loss of acinar cell polarity observed in 
Mist1KO mice prior to Kras activation. Thus, to overcome this shortcoming, we set 
out to study the role/importance of MIST1 by using a mouse line containing a 
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conditional allele of Mist1 (Mist1cKO) where we could delete the Mist1 gene in adult 
mice. As described by Karki et al. (2015), we generated and characterized a 
conditional Mist1lox/lox mouse line (Figure 4-7) and that could be crossed with other 
genetically engineered mouse models including Mist1CreER/+ and LSL-KrasG12D/+. 
LSL-KrasG12D/+ mice contain a single point mutation in the Kras gene, Glycine (G) 
replaced with Aspartic acid (D). Upon Cre recombinase activity, the Lox-Stop-Lox 
(LSL) cassette is deleted, allowing the expression of the mutant Kras oncogene 
(Jackson et al. 2001). This breeding scheme generated Mist1CreER/lox; LSL-
KrasG12D/+ (Mist1cKO/KrasG12D) mice. Tamoxifen administration in adult animals 
leads to deletion of the remaining Mist1 allele and simultaneous expression of 
KrasG12D. Additionally, in an effort to determine the role of pancreatitis in pancreatic 
cancer development, we studied Mist1CreER/+; LSL-Kras (Mist1Het/KrasG12D), 
Mist1CreER/CreER; LSL-Kras (Mist1KO/KrasG12D) and Mist1cKO/KrasG12D mice. Our 
studies revealed that upon simultaneous Mist1 deletion and Kras expression 
PanIN formation greatly decreased when compared to Mist1Het/KrasG12D and 
Mist1KO/KrasG12D animals. Upon acute pancreatitis induction, PanIN formation in 







 Generation of Mist1cKO/KrasG12D mice  
Our lab has previously shown that Mist1Het/KrasG12D mice upon Kras 
expression develop PanIN lesions within two months. Importantly, the Mist1 allele 
becomes silenced in the PanIN lesions. However, Mist1KO/KrasG12D mice revealed 
that germline knockout of Mist1 makes the pancreas greatly more susceptible to 
developing advanced grades of PanIN lesions upon Kras expression. Indeed, 
there was a 3-fold increase in PanIN formation when Mist1 was absent (Shi et al, 
2009, Shi et al., 2012). Despite these results, it remained unclear if germline 
Mist1KO mice are naturally prone to developing diseases due to the absence of the 
Mist1 gene from the beginning of life. Thus, to better understand the role of Mist1 
we asked if conditional deletion of Mist1 would produce similar effects in PanIN 
formation upon Kras expression. To test this hypothesis, Mist1CreER/+ (Mist1Het) 
were crossed with LSL-KrasG12D/+ and Mist1lox/+ to generate Mist1CreER/+; LSL-
KrasG12D/+ (Mist1Het/KrasG12D), Mist1CreER/lox; LSL-KrasG12D/+ (Mist1cKO/KrasG12D) 
and Mist1CreER/CreER; LSL-KrasG12D/+ (Mist1KO/KrasG12D) mice. Mist1Het/KrasG12D and 
Mist1KO/KrasG12D mice were used as controls for the experiments. Upon tamoxifen 
treatment, the LSL cassette will be removed and KrasG12D expression will take 
place in all groups of mice. However, in Mist1cKO/KrasG12D mice Mist1 deletion take 





Figure 5-1. Schematic of the Mist1CreER, LSL-KrasG12D and Mist1CreER/lox alleles. 
This system utilizes tamoxifen-inducible Cre-recombination to delete Mist1 and 





 PanIN formation in Mist1cKO/KrasG12D mice is markedly decreased upon 
Kras expression 
In order to monitor PanIN formation in Mist1cKO/KrasG12D mice, six week old 
animals were treated with Tamoxifen. Mist1Het/KrasG12D and Mist1KO/KrasG12D mice 
were used as the controls for the experiment. Mice were sacrificed 2.5 months post 
treatment. Our lab previously showed that upon KrasG12D expression, PanIN 
formation is 5X higher in Mist1KO/KrasG12D mice when compared to their 
Mist1Het/KrasG12D littermates. Surprisingly, when we examined Mist1cKO/KrasG12D 
mice we observed a markedly reduced PanIN formation when compared to both 
Mist1KO/KrasG12D animals (Figure 5-2). It was also interesting that 
Mist1cKO/KrasG12D mice had comparable or even less PanIN formation to that of 
Mist1Het/KrasG12D mice.  These results suggested that conditional deletion of Mist1 
prevents KrasG12D-driven PanIN initiation through an unknown mechanism. One 
possible explanation was that perhaps the Mist1 allele was not efficiently deleted 
in Mist1KO/KrasG12D animals. As illustrated in Figure 5-3, the Mist1 allele was 
deleted from nearly all acinar cells and, as reported previously (Shi et al. 2009), all 
PanINs failed to express any MIST1.  
Taken together, these data suggest that the conditional deletion of Mist1 
from six-week old mice somehow deters PanIN initiation, possibly by inactivating 
KrasG12D activity through some unknown mechanism. Germline Mist1KO mice lose 








Figure 5-2. Mist1cKO/KrasG12D mice develop markedly reduced PanIN lesions 
compared to that of Mist1Het/KrasG12D and Mist1KO/KrasG12D counterparts 2.5 
months post-KrasG12D expression. Our lab previously showed that upon 
KrasG12D expression, PanIN formation is 5X higher in Mist1KO/KrasG12D mice than 
Mist1Het/KrasG12D littermates. As illustrated above, conditional deletion of Mist1 and 










Figure 5-3. Efficient deletion of Mist1 in Mist1cKO/KrasG12D mice post- 
tamoxifen administration. Anti-MIST1 IHC revealed that the majority of the 
acinar cells were MIST1 negative, indicating that efficient deletion of the Mist1 
allele occurred through Cre recombination. Red dotted area indicates a few rare 
unrecombined acinar cells which are MIST1 positive (indicated by arrows). Healthy 
acinar cells in Mist1Het/KrasG12D mice are MIST1 positive and PanIN lesions are 





Thus we might speculate that germline Mist1KO mice are predisposed to insults 
due to the lack of Mist1 since the beginning of their life and hence exhibit 
accelerated PanIN formation upon expression of mutated KrasG12D oncogene. 
 
 Decreased acinar-ductal-metaplasia and rare PanIN initiation persisted in 
Mist1cKO/KrasG12D mice 7d post-inflammation 
Studies done in genetically engineered mouse models have hinted that 
inflammation could be a possible mediator in PDAC progression (Carrière et al. 
2011; Ji et al. 2009). Ji et al (2009), used a transgenic mouse model to ascertain 
the effects of elevated Ras activity. Their mouse consisted of K-RasG12V driven by 
a human CMV and chicken-β-actin promoter (CAG) along with a transcription stop 
loxP-GFP-STOP-loxP construct. This mouse was further crossed with acinar cell- 
specific Elastase-CreERT mice. Upon tamoxifen administration, these mice 
developed a phenotype similar to that of chronic pancreatitis, consisting of 
increased fibrosis, loss of acinar cells, formation of acinar-ductal metaplasia and 
immune cell infiltrates (Ji et al. 2009). The phenotype remarkably mimicked human 
chronic pancreatitis. Additionally, these animals developed PDAC. This finding 
elucidated that insults such as inflammation could accelerate PDAC formation and 
lead to high Kras activity. Another study used a second strain of mice with loxP-
STOP-loxP-KrasG12D and was crossed with a Pdx1-CreERT (targeted towards 
pancreatic progenitor population) to directly investigate that pancreatitis could 
accelerate the PDAC development. These mice were developed PDAC within 2.5 
months post-KrasG12D expression and acute pancreatitis induction (Carrière et al. 
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2009). This finding corroborated the speculation of pancreatitis being a contributor 
to PDAC progression. 
Thus, to determine whether PanIN lesion formation and progression could 
be accelerated by acute pancreatitis upon simultaneous deletion of Mist1 and 
KrasG12D oncogene expression in Mist1cKO/KrasG12D mice, all three groups of, 
Mist1Het/KrasG12D, Mist1cKO/KrasG12D and Mist1KO/KrasG12D mice were subjected to 
two-dosages of tamoxifen treatment. One week post-tamoxifen, these mice were 
administered eight hourly injections for two consecutive days of cholecystokinin 
(CCK) analog caerulein which binds to the CCK receptor to induce acute 
pancreatitis (AP) (protocol similar to experiments in Chapter 3). Mouse pancreata 
were harvested 7 and 21 days post-AP induction for protein, RNA and paraffin 
sections for further analyses (Figure 5-4A). Hematoxylin and eosin (H&E) 
analyses revealed that overall, Mist1cKO/KrasG12D mice contained dramatically 
increased healthy acinar cells and reduced inflammation in comparison to their 
Mist1Het/KrasG12D and Mist1KO/KrasG12D control counterparts (Figure 5-4B).Closer 
analyses of pancreata showed that significantly delayed ADM formation and 
infrequent occurrence of PanIN initiation in Mist1cKO/KrasG12D mice (Figure 5-4C). 
These findings suggest that in the initial stages of pancreatitis (7d) 
Mist1cKO/KrasG12D mice fail to initiate ADMs (precursors for PanIN formation). As a 




Figure 5-4. Decreased ADM and PanIN formation in Mist1cKO/ KrasG12D mice 
7d post-AP. (A) Schematic of Tam treatment and AP induction in Mist1Het/ 
KrasG12D, Mist1KO/KrasG12D and Mist1cKO/KrasG12D mice. Pancreatic samples were 
harvested 7 days post-AP. (B) Gross phenotype of the mice pancreata post 
KrasG12D expression and AP induction. Mist1cKO/KrasG12D mice contain increased 













Figure 5-4. Decreased ADM and PanIN formation in Mist1cKO/ KrasG12D mice. 
(C) Mist1Het/KrasG12D and Mist1KO/KrasG12D mice present increased cellular 
infiltrates, ADMs and early PanINs. Acinar-ductal-metaplasia (ADM), early PanINs 
and inflammation are reduced in MistcKO/KrasG12D mice upon KrasG12D expression 




The low inflammation occurrence in Mist1cKO/KrasG12D mice also suggest that 
endogenous KRASG12D activity is insufficient or inhibited to initiate the cellular 
reprogramming required for PanIN progression.  
We next examined the acinar and ductal characteristics of the Mist1cKO/ 
KrasG12D mice by evaluating whole cell protein extracts using immunoblot analysis. 
Absence of MIST1 protein confirmed efficient deletion of Mist1 post-tamoxifen 
administration (Figure 5-5, lanes 3 and III). Established acinar marker, AMYLASE 
was elevated in Mist1cKO/ KrasG12D mice confirming the presence of healthy acinar 
cells post-KrasG12D expression and AP induction (lanes 3 and III). ADM and ductal 
markers, SOX9 and K19 levels were decreased in comparison to Mist1Het/ KrasG12D 
and Mist1KO/ KrasG12D mouse samples as illustrated in Figure 5-5.These data 
further confirm that ADM and PanIN formation is still inhibited in Mist1cKO/ KrasG12D 
mice at early stage (7d) post AP induction.  
In order to further confirm reduced ADM and PanIN formation in 
Mist1cKO/KrasG12D mice 7d post-AP insult, we set out to perform RT-qPCR 
analyses on RNA samples from these animals. As demonstrated by the 
immunoblots, RT-qPCR also confirmed the presence of significantly increased 
acinar cells (Amylase) in Mist1cKO/KrasG12D mice in comparison to control 









Figure 5-5. Mist1cKO/KrasG12D mice show increased acinar marker (AMYLASE) 
and decreased ADM and ductal markers (SOX9 and K19) in comparison to 
their control counterparts 7d-post AP. Anti-MIST1 IHC confirmed efficient 
deletion of Mist1 in Mist1cKO/KrasG12D mice (lanes 3 and III). Established acinar 
marker, AMYLASE was elevated in Mist1cKO/KrasG12D mice confirming the 
presence of healthy acinar cells post KrasG12D expression and AP induction (lanes 
3 and III). Both ADM marker SOX9 and ductal marker K19 levels were decreased 
in comparison to both Mist1Het/KrasG12D and Mist1KO/KrasG12D mouse samples. S6 
was used as a loading control. Note: Immunoblots represent two sets of mice 






Figure 5-6. Gene expression analysis confirms the presence of increased 
acinar cells which fail to initiate PanINs and decreased inflammation in 
Mist1cKO/KrasG12D mice 7d post-AP. RT-qPCR analysis of the known acinar 
gene, Amylase showed elevated transcript levels and decreased ADM marker, 
SOX9 in Mist1cKO/KrasG12D mice in comparison to Mist1Het/KrasG12D and 
Mist1KO/KrasG12D littermates confirming the presence of healthy acinar cells that 
failed to form ADM and PanINs 7d post-AP insult. Furthermore, the stromal marker 
Vimentin was decreased compared to the control mice suggesting that 
Mist1cKO/KrasG12D animals exhibit significantly lower inflammation when compared 




Significantly decreased Sox9 and K19 transcript levels confirmed that 
acinar cells in Mist1cKO/KrasG12D mice did not undergo ADM events (a precursor 
for PanIN initiation), confirming the overall decrease in PanIN formation. 
Furthermore, stromal markers such as Vimentin, showed significantly reduced 
transcript levels in Mist1cKO/KrasG12D mice than control littermates (Figure 5-6). 
Taken together, these results demonstrate that ADM and PanIN formation were 
significantly delayed in Mist1cKO/KrasG12D mice, even upon KrasG12D expression 
and AP insult. However, the dramatic phenotype in Mist1KO/KrasG12D mice as early 
as 1 week post-AP confirmed that embryonic knockout of Mist1 leads to rapid 
PanIN formation.  
 
 Surprisingly PanIN formation is accelerated in Mist1cKO/KrasG12D mice by 3 
weeks post-AP  
We showed that Mist1cKO/KrasG12D mice failed to initiate ADM and PanIN 
formation upon KrasG12D expression and 7d post-AP in comparison to 
Mist1Het/KrasG12D and Mist1KO/KrasG12D littermates. This was a surprising result 
because we expected that AP insult would accelerate overall ADM and PanIN 
formation in Mist1cKO/KrasG12D mice. Other investigators had previously 
demonstrated that high grade PanIN formation and ADM occurred only around 1 
month following the AP insult (Carrière et al. 2009). Thus we speculated that 
Mist1cKO/KrasG12D mice might be able to accelerate PanIN formation after longer 





Figure 5-7. Accelerated PanIN progression 3 weeks post-AP in 
Mist1cKO/KrasG12D mice. (A) Schematic of Tam treatment and AP induction in 
Mist1Het/ KrasG12D, Mist1KO/KrasG12D and Mist1cKO/KrasG12D mice. Pancreatic 
samples were harvested 21 days post-AP. (B) Gross phenotype of the mice 
pancreata post-KrasG12D expression and AP induction. ADM and PanIN formation 
in Mist1cKO/KrasG12D mice were markedly elevated 3 weeks post inflammation. 
Although some pockets of acinar cells were seen, the overall PanIN population 




In order to determine whether PanIN progression was elevated in 3w post AP 
treated Mist1cKO/KrasG12D mice, paraffin sections, protein and RNA samples were 
utilized to perform immunostaining, immunoblots and RT-qPCR, respectively 
(Figure 5-7A). H&E analysis of the mice pancreata revealed decreased acinar cell 
clusters, increased PanIN formation along with elevated inflammation in 
Mist1cKO/KrasG12D mice as illustrated in Figure 5-7B. The phenotype of all three 
groups of mice were comparable. However, there were a few mice in 
Mist1cKO/KrasG12D group that failed to form ADMs and PanINs as verified by the 
presence of increased acinar cell pockets (Figure 5-8). These results suggest that 
PanIN formation accelerates in Mist1cKO/KrasG12D mice post- KrasG12D expression 
and 3wks after AP induction in comparison to 1 wk post-AP mice. I speculate that 
KrasG12D expression was elevated during the 3 week window and this led 
Mist1cKO/KrasG12D mice to form comparable PanIN formation across all three 
genotypes (Mist1Het/KrasG12D, Mist1KO/KrasG12D and Mist1cKO/KrasG12D).  
In order to verify the increased presence of PanIN lesions in Mist1cKO/ 
KrasG12D pancreata, IHC was performed using a ductal and PanIN marker. K19 
expression was prevalent in PanINs and ADMs in all groups of mice (Figure 5-9). 
Marked increase in K19 expression in Mist1cKO; LSL-KrasG12D mice confirmed the 




Figure 5-8. Variation in PanIN formation in Mist1cKO/KrasG12D mice 21d post-
AP. H&E images reveal that there is mouse to mouse variation in PanIN formation 
in Mist1cKO/KrasG12D mice. Some mice present increased pancreatic acinar cells 






Figure 5-9. Marked increase in PanIN formation in Mist1cKO/KrasG12D mice 
assessed by ductal and PanIN marker K19. Anti-MIST1 antibody IHC staining 
showed a few positive acinar cell populations in Mist1Het /KrasG12D mice. No MIST1 
positive cells were present in Mist1cKO/KrasG12D mice (insets show MIST1 positive 
and MIST1 negative acinar cell populations in Mist1Het /KrasG12D and 
Mist1cKO/KrasG12D mice, respectively (upper panel). K19 staining marks PanINs in 





In order to further determine elevated PanIN formation, immunoblot experiments 
were performed. Anti-AMYLASE immunoblot confirmed decreased amylase 
expression and decreased pancreatic acinar cells in all groups of mice. SOX9 and 
K19 protein levels were comparable in all groups indicating a similar presence of 
ADMs and PanINs (Figure 5-10). Next, RT-qPCR analyses were conducted to 
determine the gene expression of acinar, ADM, PanIN and stromal markers in 
Mist1cKO/KrasG12D mice. Comparable Amylase expression was observed in 
Mist1Het/KrasG12D and Mist1cKO /KrasG12D mice. Sox9 and K19 gene expression 
were comparable in all three groups of mice suggesting the elevated ADM and 
PanIN formation in Mist1cKO/KrasG12D mice. The stromal marker Vimentin also 
revealed the presence of a significant fibroblast cell population (Figure 5-11). 
Taken together, these findings confirmed that PanIN formation in 
Mist1cKO/KrasG12D mice were elevated after 3 weeks post-AP compared to 1 week 
post-AP. This also suggests that KrasG12D expression was elevated in Mist1cKO 
/KrasG12D mice 3 week post-AP. However, further experiments are needed to 
assess the KrasG12D levels. It was surprising to get remarkably similar results in 
both Mist1Het /KrasG12D and Mist1cKO/KrasG12D mice although Mist1Het /KrasG12D 
mice formed increased PanIN formation in 7d post-AP animals. This indicates that 
conditional knockout of Mist1 in adult mice are sensitive to PanIN formation over 









Figure 5-10. Increased PanIN formation in Mist1cKO/KrasG12D mice 21d post 
AP. Mist1cKO/KrasG12D mice contain slightly higher levels of acinar cells than 
Mist1Het/KrasG12D  and Mist1KO/KrasG12D mice as shown by anti-AMYLASE. K19 
level was slightly lower in Mist1cKO; LSL-KrasG12D when compared to the control 
littermates. HSP90 was used as a loading control. Note SOX9 expression in 
Mist1KO/KrasG12D mice (lane 2) is lower than the other two mouse groups. This 
might be due to lower concentration of protein loaded (confirmed by loading 






Figure 5-11. Gene expression analysis confirmed accelerated PanIN 
formation in Mist1cKO/KrasG12D mice 21d post-AP. RT-qPCR showing 
comparable levels of Amylase in Mist1cKO/KrasG12D and Mist1Het/KrasG12D mice. 
Sox9 and K19 gene expression in all sets of mice were similar indicating the 
development of ADM and PanIN. Occurrence of similar levels of stromal cells was 













Table 6. Summary of PanIN formation in Mist1Het/KrasG12D, Mist1KO/KrasG12D 
and Mist1cKO/KrasG12D mice post-KrasG12D expression only and post-
KrasG12D expression followed by an acute pancreatitis insult. (+) denotes the 
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Genetically engineered mouse models have been instrumental in studying 
human pancreatic diseases such as pancreatitis and pancreatic cancer. These 
mouse models have played an immense role in elucidating molecular mechanisms 
including identifying the cell-of-origin in order to better understand diseases and 
hence develop better therapeutic options. Because of the ductal phenotype of 
PDAC, pancreatic duct cells were thought to be the ultimate cell types contributing 
to PDAC formation. However, studies using genetically engineered mouse models 
have established that upon KrasG12D expression acinar cells give rise to both 
PanINs and PDAC (Kopp & Sander 2014; Kopp et al. 2012; Ji et al. 2009; Habbe 
et al. 2008; Shi et al. 2009; Shi et al. 2013). This finding instigated researchers to 
investigate acinar cell specific transcription factors. One such factor is MIST1(Pin 
et al. 2000). MIST1 is essential for maintaining well-differentiated acinar cells. 
Embryonic Mist1KO are susceptible to diseases including pancreatitis and PDAC 
(Kowalik et al. 2007; Shi et al. 2009) suggesting that MIST1 can play a tumor 
suppressive role.  
 In order to better understand the role of MIST1 in PanIN development, 
we utilized a novel mouse model which allows us to conditionally delete Mist1 in 
the adult acinar cells (Karki et al. 2015). Here, we demonstrate that conditional 
loss of Mist1 upon KrasG12D activation delayed ADM and PanIN formation. 
Additionally, upon AP insult, acinar cells initially are refractile to Kras 
transformation. However, as early as 3 weeks post-AP induction the PanIN 
formation are rapidly accelerated in Mist1cKO/KrasG12D mice. 
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 Mist1cKO/KrasG12D mice were generated to study the role of MIST1. These 
mice allowed simultaneous deletion of Mist1 and KrasG12D expression in adult 
pancreata. Our analyses revealed that these mice developed very low numbers of 
PanIN lesions two months post-KrasG12D expression in comparison to embryonic 
Mist1KO mice. These findings led us to confirm that embryonic loss of Mist1 makes 
acinar cells more susceptible to oncogenic transformation as they develop 
increased PanIN lesions upon KrasG12D expression. Indeed, previous findings have 
confirmed that embryonic Mist1KO mice lose proper apical-basal polarity revealed 
by improper zymogen localization (Pin et al. 2001). Likewise, acinar cells in these 
mice fail to secrete digestive enzymes including amylase (Direnzo et al. 2012). 
Most importantly, Mist1KO mice fail to establish proper communication with the 
neighboring cells which is confirmed by loss of CONNEXIN32 (a gap junction 
protein)(Rukstalis et al. 2003; Johnson et al. 2004). This result, for the first time 
verified that the defects in germline Mist1KO mice could contribute to accelerated 
PanIN formation. The conditional deletion of Mist1, through some unknown 
mechanism, inhibits the spontaneous PanIN formation driven by KrasG12D 
expression in contrast to Mist1KO/KrasG12D mice. Future studies should be directed 
towards measuring the activity of oncogenic KRASG12D in both Mist1KO and 
Mist1cKO mice. This experiment will be key in finding whether embryonic Mist1KO 
mice begin with elevated KrasG12D expression in comparison to Mist1cKO mice (Ji 
et al. 2009). RNA-seq analysis performed on Ptf1a conditional knockout mice 
revealed that loss of Ptf1a alone activates genes dedicated to Ras and 
inflammatory pathways (Krah et al. 2015). It would be of utmost importance to 
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perform similar gene expression profiling of both Mist1KO and Mist1cKO mice to fully 
characterize the transcription signature during PanIN formation.  
 One of the findings from when KrasG12D was expressed in 
Mist1Het/KrasG12D, Mist1KO/KrasG12D and Mist1cKO/KrasG12D mice was that PanIN 
formation in Mist1cKO/KrasG12D was rarer than the Mist1Het/KrasG12D littermates.  
The development of minimal PanINs in Mist1cKO/KrasG12D mice is very 
surprising and peculiar. This phenomenon seen in Mist1KO/KrasG12D mice has to 
be further investigated.  
  Studies in mice have shown that PanIN progression and PDAC 
development can be accelerated by insults including pancreatitis (Guerra et al. 
2007; Carrière et al. 2011; Carrière et al. 2009). In order to further elucidate the 
role of Mist1 PanIN formation, we decided to add acute pancreatitis as an insult 
post-KrasG12D expression. Samples taken as early as 7d post-AP revealed that 
PanIN formation in Mist1cKO/KrasG12D mice was dramatically lower in comparison 
to Mist1Het/KrasG12D and Mist1KO/KrasG12D animals, revealing the presence of a 
high number of acinar cell pockets, decreased markers of ADM and PanINs such 
as SOX9 presence of low immune infiltrates and stromal cell population. This 
phenotype is quite intriguing as both KrasG12D expression and an AP induction (two 
insults) could not accelerate the PanIN formation in Mist1cKO/KrasG12D mice. These 
results further motivate us to investigate how conditional deletion of Mist1 protects 
the tissue from insults such as KRAS activity and acute pancreatitis allowing delay 
in PanIN initiation. Studies have shown that advanced PanIN formation takes place 
as early as one month post pancreatitis induction (Carrière et al. 2009). Next we 
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wanted to investigate whether Mist1cKO/KrasG12D mice eventually accelerate PanIN 
formation. Consistent with this finding, indeed Mist1cKO/KrasG12D mice exhibited 
increased PanIN formation upon KrasG12D expression and 3 week post-AP. The 
frequency of PanINs were comparable to Mist1Het/KrasG12D and Mist1KO/KrasG12D 
mice which was confirmed by paraffin staining, gene expression and immunoblot 
analyses. The PanIN formation is accelerated over time in Mist1cKO/KrasG12D mice 
suggesting that these mice take time to progress lesions. We show that AP 
pancreatitis can accelerate the PanIN formation as early as 3 wk post-AP. 
However, close examination of individual Mist1cKO/KrasG12D mouse revealed the 
some mice consists of increased acinar clusters and low PanIN lesions.  In order 
to rule the technical errors, further analyses including AMYLASE, SOX9, MIST1 
and K19 staining should be performed. 
 The summary of the PanIN progression is shown in Table 6. Overall, the 
delay in PanIN formation in Mist1cKO mouse is an intriguing finding. However, to 
unravel the mechanism behind this phenomenon would be quintessential to 




CHAPTER 6. SUMMARY AND FUTURE DIRECTIONS 
The exocrine pancreas consists of acinar cells that are responsible for the 
synthesis, storage and secretion of various digestive enzymes such as amylase, 
elastase and carboxypeptidase into duct lumens (Slack 1995). Duct cells aid in 
transporting the secreted proteins to the duodenum. The pyramid shaped acinar 
cells prevail in a spherical structure called an acinus. The basal portion of an acinar 
cell consists of nuclei and rough ER (Motta et al. 1997). The apically located 
precursor enzymes (zymogens) produced by acinar cells remain inactive until 
secreted into the digestive tract via a strictly regulated exocytosis pathway 
(McNiven & Marlowe 1999).  
Transcription factors play an essential role in maintaining the function and 
identity of pancreatic acinar cells including the bHLH factors PTF1a (Krapp et al. 
1996)  and MIST1 (Lemercier et al. 1997). PTF1a plays an important role in 
differentiation of pancreatic precursors into acinar cells (Kawaguchi et al. 2002; 
Krapp et al. 1998) while MIST1 is expressed in acinar cells of the adult pancreas 
and is required to maintain acinar cell organization (Pin et al. 2001).  Mist1 null 
(Mist1KO) mice show disrupted acinar cell organization (Pin et al. 2001). 
Additionally, impaired secretion and cell-cell communication is observed in Mist1KO 
mice (Rukstalis et al. 2003), highlighting the importance of MIST1 in normal acinar 
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cell physiology. The importance of MIST1 to regulating the secretory machinery is 
also suggested by its global expression pattern. Besides being expressed in 
pancreatic acinar cells, MIST1 is expressed in other serous secretory cells 
including the acinar cells of the salivary glands, chief cells of the stomach, and 
lactating cells of the mammary glands (Pin et al. 2001). This ubiquitous presence 
in secretory cells and the phenotype observed in Mist1KO cells strongly suggest a 
role for Mist1 in establishing and maintaining proper secretory capabilities.  
The MIST1 protein is a 197 amino acid long transcription factor that has a 
conserved central bHLH domain that facilitates DNA binding and dimerization 
(Lemercier et al. 1997; Lemercier et al. 1998). Studies utilizing truncated forms of 
MIST1 revealed that the HLH domain is essential for MIST1 dimerization while the 
basic domain is essential for DNA binding (Tran et al. 2007). Interestingly, MIST1 
lacks a classic transcriptional activation domain (TAD) or transcriptional repression 
domain (TRD), suggesting that it utilizes cofactor proteins in order to regulate 
transcription. Indeed, a truncated version of Mist1 (50 aa – 140 aa) containing the 
central bHLH region is sufficient to generate a near complete transcriptional 
response (Tran et al. 2007). Thus, I hypothesized that co-factors are required to 
allow MIST1 to activate or repress specific target genes. One focus of this thesis 
was to utilize a novel mouse model to identify the binding protein partners of MIST1 
by LC-MS/MS via a biotinylation pull-down system to immunoprecipitate MIST1-
associated complexes. An N-terminal BT tag, C-terminal 6XHis-Myc tag and two 
loxP sites were introduced via homologous recombination into the Mist1 locus, 
generating the Mist1BT/Myc line. R26HA-BirA mice, expressing a BT-specific biotin 
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ligase, were crossed to Mist1BT/Myc mice to generate Mist1BT/BT; R26HA-BirA mice. 
Biotinylated protein complexes from mice pancreata were purified using 
streptavidin conjugated magnetic beads. To identify potential MIST1 binding 
partners, the samples were run via mass spectrometry. Unfortunately, we were 
unable to identify clear binding partners (a transcription factor) of MIST1 utilizing 
this strategy. However, future studies could analyze the mass spectrometry data 
list to potentially identify if any of the other proteins (non-transcription factors) could 
possibly serve as a putative binding partner depending on the cell context.  
Another focus of this thesis was to elucidate the role of MIST1 in both AP 
and PDAC conditions. Interestingly, Mist1WT mice subjected to acute pancreatitis 
develop damaged acinar cells that transiently silence the Mist1 gene, but as the 
organ undergoes recovery, Mist1 gene expression resumes.  Similar studies on 
Mist1KO mice have shown that in the absence of MIST1 protein, organ recovery is 
significantly impaired, suggesting that the MIST1 transcription network plays a key 
role in restoring normal homeostasis. In order to study the importance of MIST1 
activity to pancreatitis recovery, I asked whether Mist1 silencing is a consequence 
of pancreatitis damage or is actually a necessary event for organ recovery. To 
examine this question, I used an inducible transgenic mouse line which allows 
Mist1 gene expression to be continuously on, even under pancreatitis conditions.  
The results reveal that sustained expression of Mist1 in damaged acinar cells 
hinders the normal recovery process when compared to Mist1WT mice. My findings 
also suggest that apoptosis plays a role in deterring the recovery process in 
pancreata that fail to silence Mist1 expression. Lineage tracing experiments 
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revealed that endogenous acinar cells are involved in the pancreatitis recovery 
process. 
 Future directions for the project are to perform studies on how pancreatitis 
damage accelerates PDAC disease. Additionally, it would be very interesting to 
generate an iMist1-ENGRAILED model in order to determine if activated MIST1 
targets are responsible for the severe cell death in iMist1 mice. In this instance, we 
would use a MIST1-ENgrailed repressor fusion protein and generate a new 
iMIST1EN mouse (Wang et al. 2004). The Drosophila homeodomain protein 
Engrailed, consists of a repression domain within amino acids 2-299 (Han & 
Manley 1993). The Engrailed domain will be fused with MIST1 protein with an 
epitope tag such as Myc. The Mist1EN-Myc cDNA will then be placed into the pCAG-
CAT vector containing a lox-stop-lox (LSL) cassette. Introduction of the LSL-
Mist1EN-Myc transgene into mouse pronuclei will generate an iMist1EN-Myc transgenic 
line. Crossing iMist1EN-Myc mice to Mist1CreER mice will generate 
Mist1CreERT/+/Mist1EN-Myc animals. Upon tamoxifen administration, this approach 
allows MIST1EN-Myc to behave as a full-time repressor. Thus, we would be able to 
elucidate if turning off MIST1 target genes would give different results than that of 
AP iMIST1 studies. Upon turning off the MIST1 targets, if the acinar cells do not 
undergo severe cell death, this would suggest that indeed MIST1 induced targets 
are contributing to the devastating phenotype in our iMist1 AP studies. In contrast, 
if the cells still undergo dramatic apoptosis post-AP in Mist1CreER/+/Mist1EN-Myc mice, 
then this would indicate that presumably the genes normally repressed by MIST1, 
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including Rnd2, are responsible for causing the severe pancreas injury in the iMist1 
AP studies. 
 Previous studies using Mist1KO mice revealed that upon AP insults, these 
mice are susceptible to severe AP phenotypes along with delay in organ recovery 
(Kowalik et al. 2007). Likewise, upon KrasG12D oncogene transformation, PanIN 
lesion development is markedly accelerated in Mist1KO mice (Shi et al. 2009). 
However, germline Mist1KO mice show defects in cell-polarity, cell-cell 
communication and enzyme secretion (Johnson et al. 2004; Direnzo et al. 2012; 
Pin et al. 2001) since the beginning of life. Hence, we predict that these prior 
defects in Mist1KO mice might be the cause of sensitivity towards diseases and not 
due necessarily to the absence of MIST1 protein per se. To overcome this 
sensitivity, a conditional Mist1 knock-out mouse model was developed. The 
conditional knockout (Mist1cKO) mouse was crossed with LSL-KrasG12D mice to 
generate Mist1cKO/KrasG12D mice. Interestingly, Mist1cKO/KrasG12D mice develop 
significantly decreased PanIN lesions than Mist1KO/KrasG12D mice confirming that 
indeed the defects in pancreata of Mist1KO mice is what makes them susceptible 
to insults. Furthermore, in an effort to determine the role of pancreatitis in 
pancreatic cancer development, we studied Mist1Het/KrasG12D and 
Mist1KO/KrasG12D and Mist1cKO/KrasG12D mice. Preliminary studies revealed that 
upon simultaneous Mist1 deletion and KrasG12D activation, alongside the induction 
of pancreatitis, PanIN formation decreased compared to Mist1Het/KrasG12D animals 
during the initial stages of PanIN formation. However, as early as 3 weeks post-
AP induction PanIN lesions are markedly accelerated in Mist1cKO/KrasG12D mice.  
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Further experiments have to be performed to delineate the mechanism(s) 
behind the delayed PanIN formation in Mist1cKO/KrasG12D mice. Performing RNA-
Seq analysis to identify differential gene expression pattern in Mist1KO and Mist1cKO 
mice would be a critical experiment to determine the role of MIST1 protein. Other 
key questions to be answered are: Is there a specific signaling pathway that is 
involved in inhibiting PanIN formation? Are there other key transcription factors 
besides MIST1 that could be controlling the PanIN lesion formation? Is MIST1 
required for both PanIN initiation and progression?     
The study of TFs is of utmost importance for understanding the origin and 
mechanism of pancreas related diseases. The importance of MIST1 to pancreatitis 
and pancreatic cancer suggests that modulating key pancreas transcription 





























Afelik, S., Chen, Y. & Pieler, T., 2006. Combined ectopic expression of Pdx1 and 
Ptf1a/p48 results in the stable conversion of posterior endoderm into 
endocrine and exocrine pancreatic tissue. Genes & development, 20(11), 
pp.1441–6. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1475757&tool=pm
centrez&rendertype=abstract [Accessed February 11, 2016]. 
Ahlgren, U., Jonsson, J. & Edlund, H., 1996. The morphogenesis of the pancreatic 
mesenchyme is uncoupled from that of the pancreatic epithelium in 
IPF1/PDX1-deficient mice. Development (Cambridge, England), 122(5), 
pp.1409–16. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8625829 
[Accessed January 22, 2016]. 
Ahmed, A.M., 2002. History of diabetes mellitus. Saudi medical journal, 23(4), 
pp.373–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11953758 
[Accessed March 17, 2016]. 
Akiyama, H. et al., 2005. Osteo-chondroprogenitor cells are derived from Sox9 
expressing precursors. Proceedings of the National Academy of Sciences of 
the United States of America, 102(41), pp.14665–70. Available at: 
http://www.pnas.org/content/102/41/14665.long [Accessed March 20, 2016]. 
Alahari, S. et al., 2011. The absence of MIST1 leads to increased ethanol 
sensitivity and decreased activity of the unfolded protein response in mouse 
pancreatic acinar cells. PloS one, 6(12), p.e28863. Available at: 
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028863 
[Accessed February 17, 2016]. 
Anon, Avidin-Biotin Chemistry: A Handbook: M. Dean Savage: 9780935940114: 
Amazon.com: Books. Available at: http://www.amazon.com/Avidin-Biotin-
Chemistry-Handbook-Dean-Savage/dp/0935940111 [Accessed January 13, 
2016]. 
Ardito, C.M. et al., 2012. EGF receptor is required for KRAS-induced pancreatic 
tumorigenesis. Cancer cell, 22(3), pp.304–17. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22975374 [Accessed February 28, 2
177 
 
Aure, M.H., Konieczny, S.F. & Ovitt, C.E., 2015. Salivary gland homeostasis is 
maintained through acinar cell self-duplication. Developmental cell, 33(2), 
pp.231–7. Available at: 
http://www.cell.com/article/S1534580715001318/fulltext [Accessed February 
1, 2016]. 
Bailey, J.M., DelGiorno, K.E. & Crawford, H.C., 2014. The secret origins and 
surprising fates of pancreas tumors. Carcinogenesis. 
Banerjee, A.K. et al., 1995. Respiratory failure in acute pancreatitis. Postgraduate 
medical journal, 71(836), pp.327–30. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2398144&tool=pm
centrez&rendertype=abstract [Accessed April 3, 2016]. 
Banks, P.A., Conwell, D.L. & Toskes, P.P., 2010. The management of acute and 
chronic pancreatitis. Gastroenterology & hepatology, 6(2 Suppl 3), pp.1–16. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2886461&tool=pm
centrez&rendertype=abstract [Accessed February 12, 2016]. 
Bardeesy, N., Aguirre, A.J., et al., 2006. Both p16(Ink4a) and the p19(Arf)-p53 
pathway constrain progression of pancreatic adenocarcinoma in the mouse. 
Proceedings of the National Academy of Sciences of the United States of 
America, 103(15), pp.5947–52. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1458678&tool=pm
centrez&rendertype=abstract [Accessed March 24, 2016]. 
Bardeesy, N., Cheng, K.-H., et al., 2006. Smad4 is dispensable for normal 
pancreas development yet critical in progression and tumor biology of 
pancreas cancer. Genes & development, 20(22), pp.3130–46. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1635148&tool=pm
centrez&rendertype=abstract [Accessed March 24, 2016]. 
Bardeesy, N. & DePinho, R.A., 2002. Pancreatic cancer biology and genetics. 
Nature reviews. Cancer, 2(12), pp.897–909. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12459728 [Accessed February 9, 2016]. 
van Belle, T.L., Coppieters, K.T. & von Herrath, M.G., 2011. Type 1 diabetes: 
etiology, immunology, and therapeutic strategies. Physiological reviews, 91(1), 
pp.79–118. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21248163 





Van Belle, T.L., Taylor, P. & von Herrath, M.G., 2009. Mouse Models for Type 1 
Diabetes. Drug discovery today. Disease models, 6(2), pp.41–45. Available 
at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2855847&tool=pm
centrez&rendertype=abstract [Accessed February 21, 2016]. 
Beres, T.M. et al., 2006. PTF1 is an organ-specific and Notch-independent basic 
helix-loop-helix complex containing the mammalian Suppressor of Hairless 
(RBP-J) or its paralogue, RBP-L. Molecular and cellular biology, 26(1), 
pp.117–30. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1317634&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Bhatia, M. et al., 2012. Apoptosis versus necrosis in acute pancreatitis Apoptosis 
versus necrosis in acute pancreatitis. 
Bhatia, M., 2005. Inflammatory response on the pancreatic acinar cell injury. 
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical 
Society and the Scandinavian Surgical Society, 94(2), pp.97–102. Available 
at: http://www.ncbi.nlm.nih.gov/pubmed/16111089 [Accessed April 3, 2016]. 
Bhatia, M. et al., 2005. Pathophysiology of acute pancreatitis. Pancreatology : 
official journal of the International Association of Pancreatology (IAP) ... [et al.], 
5(2-3), pp.132–44. Available at: 
http://www.sciencedirect.com/science/article/pii/S142439030580050X 
[Accessed April 2, 2016]. 
Bockman, D.E. et al., 2003. Origin and Development of the Precursor Lesions in 
Experimental Pancreatic Cancer in Rats. Laboratory Investigation, 83(6), 
pp.853–859. Available at: 
http://dx.doi.org/10.1097/01.LAB.0000074918.31303.5A [Accessed March 17, 
2016]. 
de Boer, E. et al., 2003. Efficient biotinylation and single-step purification of tagged 
transcription factors in mammalian cells and transgenic mice. Proceedings of 
the National Academy of Sciences of the United States of America, 100(13), 
pp.7480–5. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=164612&tool=pmc
entrez&rendertype=abstract [Accessed January 20, 2016]. 
Börner, A. et al., 2009. Subcellular protein extraction from human pancreatic 
cancer tissues. BioTechniques, 46(4), pp.297–304. Available at: 





Bragado, M.J. et al., 1996. Impairment of intracellular calcium homoeostasis in the 
exocrine pancreas after caerulein-induced acute pancreatitis in the rat. 
Clinical science (London, England : 1979), 91(3), pp.365–9. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/8869421 [Accessed April 3, 2016]. 
Bredemeyer, A.J. et al., 2009. The gastric epithelial progenitor cell niche and 
differentiation of the zymogenic (chief) cell lineage. Developmental biology, 
325(1), pp.211–24. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2634829&tool=pm
centrez&rendertype=abstract [Accessed January 18, 2016]. 
Butler, A.E. et al., 2003. Beta-cell deficit and increased beta-cell apoptosis in 
humans with type 2 diabetes. Diabetes, 52(1), pp.102–10. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12502499 [Accessed March 23, 2016]. 
Capoccia, B.J. et al., 2011. Transcription factor MIST1 in terminal differentiation of 
mouse and human plasma cells. Physiological genomics, 43(3), pp.174–86. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3055710&tool=pm
centrez&rendertype=abstract [Accessed June 23, 2011]. 
Carrière, C. et al., 2011. Acute pancreatitis accelerates initiation and progression 
to pancreatic cancer in mice expressing oncogenic Kras in the Nestin cell 
lineage. PLoS ONE. 
Carrière, C. et al., 2009. Acute pancreatitis markedly accelerates pancreatic 
cancer progression in mice expressing oncogenic Kras. Biochemical and 
Biophysical Research Communications. 
Chen, E.I. et al., 2007. Optimization of mass spectrometry-compatible surfactants 
for shotgun proteomics. Journal of proteome research, 6(7), pp.2529–38. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2570269&tool=pm
centrez&rendertype=abstract [Accessed February 16, 2016]. 
Chevet, E., Hetz, C. & Samali, A., 2015. Endoplasmic reticulum stress-activated 
cell reprogramming in oncogenesis. Cancer discovery, 5(6), pp.586–97. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/25977222 [Accessed 
February 17, 2016]. 
Chiefari, E. et al., 2011. Functional variants of the HMGA1 gene and type 2 
diabetes mellitus. JAMA, 305(9), pp.903–12. Available at: 
http://jama.jamanetwork.com/article.aspx?articleid=645914#ref-joc15012-19 




Choi, H. et al., 2011. SAINT: probabilistic scoring of affinity purification-mass 
spectrometry data. Nature methods, 8(1), pp.70–3. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3064265&tool=pm
centrez&rendertype=abstract [Accessed November 29, 2015]. 
Choi-Rhee, E., Schulman, H. & Cronan, J.E., 2004. Promiscuous protein 
biotinylation by Escherichia coli biotin protein ligase. Protein science : a 
publication of the Protein Society, 13(11), pp.3043–50. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2286582&tool=pm
centrez&rendertype=abstract [Accessed December 1, 2015]. 
Collins, M.A. et al., 2014. MAPK signaling is required for dedifferentiation of acinar 
cells and development of pancreatic intraepithelial neoplasia in mice. 
Gastroenterology. 
Collins, M.A. et al., 2012. Oncogenic Kras is required for both the initiation and 
maintenance of pancreatic cancer in mice. The Journal of clinical investigation, 
122(2), pp.639–53. Available at: http://www.jci.org/articles/view/59227 
[Accessed January 13, 2016]. 
Criddle, D.N. et al., 2007. Calcium signalling and pancreatic cell death: apoptosis 
or necrosis? Cell death and differentiation, 14(7), pp.1285–94. Available at: 
http://dx.doi.org/10.1038/sj.cdd.4402150 [Accessed April 3, 2016]. 
Criscimanna, A. et al., 2011. Duct cells contribute to regeneration of endocrine and 
acinar cells following pancreatic damage in adult mice. Gastroenterology. 
Cronan, J.E., 1990. Biotination of proteins in vivo. A post-translational modification 
to label, purify, and study proteins. The Journal of biological chemistry, 
265(18), pp.10327–33. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/2113052 [Accessed December 15, 
2015]. 
Davies, M.G. & Hagen, P.O., 1997. Systemic inflammatory response syndrome. 
The British journal of surgery, 84(7), pp.920–35. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9240130 [Accessed April 3, 2016]. 
Dawra, R. et al., 2011. Intra-acinar trypsinogen activation mediates early stages of 
pancreatic injury but not inflammation in mice with acute pancreatitis. 
Gastroenterology, 141(6), pp.2210–2217.e2. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3587766&tool=pm





Desai, B.M. et al., 2007. Preexisting pancreatic acinar cells contribute to acinar 
cell, but not islet beta cell, regeneration. The Journal of clinical investigation, 
117(4), pp.971–7. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1838936&tool=pm
centrez&rendertype=abstract [Accessed April 4, 2016]. 
Diehl, A.K. et al., 1997. Gallstone size and risk of pancreatitis. Archives of internal 
medicine, 157(15), pp.1674–8. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9250228 [Accessed April 2, 2016]. 
Direnzo, D. et al., 2012. Induced Mist1 expression promotes remodeling of mouse 
pancreatic acinar cells. Gastroenterology, 143(2), pp.469–80. Available at: 
http://www.gastrojournal.org/article/S0016508512005616/fulltext [Accessed 
January 12, 2016]. 
Domcke, S. et al., 2015. Competition between DNA methylation and transcription 
factors determines binding of NRF1. Nature, 528(7583), pp.575–579. 
Available at: http://dx.doi.org/10.1038/nature16462 [Accessed December 16, 
2015]. 
Driegen, S. et al., 2005. A generic tool for biotinylation of tagged proteins in 
transgenic mice. Transgenic Research, 14(4), pp.477–482. Available at: 
http://link.springer.com/10.1007/s11248-005-7220-2 [Accessed January 13, 
2016]. 
Dutta, S. et al., 1998. Regulatory factor linked to late-onset diabetes? Nature, 
392(6676), p.560. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9560151 
[Accessed March 23, 2016]. 
Fallon, M.B. et al., 1995. Effect of cerulein hyperstimulation on the paracellular 
barrier of rat exocrine pancreas. Gastroenterology, 108(6), pp.1863–1872. 
Available at: http://www.gastrojournal.org/article/0016508595901515/fulltext 
[Accessed March 16, 2016]. 
von Figura, G. et al., 2014. Nr5a2 maintains acinar cell differentiation and 
constrains oncogenic Kras-mediated pancreatic neoplastic initiation. Gut, 
63(4), pp.656–64. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3883808&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Flandez, M. et al., 2013. Nr5a2 heterozygosity sensitises to, and cooperates with, 
inflammation in KRasG12V-driven pancreatic tumourigenesis. Gut, pp.1–9. 





Foti, D. et al., 2003. A nucleoprotein complex containing Sp1, C/EBP beta, and 
HMGI-Y controls human insulin receptor gene transcription. Molecular and 
cellular biology, 23(8), pp.2720–32. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=152545&tool=pmc
entrez&rendertype=abstract [Accessed March 23, 2016]. 
Frossard, J.-L. et al., 1999. The role of intercellular adhesion molecule 1 and 
neutrophils in acute pancreatitis and pancreatitis-associated lung injury. 
Gastroenterology, 116(3), pp.694–701. Available at: 
http://www.gastrojournal.org/article/S0016508599701927/fulltext [Accessed 
April 3, 2016]. 
Furukawa, T., Sunamura, M. & Horii, A., 2006. Molecular mechanisms of 
pancreatic carcinogenesis. Cancer science, 97(1), pp.1–7. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/16367914 [Accessed March 24, 2016]. 
Gannon, M. et al., 2008. pdx-1 function is specifically required in embryonic beta 
cells to generate appropriate numbers of endocrine cell types and maintain 
glucose homeostasis. Developmental biology, 314(2), pp.406–17. Available 
at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2269701&tool=pm
centrez&rendertype=abstract [Accessed March 18, 2016]. 
Gannon, M., Gamer, L.W. & Wright, C. V, 2001. Regulatory regions driving 
developmental and tissue-specific expression of the essential pancreatic gene 
pdx1. Developmental biology, 238(1), pp.185–201. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/11784003 [Accessed March 18, 2016]. 
Garside, V.C. et al., 2010. MIST1 regulates the pancreatic acinar cell expression 
of Atp2c2, the gene encoding secretory pathway calcium ATPase 2. 
Experimental cell research, 316(17), pp.2859–70. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3342848&tool=pm
centrez&rendertype=abstract [Accessed January 20, 2016]. 
Gittes, G.K., 2009. Developmental biology of the pancreas: a comprehensive 
review. Developmental biology, 326(1), pp.4–35. Available at: 
http://www.sciencedirect.com/science/article/pii/S0012160608012785 
[Accessed December 28, 2015]. 
Glimcher, L.H., 2010. XBP1: the last two decades. Annals of the rheumatic 
diseases, 69 Suppl 1, pp.i67–71. Available at: 





Gorelick, F.S., 2003. Alcohol and zymogen activation in the pancreatic acinar cell. 
Pancreas, 27(4), pp.305–310. 
Grady, T. et al., 1998. Zymogen proteolysis within the pancreatic acinar cell is 
associated with cellular injury. American Journal of Physiology, 275(5 Pt 1), 
pp.G1010–G1017. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9815031. 
Green, M., 1990. [5] Avidin and streptavidin. Methods in Enzymology, 184, pp.51–
67. Available at: 
http://linkinghub.elsevier.com/retrieve/pii/007668799084259J. 
Greer, R.L. et al., 2013. Numb regulates acinar cell dedifferentiation and survival 
during pancreatic damage and acinar-to-ductal metaplasia. Gastroenterology. 
Gu, G., Dubauskaite, J. & Melton, D.A., 2002. Direct evidence for the pancreatic 
lineage: NGN3+ cells are islet progenitors and are distinct from duct 
progenitors. Development (Cambridge, England), 129(10), pp.2447–57. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/11973276 [Accessed 
March 18, 2016]. 
Guerra, C. et al., 2011. Article Pancreatitis-Induced Inflammation Contributes to 
Pancreatic Cancer by Inhibiting Oncogene-Induced Senescence. Cancer Cell, 
pp.728–739. 
Guerra, C. et al., 2007. Chronic pancreatitis is essential for induction of pancreatic 
ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer cell, 11(3), 
pp.291–302. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17349585 
[Accessed February 27, 2013]. 
Gukovsky, I. et al., 1998. Early NF-kappaB activation is associated with hormone-
induced pancreatitis. The American journal of physiology, 275(6 Pt 1), 
pp.G1402–14. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9843778 
[Accessed April 3, 2016]. 
Guo, X. et al., 2007. Cloning, expression, and functional characterization of 
zebrafish Mist1. Biochemical and biophysical research communications, 
359(1), pp.20–6. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17531198 
[Accessed March 24, 2016]. 
Guz, Y. et al., 1995. Expression of murine STF-1, a putative insulin gene 
transcription factor, in beta cells of pancreas, duodenal epithelium and 
pancreatic exocrine and endocrine progenitors during ontogeny. Development 
(Cambridge, England), 121(1), pp.11–8. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/7867492 [Accessed March 18, 2016]. 
184 
 
Habbe, N. et al., 2008. Spontaneous induction of murine pancreatic intraepithelial 
neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. 
Proceedings of the National Academy of Sciences, 105(48), pp.18913–18918. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2596215&tool=pm
centrez&rendertype=abstract [Accessed October 7, 2015]. 
Halangk, W. et al., 2000. Role of cathepsin B in intracellular trypsinogen activation 
and the onset of acute pancreatitis. The Journal of clinical investigation, 
106(6), pp.773–81. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=381392&tool=pmc
entrez&rendertype=abstract [Accessed April 3, 2016]. 
Hale, M.A. et al., 2014. The nuclear hormone receptor family member NR5A2 
controls aspects of multipotent progenitor cell formation and acinar 
differentiation during pancreatic organogenesis. Development (Cambridge, 
England), 141(16), pp.3123–33. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4197540&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Han, K. & Manley, J.L., 1993. Functional domains of the Drosophila Engrailed 
protein. The EMBO journal, 12(7), pp.2723–33. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=413523&tool=pmc
entrez&rendertype=abstract [Accessed April 22, 2016]. 
Hani, E.H. et al., 1999. Defective mutations in the insulin promoter factor-1 (IPF-1) 
gene in late-onset type 2 diabetes mellitus. The Journal of clinical investigation, 
104(9), pp.R41–8. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=409821&tool=pmc
entrez&rendertype=abstract [Accessed March 23, 2016]. 
Haumaitre, C. et al., 2005. Lack of TCF2/vHNF1 in mice leads to pancreas 
agenesis. Proceedings of the National Academy of Sciences of the United 
States of America, 102(5), pp.1490–5. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=547822&tool=pmc
entrez&rendertype=abstract [Accessed March 20, 2016]. 
Hayashi, K. et al., 1999. Regional differences in the cellular proliferation activity of 
the regenerating rat pancreas after partial pancreatectomy. Archives of 
histology and cytology, 62(4), pp.337–46. Available at: 





Hazem, Z.M., 2009. Acute biliary pancreatitis: diagnosis and treatment. Saudi 
journal of gastroenterology : official journal of the Saudi Gastroenterology 
Association, 15(3), pp.147–55. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2841412&tool=pm
centrez&rendertype=abstract [Accessed February 26, 2016]. 
Hess et al., 2011. Extensive pancreas regeneration following acinar-specific 
disruption of Xbp1 in mice. Gastroenterology, 141(4), pp.1463–72. Available 
at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3186847&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Hess, S., 2013. Sample Preparation Guide for Mass Spectrometry–Based 
Proteomics. Spectroscopy. Available at: 
http://authors.library.caltech.edu/41345/ [Accessed February 18, 2016]. 
Hewes, R.S. et al., 2006. Regulation of secretory protein expression in mature cells 
by DIMM, a basic helix-loop-helix neuroendocrine differentiation factor. The 
Journal of neuroscience : the official journal of the Society for Neuroscience, 
26(30), pp.7860–9. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/16870731 [Accessed February 20, 
2016]. 
Hewes, R.S. et al., 2003. The bHLH protein Dimmed controls neuroendocrine cell 
differentiation in Drosophila. Development (Cambridge, England), 130(9), 
pp.1771–81. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12642483 
[Accessed March 24, 2016]. 
Hingorani, S.R. et al., 2003. Preinvasive and invasive ductal pancreatic cancer and 
its early detection in the mouse. Cancer cell, 4(6), pp.437–50. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/14706336. 
Hirschhorn, J.N., 2003. Genetic epidemiology of type 1 diabetes. Pediatric 
diabetes, 4(2), pp.87–100. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/14655265 [Accessed March 22, 2016]. 
Holmstrom, S.R. et al., 2011. LRH-1 and PTF1-L coregulate an exocrine pancreas-
specific transcriptional network for digestive function. Genes & development, 
25(16), pp.1674–9. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3165932&tool=pm





Houbracken, I. et al., 2011. Lineage Tracing Evidence for Transdifferentiation of 
Acinar to Duct Cells and Plasticity of Human Pancreas. Gastroenterology. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/21703267 [Accessed July 
21, 2011]. 
Huang, C. & Jacobson, K., 2010. Detection of protein-protein interactions using 
nonimmune IgG and BirA-mediated biotinylation. BioTechniques, 49(6), 
pp.881–6. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4441393&tool=pm
centrez&rendertype=abstract [Accessed January 13, 2016]. 
Huang, H. et al., 2013. Activation of nuclear factor-κB in acinar cells increases the 
severity of pancreatitis in mice. Gastroenterology, 144(1), pp.202–10. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3769090&tool=pm
centrez&rendertype=abstract [Accessed April 3, 2016]. 
Huang, H. et al., 2013. Oncogenic K-Ras requires activation for enhanced activity. 
Oncogene, (November 2012), pp.1–4. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/23334325 [Accessed March 25, 2013]. 
Huh, W.J. et al., 2010. XBP1 controls maturation of gastric zymogenic cells by 
induction of MIST1 and expansion of the rough endoplasmic reticulum. 
Gastroenterology, 139(6), pp.2038–49. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2997137&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Husain, S.Z. et al., 2007. Caerulein-induced intracellular pancreatic zymogen 
activation is dependent on calcineurin. American journal of physiology. 
Gastrointestinal and liver physiology, 292(6), pp.G1594–9. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/17332472 [Accessed April 3, 2016]. 
Jackson, E.L. et al., 2001. Analysis of lung tumor initiation and progression using 
conditional expression of oncogenic K-ras. Genes & development, 15(24), 
pp.3243–8. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=312845&tool=pmc
entrez&rendertype=abstract [Accessed January 19, 2016]. 
Jacquemin, P., Lemaigre, F.P. & Rousseau, G.G., 2003. The Onecut transcription 
factor HNF-6 (OC-1) is required for timely specification of the pancreas and 
acts upstream of Pdx-1 in the specification cascade. Developmental biology, 
258(1), pp.105–16. Available at: 




Jarvik, J.W. & Telmer, C.A., 1998. Epitope tagging. Annual review of genetics, 32, 
pp.601–18. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9928493 
[Accessed January 13, 2016]. 
Jemal, A. et al., 2011. Global cancer statistics. CA: a cancer journal for clinicians, 
61(2), pp.69–90. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21296855 
[Accessed July 12, 2014]. 
Jensen, J.N. et al., 2005. Recapitulation of elements of embryonic development in 
adult mouse pancreatic regeneration. Gastroenterology. 
Ji, B. et al., 2009. Ras activity levels control the development of pancreatic 
diseases. Gastroenterology, 137(3), pp.1072–82, 1082.e1–6. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2789008&tool=pm
centrez&rendertype=abstract. 
Jia, D., 2008. Deciphering the bHLH transcription factor Mist1: Dual roles in 
pancreas development. Theses and Dissertations Available from ProQuest, 
pp.1 – 188. Available at: http://docs.lib.purdue.edu/dissertations/AAI3418662 
[Accessed January 12, 2016]. 
Jia, D., Sun, Y. & Konieczny, S.F., 2008. Mist1 regulates pancreatic acinar cell 
proliferation through p21 CIP1/WAF1. Gastroenterology, 135(5), pp.1687–97. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2853247&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Johnson et al., 2004. Mist1 is necessary for the establishment of granule 
organization in serous exocrine cells of the gastrointestinal tract. Mechanisms 
of development, 121(3), pp.261–72. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/15003629 [Accessed January 20, 2016]. 
Johnson, C.L. et al., 2014. Silencing of the Fibroblast Growth Factor 21 gene is an 
underlying cause of acinar cell 3 injury in mice lacking MIST1. Am J Physiol 
Endocrinol Metab. 
Jr, Z.R. et al., 2008. The role of NF-kB activation in the pathogenesis of acute 
pancreatitis. , pp.259–267. 
Kanda, M. et al., 2012. Presence of Somatic Mutations in Most Early-Stage 
Pancreatic Intraepithelial Neoplasia. Gastroenterology, 142(4), pp.730–
733.e9. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3321090&tool=pm




Karemaker, I.D. & Vermeulen, M., 2016. In need of good neighbours : transcription 
factors require local DNA hypomethylation for target binding. EMBO Journal, 
35(4), pp.1–2. 
Karki, A. et al., 2015. Silencing Mist1 Gene Expression Is Essential for Recovery 
from Acute Pancreatitis. PloS one, 10(12), p.e0145724. Available at: 
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0145724#ref
erences [Accessed January 12, 2016]. 
Katayama, H., Nagasu, T. & Oda, Y., 2001. Improvement of in-gel digestion 
protocol for peptide mass fingerprinting by matrix-assisted laser 
desorption/ionization time-of-flight mass spectrometry. Rapid 
communications in mass spectrometry : RCM, 15(16), pp.1416–21. Available 
at: http://www.ncbi.nlm.nih.gov/pubmed/11507753 [Accessed February 16, 
2016]. 
Kawaguchi, Y. et al., 2002. The role of the transcriptional regulator Ptf1a in 
converting intestinal to pancreatic progenitors. Nature genetics, 32(1), 
pp.128–34. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12185368 
[Accessed January 22, 2016]. 
Kern, H.F., 1993. Fine Structure of the Human Exocrine Pancreas. The Pancreas: 
Biology, OPathobiology and Disease, pp.9–19. 
Kim et al., 2015. The basic helix-loop-helix transcription factor E47 reprograms 
human pancreatic cancer cells to a quiescent acinar state with reduced 
tumorigenic potential. Pancreas, 44(5), pp.718–27. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4464938&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Kim, J. et al., 2009. Use of in vivo biotinylation to study protein-protein and protein-
DNA interactions in mouse embryonic stem cells. Nature protocols, 4(4), 
pp.506–17. Available at: http://dx.doi.org/10.1038/nprot.2009.23 [Accessed 
January 13, 2016]. 
Kim, J.Y. et al., 2002. Transporter-mediated bile acid uptake causes Ca2+-
dependent cell death in rat pancreatic acinar cells. Gastroenterology, 122(7), 
pp.1941–53. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12055600 
[Accessed April 3, 2016]. 
Kopp, J.L. et al., 2012. Identification of Sox9-dependent acinar-to-ductal 
reprogramming as the principal mechanism for initiation of pancreatic ductal 
adenocarcinoma. Cancer cell, 22(6), pp.737–50. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3568632&tool=pm
centrez&rendertype=abstract [Accessed January 19, 2016]. 
189 
 
Kopp, J.L. et al., 2011. Sox9+ ductal cells are multipotent progenitors throughout 
development but do not produce new endocrine cells in the normal or injured 
adult pancreas. Development (Cambridge, England), 138(4), pp.653–65. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3026412&tool=pm
centrez&rendertype=abstract [Accessed March 20, 2016]. 
Kopp, J.L. & Sander, M., 2014. New insights into the cell lineage of pancreatic 
ductal adenocarcinoma: evidence for tumor stem cells in premalignant lesions? 
Gastroenterology, 146(1), pp.24–6. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/24275238. 
Kowalik, A.S. et al., 2011. Mice lacking the transcription factor Mist1 exhibit an 
altered stress response and increased sensitivity to caerulein-induced 
pancreatitis. American Journal Of Physiology, (December 2006). 
Kowalik, A.S. et al., 2007. Mice lacking the transcription factor Mist1 exhibit an 
altered stress response and increased sensitivity to caerulein-induced 
pancreatitis. American journal of physiology Gastrointestinal and liver 
physiology, 292(4), pp.G1123–G1132. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/17170023. 
Krah, N. et al., 2015. The acinar differentiation determinant PTF1A inhibits initiation 
of pancreatic ductal adenocarcinoma. eLife, 4, p.e07125. Available at: 
http://elifesciences.org/content/4/e07125v2 [Accessed February 17, 2016]. 
Krapp, A. et al., 1998. The bHLH protein PTF1-p48 is essential for the formation 
of the exocrine and the correct spatial organization of the endocrine pancreas. 
Genes & development, 12(23), pp.3752–63. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=317250&tool=pmc
entrez&rendertype=abstract [Accessed January 22, 2016]. 
Krapp, A. et al., 1996. The p48 DNA-binding subunit of transcription factor PTF1 
is a new exocrine pancreas-specific basic helix-loop-helix protein. The EMBO 
journal, 15(16), pp.4317–29. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=452157&tool=pmc
entrez&rendertype=abstract [Accessed February 11, 2016]. 
Krepela, E. et al., 1990. Increased cathepsin B activity in human lung tumors. 
Neoplasma, 37(1), pp.61–70. Available at: 





De La O, J.-P. et al., 2008. Notch and Kras reprogram pancreatic acinar cells to 
ductal intraepithelial neoplasia. Proceedings of the National Academy of 
Sciences of the United States of America, 105(48), pp.18907–12. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2585942&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Lemercier, C. et al., 1997. Mist1: a novel basic helix-loop-helix transcription factor 
exhibits a developmentally regulated expression pattern. Developmental 
Biology, 182(1), pp.101–113. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9073453. 
Lemercier, C. et al., 1998. The basic helix-loop-helix transcription factor Mist1 
functions as a transcriptional repressor of myoD. The EMBO journal, 17(5), 
pp.1412–22. Available at: 
http://emboj.embopress.org/content/17/5/1412.abstract [Accessed January 
12, 2016]. 
Lemercier, C. et al., 2000. The rat Mist1 gene: structure and promoter 
characterization. Gene, 242(1-2), pp.209–218. Available at: 
http://www.sciencedirect.com/science/article/pii/S0378111999005235 
[Accessed March 24, 2016]. 
Lennerz, J.K.M. et al., 2010. The transcription factor MIST1 is a novel human 
gastric chief cell marker whose expression is lost in metaplasia, dysplasia, 
and carcinoma. The American journal of pathology, 177(3), pp.1514–33. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2928982&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Leppä, S. et al., 1996. Syndecan-1 expression in mammary epithelial tumor cells 
is E-cadherin-dependent. Journal of cell science, 109 ( Pt 6, pp.1393–403. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/8799827 [Accessed 
February 12, 2016]. 
Lerch, M.M. & Gorelick, F.S., 2013. Models of acute and chronic pancreatitis. 
Gastroenterology, 144(6), pp.1180–93. Available at: 
http://www.gastrojournal.org/article/S0016508513001984/fulltext [Accessed 
November 29, 2015]. 






Lioubinski, O. et al., 2003. Expression of Sox transcription factors in the developing 
mouse pancreas. Developmental dynamics : an official publication of the 
American Association of Anatomists, 227(3), pp.402–8. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12815626 [Accessed March 20, 2016]. 
Lowenfels, A.B. et al., 1993. Pancreatitis and the risk of pancreatic cancer. 
International Pancreatitis Study Group. The New England journal of medicine, 
328(20), pp.1433–7. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/8479461 [Accessed February 17, 2016]. 
Lund, H. et al., 2006. Long-term recurrence and death rates after acute pancreatitis. 
Scandinavian journal of gastroenterology, 41(2), pp.234–8. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/16484129 [Accessed April 2, 2016]. 
Luo, X. et al., 2005. Aberrant localization of intracellular organelles, Ca2+ signaling, 
and exocytosis in Mist1 null mice. The Journal of biological chemistry, 280(13), 
pp.12668–75. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15665001 
[Accessed February 17, 2016]. 
MacDonald, R.J., Swift, G.H. & Real, F.X., 2010. Transcriptional control of acinar 
development and homeostasis., Elsevier Inc. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/21074728 [Accessed April 24, 2013]. 
MacFarlane, W.M. et al., 1994. Glucose modulates the binding activity of the beta-
cell transcription factor IUF1 in a phosphorylation-dependent manner. The 
Biochemical journal, 303 ( Pt 2, pp.625–31. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1137373&tool=pm
centrez&rendertype=abstract [Accessed February 11, 2016]. 
di Magliano, M.P. & Logsdon, C.D., 2013. Roles for KRAS in pancreatic tumor 
development and progression. Gastroenterology, 144(6), pp.1220–9. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3902845&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Malka, D. et al., 2002. Risk of pancreatic adenocarcinoma in chronic pancreatitis. 
Gut, 51(6), pp.849–52. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1773474&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Martinelli, P. et al., 2015. The acinar regulator Gata6 suppresses KrasG12V-driven 





Masui, T. et al., 2007. Early pancreatic development requires the vertebrate 
Suppressor of Hairless (RBPJ) in the PTF1 bHLH complex. Genes & 
development, 21(20), pp.2629–43. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2000326&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Masui, T. et al., 2010. Replacement of Rbpj with Rbpjl in the PTF1 complex 
controls the final maturation of pancreatic acinar cells. Gastroenterology, 
139(1), pp.270–80. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2902682&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Matull, W.R., Pereira, S.P. & O’Donohue, J.W., 2006. Biochemical markers of 
acute pancreatitis. Journal of clinical pathology, 59(4), pp.340–4. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1860356&tool=pm
centrez&rendertype=abstract [Accessed April 3, 2016]. 
Mayerle, J., Sendler, M. & Lerch, M., 2013. Secretagogue ( Caerulein ) induced 
pancreatitis in rodents. The Pancreapedia, pp.1–9. 
McNiven, M.A. & Marlowe, K.J., 1999. Contributions of molecular motor enzymes 
to vesicle-based protein transport in gastrointestinal epithelial cells. 
Gastroenterology, 116(2), pp.438–451. Available at: 
http://www.sciencedirect.com/science/article/pii/S0016508599701423 
[Accessed February 9, 2016]. 
Means, A.L. & Leach, S.D., 2001. Lineage commitment and cellular differentiation 
in exocrine pancreas. Pancreatology : official journal of the International 
Association of Pancreatology (IAP) ... [et al.], 1(6), pp.587–96. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12120241 [Accessed March 18, 2016]. 
Mehmood, R. et al., 2014. Epigenetic reprogramming in Mist1-/- mice predicts the 
molecular response to cerulein-induced pancreatitis. PLoS ONE. 
Mills, J.C. & Taghert, P.H., 2012. Scaling factors: transcription factors regulating 
subcellular domains. BioEssays : news and reviews in molecular, cellular and 
developmental biology, 34(1), pp.10–6. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3692000&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Molero, X. et al., 2012. Gene expression dynamics after murine pancreatitis 
unveils novel roles for Hnf1α in acinar cell homeostasis. Gut, 61(8), pp.1187–
96. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21948943 [Accessed 




Moore, A., Bonner-Weir, S. & Weissleder, R., 2001. Noninvasive In Vivo 
Measurement of  -Cell Mass in Mouse Model of Diabetes. Diabetes, 50(10), 
pp.2231–2236. Available at: 
http://diabetes.diabetesjournals.org/content/50/10/2231.full [Accessed March 
22, 2016]. 
Moore, A.W. et al., 2000. A genomewide survey of basic helix-loop-helix factors in 
Drosophila. Proceedings of the National Academy of Sciences of the United 
States of America, 97(19), pp.10436–41. Available at: 
http://www.pnas.org/content/97/19/10436 [Accessed March 24, 2016]. 
Morris, J.P., Wang, S.C. & Hebrok, M., 2010. KRAS, Hedgehog, Wnt and the 
twisted developmental biology of pancreatic ductal adenocarcinoma. Nature 
reviews. Cancer, 10(10), pp.683–95. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4085546&tool=pm
centrez&rendertype=abstract [Accessed December 23, 2015]. 
Motta, P.M. et al., 1997. Histology of the exocrine pancreas. Microscopy Research 
and Technique, 37(5-6), pp.384–398. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9220418. 
Murtaugh, L.C., 2014. Pathogenesis of pancreatic cancer: lessons from animal 
models. Toxicologic pathology, 42(1), pp.217–28. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/24178582. 
Murtaugh, L.C. & Keefe, M.D., 2014. Regeneration and Repair of the Exocrine 
Pancreas. Annual review of physiology, (October), pp.1–21. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/25386992. 
Murtaugh, L.C. & Melton, D.A., 2003. Genes, signals, and lineages in pancreas 
development. Annual review of cell and developmental biology, 19, pp.71–89. 
Available at: 
http://www.annualreviews.org/doi/pdf/10.1146/annurev.cellbio.19.111301.14
4752 [Accessed March 15, 2016]. 
Nam, K.T. et al., 2010. Mature chief cells are cryptic progenitors for metaplasia in 
the stomach. Gastroenterology, 139(6), pp.2028–2037.e9. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2997152&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Nozaki, K. et al., 2008. A molecular signature of gastric metaplasia arising in 
response to acute parietal cell loss. Gastroenterology, 134(2), pp.511–22. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2857727&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
194 
 
Oliver-Krasinski, J.M. et al., 2009. The diabetes gene Pdx1 regulates the 
transcriptional network of pancreatic endocrine progenitor cells in mice. The 
Journal of clinical investigation, 119(7), pp.1888–98. Available at: 
https://www.jci.org/articles/view/37028#B30 [Accessed March 23, 2016]. 
Pandol, S.J. et al., 2007. Acute pancreatitis: bench to the bedside. 
Gastroenterology, 132(3), pp.1127–51. Available at: 
http://www.gastrojournal.org/article/S0016508507003095/fulltext [Accessed 
April 3, 2016]. 
Pandol, S.J., 2010. Anatomy. Available at: 
http://www.ncbi.nlm.nih.gov/books/NBK54134/ [Accessed March 16, 2016]. 
Pandol, S.J., Gorelick, F.S. & Lugea, A., 2011. Environmental and genetic 
stressors and the unfolded protein response in exocrine pancreatic function - 
a hypothesis. Frontiers in physiology, 2, p.8. Available at: 
http://journal.frontiersin.org/article/10.3389/fphys.2011.00008/abstract 
[Accessed March 21, 2016]. 
Park, D. & Taghert, P.H., 2009. Peptidergic neurosecretory cells in insects: 
organization and control by the bHLH protein DIMMED. General and 
comparative endocrinology, 162(1), pp.2–7. Available at: 
http://www.sciencedirect.com/science/article/pii/S0016648008004541 
[Accessed March 24, 2016]. 
Pasca di Magliano, M. et al., 2013. Advances in acute and chronic pancreatitis: 
from development to inflammation and repair. Gastroenterology, 144(1), 
pp.e1–4. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4096699&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Peery, A.F. et al., 2012. Burden of gastrointestinal disease in the United States: 
2012 update. Gastroenterology, 143(5), pp.1179–87.e1–3. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3480553&tool=pm
centrez&rendertype=abstract [Accessed December 4, 2015]. 
Pictet, R.L. et al., 1972. An ultrastructural analysis of the developing embryonic 
pancreas. Developmental Biology, 29(4), pp.436–467. Available at: 
http://www.sciencedirect.com/science/article/pii/0012160672900838 
[Accessed February 10, 2016]. 
Pierreux, C.E. et al., 2006. The transcription factor hepatocyte nuclear factor-6 
controls the development of pancreatic ducts in the mouse. Gastroenterology, 
130(2), pp.532–41. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/16472605 [Accessed March 20, 2016]. 
195 
 
Pin et al., 2001. The bHLH transcription factor Mist1 is required to maintain 
exocrine pancreas cell organization and acinar cell identity. The Journal of cell 
biology, 155(4), pp.519–530. Available at: 
http://www.mendeley.com/catalog/bhlh-transcription-factor-mist1-required-
maintain-exocrine-pancreas-cell-organization-acinar-cell-id/ [Accessed 
February 16, 2016]. 
Pin, Bonvissuto, A.C. & Konieczny, S.F., 2000. Mist1 expression is a common link 
among serous exocrine cells exhibiting regulated exocytosis. The Anatomical 
record, 259(2), pp.157–67. Available at: 
http://www.mendeley.com/research/mist1-expression-common-link-among-
serous-exocrine-cells-exhibiting-regulated-exocytosis/ [Accessed February 
16, 2016]. 
Pin, C.L., Lemercier, C. & Konieczny, S.F., 1999. Cloning of the murine Mist1 gene 
and assignment to mouse chromosome band 5G2-5G3. Cytogenetics and cell 
genetics, 86(3-4), pp.219–22. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/10575209 [Accessed January 26, 2016]. 
Pin, C.L., Ryan, J.F. & Mehmood, R., 2015. Acinar cell reprogramming: a clinically 
important target in pancreatic disease. Epigenomics, 7(2), pp.267–81. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/25942535 [Accessed 
February 17, 2016]. 
Pinho, A. V et al., 2011. Adult pancreatic acinar cells dedifferentiate to an 
embryonic progenitor phenotype with concomitant activation of a senescence 
programme that is present in chronic pancreatitis. Gut, 60(7), pp.958–66. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/21193456 [Accessed June 
29, 2011]. 
Pinho, A. V., Chantrill, L. & Rooman, I., 2014. Chronic pancreatitis: A path to 
pancreatic cancer. Cancer Letters. 
Poll, A. V et al., 2006. A vHNF1/TCF2-HNF6 cascade regulates the transcription 
factor network that controls generation of pancreatic precursor cells. Diabetes, 
55(1), pp.61–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16380477 
[Accessed March 20, 2016]. 
Pour, P.M., 1994. Pancreatic centroacinar cells. The regulator of both exocrine and 
endocrine function. International journal of pancreatology : official journal of 
the International Association of Pancreatology, 15(1), pp.51–64. Available at: 





Prévot, P.P. et al., 2013. Let-7b and miR-495 stimulate differentiation and prevent 
metaplasia of pancreatic acinar cells by repressing HNF6. Gastroenterology. 
Prévot, P.-P. et al., 2012. Role of the ductal transcription factors HNF6 and Sox9 
in pancreatic acinar-to-ductal metaplasia. Gut, 61(12), pp.1723–32. Available 
at: http://www.ncbi.nlm.nih.gov/pubmed/22271799 [Accessed April 20, 2013]. 
Puri, S. & Hebrok, M., 2010. Cellular plasticity within the pancreas--lessons 
learned from development. Developmental cell, 18(3), pp.342–56. Available 
at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4085547&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Ramsby, M. & Makowski, G., 2011. Differential detergent fractionation of 
eukaryotic cells. Cold Spring Harbor protocols, 2011(3), p.prot5592. Available 
at: http://cshprotocols.cshlp.org/content/2011/3/prot5592.abstract [Accessed 
February 16, 2016]. 
Ramsey, V.G. et al., 2007. The maturation of mucus-secreting gastric epithelial 
progenitors into digestive-enzyme secreting zymogenic cells requires Mist1. 
Development (Cambridge, England), 134(1), pp.211–22. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/17164426 [Accessed January 20, 2016]. 
Rausa, F. et al., 1997. The cut-homeodomain transcriptional activator HNF-6 is 
coexpressed with its target gene HNF-3 beta in the developing murine liver 
and pancreas. Developmental biology, 192(2), pp.228–46. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9441664 [Accessed March 20, 2016]. 
Reichert, M. & Rustgi, A.K., 2011. Pancreatic ductal cells in development, 
regeneration, and neoplasia. Journal of Clinical Investigation, 121(12), 
pp.4572–8. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3225990&tool=pm
centrez&rendertype=abstract. 
Rempel, S.A. et al., 1994. Cathepsin B expression and localization in glioma 
progression and invasion. Cancer research, 54(23), pp.6027–31. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/7954439 [Accessed February 12, 2016]. 
Rigaut, G. et al., 1999. A generic protein purification method for protein complex 
characterization and proteome exploration. Nature biotechnology, 17(10), 
pp.1030–2. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10504710 





Rodolosse, A. et al., 2004. PTF1alpha/p48 transcription factor couples proliferation 
and differentiation in the exocrine pancreas [corrected]. Gastroenterology, 
127(3), pp.937–49. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/15362048 [Accessed February 17, 
2016]. 
Rooman, I. & Real, F.X., 2012. Pancreatic ductal adenocarcinoma and acinar cells: 
a matter of differentiation and development? Gut, 61(3), pp.449–58. Available 
at: http://www.ncbi.nlm.nih.gov/pubmed/21730103 [Accessed March 17, 
2016]. 
Rose, S.D. et al., 2001. The role of PTF1-P48 in pancreatic acinar gene expression. 
The Journal of biological chemistry, 276(47), pp.44018–26. Available at: 
http://www.jbc.org/content/276/47/44018.abstract [Accessed March 18, 2016]. 
Rovira, M. et al., 2010. Isolation and characterization of centroacinar/terminal 
ductal progenitor cells in adult mouse pancreas. Proceedings of the National 
Academy of Sciences of the United States of America, 107(1), pp.75–80. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2806716&tool=pm
centrez&rendertype=abstract [Accessed March 18, 2016]. 
Rukstalis, J.M. et al., 2003. Exocrine specific expression of Connexin32 is 
dependent on the basic helix-loop-helix transcription factor Mist1. Journal of 
Cell Science, 116(Pt 16), pp.3315–3325. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/12829745. 
Ryan, D., Hong, T. & Bardeesy, N., 2014. Pancreatic adenocarcinoma. New 
England Journal of Medicine, 371(11), pp.1039–49. 
Saluja, A.K. et al., 1999. Secretagogue-induced digestive enzyme activation and 
cell injury in rat pancreatic acini. Am J Physiol Gastrointest Liver Physiol, 
276(4), pp.G835–842. Available at: 
http://ajpgi.physiology.org/content/276/4/G835.long [Accessed April 3, 2016]. 
Schröder, M. & Kaufman, R.J., 2005. ER stress and the unfolded protein response. 
Mutation research, 569(1-2), pp.29–63. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/15603751 [Accessed November 18, 
2015]. 
Schröder, M. & Kaufman, R.J., 2005. THE MAMMALIAN UNFOLDED PROTEIN 
RESPONSE. Annual Review of Biochemistry, 74(1), pp.739–789. Available at: 




Sendler, M. et al., 2012. Tumour necrosis factor   secretion induces protease 
activation and acinar cell necrosis in acute experimental pancreatitis in mice. 
Gut. 
Seymour, P.A. et al., 2007. SOX9 is required for maintenance of the pancreatic 
progenitor cell pool. Proceedings of the National Academy of Sciences of the 
United States of America, 104(6), pp.1865–70. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1794281&tool=pm
centrez&rendertype=abstract [Accessed March 18, 2016]. 
Seymour, P.A., 2014. Sox9: a master regulator of the pancreatic program. The 
review of diabetic studies : RDS, 11(1), pp.51–83. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4295800&tool=pm
centrez&rendertype=abstract [Accessed March 20, 2016]. 
Shi, G. et al., 2009. Loss of the Acinar-Restricted Transcription Factor Mist1 
Accelerates Kras-Induced Pancreatic Intraepithelial Neoplasia. 
Gastroenterology, 136(4), pp.1368–1378. Available at: 
http://www.gastrojournal.org/article/S0016508509000043/fulltext [Accessed 
January 12, 2016]. 
Shi, G. et al., 2012. Maintenance of acinar cell organization is critical to preventing 
Kras-induced acinar-ductal metaplasia. Oncogene, (September 2011), pp.1–
9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22665051. 
Shi, G. et al., 2013. Maintenance of acinar cell organization is critical to preventing 
Kras-induced acinar-ductal metaplasia. Oncogene, 32(15), pp.1950–8. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3435479&tool=pm
centrez&rendertype=abstract [Accessed February 17, 2016]. 
Siveke, J.T. et al., 2008. Notch Signaling Is Required for Exocrine Regeneration 
After Acute Pancreatitis. Gastroenterology. 
Slack, J.M., 1995. Developmental biology of the pancreas. Development 
(Cambridge, England), 121(6), pp.1569–80. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/7600975. 
Solar, M. et al., 2009. Pancreatic exocrine duct cells give rise to insulin-producing 
beta cells during embryogenesis but not after birth. Developmental cell, 17(6), 
pp.849–60. Available at: 
http://www.cell.com/article/S1534580709004778/fulltext [Accessed March 20, 
2016]. 
Stanger, B.Z. & Hebrok, M., 2013. Control of cell identity in pancreas development 
and regeneration. Gastroenterology. 
199 
 
Stefan, Y. et al., 1982. Quantitation of endocrine cell content in the pancreas of 
nondiabetic and diabetic humans. Diabetes, 31(8 Pt 1), pp.694–700. Available 
at: http://www.ncbi.nlm.nih.gov/pubmed/6131002 [Accessed February 9, 
2016]. 
Stevenson, K. & Carter, C.R., 2013. Acute pancreatitis. Surgery (Oxford), 31(6), 
pp.295–303. Available at: 
http://www.sciencedirect.com/science/article/pii/S0263931913000835 
[Accessed April 2, 2016]. 
Steward, M.C., Ishiguro, H. & Case, R.M., 2005. Mechanisms of bicarbonate 
secretion in the pancreatic duct. Annual review of physiology, 67, pp.377–409. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/15709963 [Accessed 
March 16, 2016]. 
Streaker, E.D. & Beckett, D., 2006. Nonenzymatic biotinylation of a biotin carboxyl 
carrier protein: unusual reactivity of the physiological target lysine. Protein 
science : a publication of the Protein Society, 15(8), pp.1928–35. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2242587&tool=pm
centrez&rendertype=abstract [Accessed December 1, 2015]. 
Strobel, O. et al., 2007. In vivo lineage tracing defines the role of acinar-to-ductal 
transdifferentiation in inflammatory ductal metaplasia. Gastroenterology, 
133(6), pp.1999–2009. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2254582&tool=pm
centrez&rendertype=abstract. 
Su, K.H., Cuthbertson, C. & Christophi, C., 2006. Review of experimental animal 
models of acute pancreatitis. HPB : the official journal of the International 
Hepato Pancreato Biliary Association. 
Teng, Y.H.-F., Aquino, R.S. & Park, P.W., 2012. Molecular functions of syndecan-
1 in disease. Matrix biology : journal of the International Society for Matrix 
Biology, 31(1), pp.3–16. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3568394&tool=pm
centrez&rendertype=abstract [Accessed February 12, 2016]. 
Tian, X. et al., 2010. RAB26 and RAB3D are direct transcriptional targets of MIST1 
that regulate exocrine granule maturation. Molecular and cellular biology, 
30(5), pp.1269–84. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2820885&tool=pm





Tran, T. et al., 2007. The bHLH domain of Mistl is sufficient to activate gene 
transcription. Gene expression, 13(4-5), pp.241–53. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/17605298. 
Türkvatan, A. et al., 2013. Congenital variants and anomalies of the pancreas and 
pancreatic duct: imaging by magnetic resonance cholangiopancreaticography 
and multidetector computed tomography. Korean journal of radiology, 14(6), 
pp.905–13. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3835637&tool=pm
centrez&rendertype=abstract [Accessed March 20, 2016]. 
Tyanova, S. et al., 2015. Visualization of LC-MS/MS proteomics data in MaxQuant. 
Proteomics, 15(8), pp.1453–6. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/25644178 [Accessed October 12, 2015]. 
Vitale, G.C., 2007. Early management of acute gallstone pancreatitis. Annals of 
surgery, 245(1), pp.18–9. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1867941&tool=pm
centrez&rendertype=abstract [Accessed April 2, 2016]. 
Wang, G.-J. et al., 2009. Acute pancreatitis: etiology and common pathogenesis. 
World journal of gastroenterology, 15(12), pp.1427–30. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2665136&tool=pm
centrez&rendertype=abstract [Accessed March 11, 2016]. 
Wang, N. et al., 2004. Expression of an engrailed-LMO4 fusion protein in 
mammary epithelial cells inhibits mammary gland development in mice. 
Oncogene, 23, pp.1507–1513. 
Ward, J. et al., 1996. Progressive disruption of acinar cell calcium signaling is an 
early feature of cerulein-induced pancreatitis in mice. Gastroenterology, 
111(2), pp.481–491. Available at: 
http://www.sciencedirect.com/science/article/pii/S0016508596003691 
[Accessed April 3, 2016]. 
Willemer, S., Elsässer, H.P. & Adler, G., 1992. Hormone-induced pancreatitis. 
European surgical research. Europäische chirurgische Forschung. 
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